var title_f9_47_9968="Cholangiocarcinoma MRCP";
var content_f9_47_9968=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Distal cholangiocarcinoma as seen on MRCP",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 249px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This magnetic resonance cholangiopancreatography (MRCP) image, obtained without having to opacify the bile ducts, demonstrates a circumferential narrowing of the distal common bile duct (CBD, arrow) due to a focal distal cholangiocarcinoma. The obstructing tumor is causing dilation of the CBD.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9968=[""].join("\n");
var outline_f9_47_9968=null;
var title_f9_47_9969="Scabies infant trunk";
var content_f9_47_9969=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F52588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F52588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scabies, infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The rash of scabies may be more diffuse in infants, spreading to the trunk and scalp in addition to the extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher, GR, Ludwig, S, Baskin, MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy;2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9969=[""].join("\n");
var outline_f9_47_9969=null;
var title_f9_47_9970="Patient information: How to use your dry powder inhaler (adults) (The Basics)";
var content_f9_47_9970=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16114\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/19/306\">",
"         Dry powder inhalers",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?4/11/4275\">",
"         Patient information: Asthma in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/34/41506\">",
"         Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/43/30386\">",
"         Patient information: Inhalers (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/22/30052\">",
"         Patient information: Medicines for asthma (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?28/25/29075\">",
"         Patient information: Asthma inhaler techniques in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/63/39925\">",
"         Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: How to use your dry powder inhaler (adults) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/how-to-use-your-dry-powder-inhaler-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H16518135\">",
"      <span class=\"h1\">",
"       Are there different types of dry powder inhalers?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. There are 2 main types of dry powder inhalers (",
"      <a class=\"graphic graphic_picture graphicRef67084 \" href=\"UTD.htm?0/19/306\">",
"       picture 1",
"      </a>",
"      ):",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Single-dose inhalers",
"       </li>",
"       <li>",
"        Multiple-dose inhalers",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      The directions for the 2 types of dry powder inhalers are slightly different.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16518142\">",
"      <span class=\"h1\">",
"       How do I use my dry powder inhaler?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Each dry powder inhaler has its own directions. Your doctor or nurse will show you how to use your inhaler. &nbsp;",
"     </p>",
"     <p>",
"      In general, these are the steps for using a dry powder inhaler:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Open the inhaler or take off the cover",
"       </li>",
"       <li>",
"        Load a dose of medicine:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        For single-dose inhalers, you load a dose by taking a pill out of its packaging and putting the pill into the inhaler. Then you need to push 1 or more buttons on the inhaler to poke holes in the pill.",
"       </li>",
"       <li>",
"        For multiple-dose inhalers, you load a dose by sliding a lever or twisting the bottom (or another part) of the inhaler.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Hold your inhaler in the correct position &mdash; Some inhalers need to be held upright, but others need to be horizontal. Multiple-dose inhalers usually need to be horizontal.",
"       </li>",
"       <li>",
"        Breathe out normally&mdash;but",
"        <strong>",
"         not",
"        </strong>",
"        into the inhaler",
"       </li>",
"       <li>",
"        Put your mouth on the mouthpiece",
"       </li>",
"       <li>",
"        Breathe in quickly and steadily, and as deeply as possible",
"       </li>",
"       <li>",
"        Remove your mouth from the mouthpiece and hold your breath for 5 to 10 seconds",
"       </li>",
"       <li>",
"        Let your breath out&mdash;but",
"        <strong>",
"         not",
"        </strong>",
"        into the inhaler",
"       </li>",
"       <li>",
"        For single-dose inhalers, open the inhaler, take out the used pill, and throw it away",
"       </li>",
"       <li>",
"        If you are supposed to take 2 puffs of your inhaler, load another dose and breathe it in",
"       </li>",
"       <li>",
"        Close your inhaler or replace the cover or cap",
"       </li>",
"       <li>",
"        Rinse your mouth out with water, gargle, and spit out the water",
"       </li>",
"       <li>",
"        Store your inhaler in a cool, dry place",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16518149\">",
"      <span class=\"h1\">",
"       Do I need to clean my inhaler?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. Do",
"      <strong>",
"       not",
"      </strong>",
"      wash a dry powder inhaler with water or put it under water. If the mouthpiece gets dirty, you can wipe it with a dry cloth.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16518156\">",
"      <span class=\"h1\">",
"       How do I know when my inhaler is empty?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many dry powder inhalers come with a built-in dose counter. A counter keeps track of how many doses are left in your inhaler.",
"     </p>",
"     <p>",
"      When the counter reads 0 (zero), it&rsquo;s time to throw out the inhaler because it has no more medicine in it. Make sure to have another inhaler on hand before the counter reads 0.",
"     </p>",
"     <p>",
"      If your inhaler doesn&rsquo;t have a built-in counter, you need to keep track of the number of doses left in your inhaler. Based on how often you use your inhaler, you can figure out when you will need a refill and write this date down.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16518163\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/11/4275?source=see_link\">",
"       Patient information: Asthma in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/43/30386?source=see_link\">",
"       Patient information: Inhalers (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/34/41506?source=see_link\">",
"       Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/22/30052?source=see_link\">",
"       Patient information: Medicines for asthma (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/25/29075?source=see_link\">",
"       Patient information: Asthma inhaler techniques in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=see_link\">",
"       Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?9/47/9970?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16114 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-218.189.88.190-50AA3700D9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9970=[""].join("\n");
var outline_f9_47_9970=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16518135\">",
"      Are there different types of dry powder inhalers?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16518142\">",
"      How do I use my dry powder inhaler?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16518149\">",
"      Do I need to clean my inhaler?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16518156\">",
"      How do I know when my inhaler is empty?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16518163\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16114\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/19/306\">",
"      Dry powder inhalers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/11/4275?source=related_link\">",
"      Patient information: Asthma in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/25/29075?source=related_link\">",
"      Patient information: Asthma inhaler techniques in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=related_link\">",
"      Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/34/41506?source=related_link\">",
"      Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/43/30386?source=related_link\">",
"      Patient information: Inhalers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/22/30052?source=related_link\">",
"      Patient information: Medicines for asthma (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_47_9971="Perianal condyloma acuminatum in child";
var content_f9_47_9971=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Condyloma acuminatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Several soft brown papules are present on the perianal skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9971=[""].join("\n");
var outline_f9_47_9971=null;
var title_f9_47_9972="Parathyroid location";
var content_f9_47_9972=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F56752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F56752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Locations of parathyroid glands",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 382px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Most patients have four parathyroid glands, two superior and two inferior glands. The terms \"superior\" and \"inferior\" refer to a gland's embryologic origin, rather than the gland's location in the neck. The parathyroids are usually in close association with the thyroid gland. The superior parathyroid glands are usually one to two centimeters cranial to the junction of the recurrent laryngeal nerve with the inferior thyroid artery and within one centimeter of the entry point for the recurrent laryngeal nerve into the ligament of Berry and the cricoid cartilage. Superior parathyroid glands can be undescended, or can be parapharyngeal, retropharyngeal, or retrotracheal within the middle cervical/mediastinal compartment. Enlarged parathyroid glands can travel straight down the tracheoesophageal groove or the retropharyngeal space into the chest. The two inferior parathyroid glands reside in the anterior mediastinal compartment, anterior to the recurrent laryngeal nerve. They are most often found in the thyrothymic tract, or just inside the thyroid capsule on the inferior portion of the thyroid lobes.",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9972=[""].join("\n");
var outline_f9_47_9972=null;
var title_f9_47_9973="Basic case 4 with answer";
var content_f9_47_9973=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57503&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57503&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Sinus rhythm with ventricular bigeminy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 142px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sinus rhythm with ventricular bigeminy. Each sinus beat is followed by a uniform premature complex with prolonged duration and no apparent preceding P wave; these findings are indicative of ventricular ectopic beats.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9973=[""].join("\n");
var outline_f9_47_9973=null;
var title_f9_47_9974="Muscular VSD multiple color still frame";
var content_f9_47_9974=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 568px\">",
"   <div class=\"ttl\">",
"    Muscular VSD multiple color still frame",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 548px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Paired apical images with and without color flow mapping show a large posterior muscular VSD and two smaller apical muscular VSDs (arrows). Though the larger posterior defect near the crux is easily seen without color flow mapping, the apical defects are more easily missed without color flow Doppler interrogation of the septum.",
"    <div class=\"footnotes\">",
"     LA: left atrium; RA: right atrium; LV: left ventricle; RV: right ventricle; arrows: multiple muscular VSDs.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9974=[""].join("\n");
var outline_f9_47_9974=null;
var title_f9_47_9975="Aminophylline: Pediatric drug information";
var content_f9_47_9975=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Aminophylline: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14648?source=see_link\">",
"    see \"Aminophylline: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/11/16564?source=see_link\">",
"    see \"Aminophylline: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F133450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aminophylline Injection;",
"     </li>",
"     <li>",
"      JAA-Aminophylline",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1056475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiasthmatic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Bronchodilator",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Respiratory Stimulant",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Theophylline Derivative",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11431484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     All dosages expressed as aminophylline; dose should be individualized based on serum concentrations. Due to longer half-life than older patients, the time to achieve steady-state serum concentration is prolonged in neonates (see theophylline half-life table); obtain serum theophylline concentration after 48-72 hours of therapy (usually 72 hours in neonates); repeat values should be obtained 3 days after each change in dosage or weekly if on a stabilized dosage. If renal function decreased, consider dose reduction and additional monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Apnea of prematurity:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Loading dose: 5-8 mg/kg/dose; in a prospective randomized controlled trial of 61 neonates (birth weight: &lt;1500 g), a loading dose of 8 mg/kg/dose achieved targeted theophylline serum concentrations in more patients compared to a loading dose of 6 mg/kg/dose (Hochwald, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maintenance: Initial: 2-6 mg/kg/day divided every 8-12 hours (Bhatt-Mehta, 2003; Hochwald, 2002); increased dosages may be indicated as liver metabolism increases; monitor serum concentrations to determine appropriate dosages",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Manufacturer's labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Loading dose: 5.7 mg/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     PNA &le;24 days: 1.27 mg/kg/dose  every 12 hours to achieve a target concentration of 7.5 mcg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     PNA &gt;24 days: 1.9 mg/kg/dose every 12 hours to achieve a target concentration of 7.5 mcg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Dose reduction and frequent monitoring of serum theophylline concentrations are required in neonates with decreased renal function; 50% of dose is excreted unchanged in the urine of neonates.",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1056470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14648?source=see_link\">",
"      see \"Aminophylline: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     All dosages expressed as",
"     <b>",
"      aminophylline",
"     </b>",
"     ; use ideal body weight to calculate dose; adjust dose based on steady-state serum concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants, Children, Adolescents, and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Acute symptoms:",
"     </b>",
"     Manufacturer&rsquo;s labeling:",
"     <b>",
"      Note:",
"     </b>",
"     Not recommended  for the treatment of asthma exacerbations (NAEPP, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Loading Dose: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patients",
"     <b>",
"      not",
"     </b>",
"     currently receiving aminophylline or theophylline: 5.7 mg/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patients currently receiving aminophylline or theophylline: A loading dose is not recommended without first obtaining a serum theophylline concentration in patients who have received aminophylline or theophylline within the past 24 hours. The loading dose should be calculated as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Dose = (C desired &ndash; C measured) (V",
"     <sub>",
"      d",
"     </sub>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     C desired = desired serum theophylline concentration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     C measured = measured serum theophylline concentration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maintenance dose: Continuous I.V. infusion:",
"     <b>",
"      Note:",
"     </b>",
"     Dosing presented is to achieve a target concentration of 10 mcg/mL. Lower initial doses may be required in patients with reduced theophylline clearance. Dosage should be adjusted according to serum concentration measurements during the first 12- to 24-hour period.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants 4-6 weeks: 1.9 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants 6-52 weeks: Dose (mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ) = [(0.008 X age in weeks) + 0.21] divided by 0.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 1 to &lt;9 years: 1.01 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 9 to &lt;12 years: 0.89 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adolescents 12 to &lt;16 years (otherwise healthy, nonsmokers): 0.63 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; maximum dose: 900 mg/",
"     <b>",
"      day",
"     </b>",
"     unless serum concentrations indicate need for larger dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adolescents 12 to &lt;16 years (cigarette or marijuana smokers): 0.89 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adolescents and Adults 16-60 years (otherwise healthy, nonsmokers): 0.51 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; maximum dose: 900 mg/",
"     <b>",
"      day",
"     </b>",
"     unless serum concentrations indicate need for larger dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults &gt;60 years: 0.38 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; maximum dose: 400 mg/",
"     <b>",
"      day",
"     </b>",
"     unless serum concentrations indicate need for larger dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cardiac decompensation, cor pulmonale, hepatic dysfunction, sepsis with multiorgan failure, shock: Initial: 0.25 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; maximum dose: 400 mg/",
"     <b>",
"      day",
"     </b>",
"     unless serum concentrations indicate need for larger dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment based on serum theophylline concentrations:",
"     </b>",
"     Infants, Children, Adolescents, and Adults:",
"     <b>",
"      Note:",
"     </b>",
"     Recheck serum theophylline concentrations 12 hours (children) or 24 hours (adults) after I.V. dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;9.9 mcg/mL: If tolerated, but symptoms remain, increase dose by ~25%. Recheck serum theophylline concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10-14.9 mcg/mL: Maintain dosage if tolerated. Recheck serum concentrations at 24-hour intervals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15-19.9 mcg/mL: Consider 10% dose reduction to improve safety margin even if dose is tolerated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20-24.9 mcg/mL: Decrease dose by ~25%. Recheck serum concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-30 mcg/mL: Stop infusion for 12 hours (children) or 24 hours (adults) and decrease subsequent doses by at least 25%. Recheck serum concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;30 mcg/mL: Stop dosing and treat overdose; if resumed, decrease subsequent doses by at least 50%. Recheck serum concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants 1-3 months: Consider dose reduction and frequent monitoring of serum theophylline concentrations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants &gt;3 months, Children, Adolescents, and Adults: No adjustment necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Dose reduction and frequent monitoring of serum theophylline concentration are required in patients with decreased hepatic function (eg, cirrhosis, acute hepatitis, cholestasis).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Manufacturer&rsquo;s labeling:",
"     </b>",
"     Infants, Children, Adolescents, and Adults: Initial: 0.25 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; maximum dose: 400 mg/",
"     <b>",
"      day",
"     </b>",
"     unless serum concentrations indicate need for larger dose.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F133426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as dihydrate: 25 mg/mL (10 mL, 20 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as dihydrate [preservative free]: 25 mg/mL (10 mL, 20 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as dihydrate: 100 mg [DSC], 200 mg [DSC]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F14224883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1056480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Parenteral: Loading doses should be administered over 30 minutes; do not administer I.M. (I.M. administration causes intense pain); further dilute  to a concentration of 1 mg/mL and infuse over 20-30 minutes; maximum concentration: 25 mg/mL; maximum rate of infusion: 0.36 mg/kg/minute, and not to exceed 25 mg/minute",
"    </p>",
"   </div>",
"   <div class=\"block uicp drugH1Div\" id=\"F14471281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     1 mg/mL",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F133499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in dextran 6% in D",
"     <sub>",
"      5",
"     </sub>",
"     W, dextran 6% in NS, D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, D",
"     <sub>",
"      20",
"     </sub>",
"     W, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in fat emulsion 10%.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Allopurinol, amifostine, amphotericin B cholesteryl sulfate complex, anidulafungin, atracurium,  aztreonam, bivalirudin, caffeine citrate, cimetidine, cladribine, clonidine, dexmedetomidine, docetaxel, doripenem, doxorubicin liposome, enalaprilat, esmolol, etoposide phosphate, famotidine, filgrastim, fluconazole, fludarabine, foscarnet, gallium, gemcitabine, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydrocortisone sodium succinate, inamrinone, labetalol, levofloxacin, linezolid, melphalan, meropenem, micafungin, morphine, oxaliplatin, paclitaxel, pancuronium, pantoprazole, pemetrexed, piperacillin/tazobactam, potassium chloride, propofol, ranitidine, remifentanil, sargramostim, tacrolimus, teniposide, thiotepa, vecuronium, vitamin B complex with C.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amiodarone, ciprofloxacin, dobutamine, fenoldopam, hydralazine, isoproterenol, ondansetron, TrophAmine&reg;, vinorelbine, warfarin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftazidime, cisatracurium, diltiazem, methylprednisolone sodium succinate, verapamil.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Caffeine citrate, heparin, metoclopramide, pantoprazole, pentobarbital, thiopental.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Ceftriaxone, dimenhydrinate, doxapram, potassium phosphate.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F13796880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Store at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); protect from light. Do not use solutions if discolored or if crystals are present.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1056479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of symptoms and reversible airflow obstruction associated with asthma, COPD, or other chronic lung diseases [FDA approved in pediatric patients (age not specified) and adults]; has also been used for treatment of apnea of prematurity and to increase diaphragmatic contractility",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F133500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Aminophylline may be confused with amitriptyline, ampicillin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F133498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Adverse events observed at therapeutic serum levels:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Flutter, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Behavior alterations (children), headache, insomnia, irritability, restlessness, seizures",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Allergic skin reactions, exfoliative dermatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Diuresis (transient)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1056483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to aminophylline, theophylline, ethylenediamine, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F13796879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Prior to initiation of aminophylline therapy or dosage increase, various drug interactions and disease states that may alter theophylline clearance should be considered. Aminophylline and theophylline may exacerbate certain medical conditions [eg, acute peptic ulcer disease, seizure disorders, and cardiac arrhythmias (excluding bradyarrhythmias)]; use with extreme caution  in these patients.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13796878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     If a patient develops signs and symptoms of theophylline toxicity (eg, persistent, repetitive vomiting), serum concentrations should be measured and subsequent doses held. Theophylline clearance may be decreased in neonates, infants &lt;3 months of age with decreased renal function, infants &lt;1 year, elderly patients &gt;60 years of age, in patients following cessation of smoking, in patients with certain disease states (ie, acute pulmonary edema, congestive heart failure, cor pulmonale, fever, hepatic disease, hypothyroidism, acute hepatitis, cirrhosis, sepsis with multiorgan failure, and shock), and when metabolic inhibitors (eg, cimetidine, erythromycin, tacrine) are administered or metabolic inducers (eg, carbamazepine, rifampin) are discontinued. Due to potential saturation of theophylline clearance at serum concentrations within (or in some patients less than) the therapeutic range, dosage adjustment should be made in small increments (maximum: 25% dose increase). Additional increases in dose due to an exacerbation of symptoms should not be made unless the steady state serum theophylline concentration is &lt;10 mcg/mL.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F133489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F133420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adalimumab: May decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adenosine: Theophylline Derivatives may diminish the therapeutic effect of Adenosine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglutethimide: May increase the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antithyroid Agents: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines: Theophylline Derivatives may diminish the therapeutic effect of Benzodiazepines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Beta1 Selective): May diminish the bronchodilatory effect of Theophylline Derivatives. Management: Monitor for reduced theophylline efficacy during concomitant use with any beta-blocker.  Beta-1 selective agents are less likely to antagonize theophylline than nonselective agents, but selectivity may be lost at higher doses.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Nonselective): May diminish the bronchodilatory effect of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Theophylline Derivatives may decrease the serum concentration of CarBAMazepine. CarBAMazepine may decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disulfiram: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Febuxostat: May increase serum concentrations of the active metabolite(s) of Theophylline Derivatives. Specifically, concentrations of 1-methylxanthine, a metabolite of unknown clinical importance, may become elevated. Management: The U.S. febuxostat labeling recommends using caution in patients receiving concomitant theophylline due to risks of increased theophylline metabolite exposure. The Canadian febuxostat labeling contraindicates its use with theophylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FluvoxaMINE: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Formoterol: Theophylline Derivatives may enhance the adverse/toxic effect of Formoterol. Theophylline Derivatives may enhance the hypokalemic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Theophylline Derivatives may decrease the serum concentration of Fosphenytoin. Fosphenytoin may decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indacaterol: Theophylline Derivatives may enhance the adverse/toxic effect of Indacaterol. Theophylline Derivatives may enhance the hypokalemic effect of Indacaterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Interferons: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoproterenol: May decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the hypertensive effect of Sympathomimetics. Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid.  Specific dose adjustment recommendations are not presently available.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Theophylline Derivatives may decrease the serum concentration of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin; Telithromycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mexiletine: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pancuronium: Theophylline Derivatives may enhance the adverse/toxic effect of Pancuronium. Theophylline Derivatives may diminish the neuromuscular-blocking effect of Pancuronium.  Management: Pancuronium dosage adjustment may be necessary to induce paralysis  in patients receiving concomitant theophylline derivatives. Monitor closely for adverse effects (e.g., cardiac effects) with concomitant use of these agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Theophylline Derivatives may decrease the serum concentration of Phenytoin. Phenytoin may decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May decrease the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Fosamprenavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: May decrease the metabolism of Theophylline Derivatives. Ciprofloxacin and enoxacin are of greatest concern.  Theophylline/quinolone therapy might augment the seizure-producing potential of each of the individual agents.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Gemifloxacin; Levofloxacin (Systemic); Lomefloxacin; Moxifloxacin (Systemic); Nalidixic Acid; Sparfloxacin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Regadenoson: Aminophylline may diminish the vasodilatory effect of Regadenoson.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiabendazole: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: May increase the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ticlopidine: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zafirlukast: Theophylline Derivatives may decrease the serum concentration of Zafirlukast. Zafirlukast may increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F133422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F133436\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to Theophylline monograph.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1056474\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum theophylline concentrations, heart rate, respiratory rate, number and severity of apnea spells (when used for apnea of prematurity); arterial or capillary blood gases (if applicable); pulmonary function tests",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1056478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapeutic concentrations:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Asthma: 5-15 mcg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Apnea of prematurity: 6-12 mcg/mL; goal concentration is reduced due to decreased protein binding and higher free fraction",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Guidelines  for Drawing Theophylline Serum Concentrations",
"     </caption>",
"     <col align=\"left\" width=\"50\">",
"     </col>",
"     <col align=\"left\" width=\"50\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Dosage Form",
"        </p>",
"       </th>",
"       <th align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         When to Obtain Sample",
"         <sup>",
"          A",
"         </sup>",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"middle\">",
"      <tr>",
"       <td align=\"left\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          A",
"         </sup>",
"         The time to achieve steady-state serum concentration is prolonged in patients with longer half-lives (eg, infants and adults with cardiac or liver failure; see theophylline half-life table). In these patients, serum theophylline concentrations should be drawn after 48-72 hours of therapy; may need to obtain concentrations prior to steady-state to assess the patient's current progress or evaluate potential toxicity.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         I.V. bolus",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         30 min after end of 30-min infusion",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Continuous I.V. infusion",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         12-24 h after initiation of infusion",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1056469\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competitively inhibits two isoenzymes of the enzyme phosphodiesterase resulting in increased concentrations of cyclic adenine monophosphate (cAMP) which may be responsible for most effects; effects on the myocardium and neuromuscular transmission may be due to the intracellular translocation of ionized calcium; overall produces relaxation of the smooth muscle of the respiratory tract, suppression of the response of airways to stimuli, increases the force of contraction of diaphragmatic muscles; pulmonary, coronary, and renal artery dilation; CNS stimulation, diuresis, stimulation of catecholamine release, gastric acid secretion, and relaxation of biliary and GI smooth muscle",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1056482\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Aminophylline is the ethylenediamine salt of theophylline, pharmacokinetic parameters are those of",
"     <b>",
"      theophylline",
"     </b>",
"     ; fraction available: 80% (eg, 100 mg aminophylline = 80 mg theophylline); refer to theophylline monograph.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F13796898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Theophylline dose is 80% of aminophylline dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Each mg/kg of theophylline administered as a bolus will increase the serum theophylline concentration by an average of 2 mcg/mL.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronson JK, Hardman M, and Reynolds DJ, \"ABC of Monitoring Drug Therapy. Theophylline, \"",
"      <i>",
"       BMJ",
"      </i>",
"      , 1992, 305(6865):1355-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/47/9975/abstract-text/1483087/pubmed\" id=\"1483087\" target=\"_blank\">",
"        1483087",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bhatt-Mehta V and Schumacher RE, &ldquo;Treatment of Apnea of Prematurity,&rdquo;",
"      <i>",
"       Paediatr Drugs",
"      </i>",
"      , 2003, 5(3):195-210.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/47/9975/abstract-text/12608884/pubmed\" id=\"12608884\" target=\"_blank\">",
"        12608884",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hochwald C, Kennedy K, Chang J, et al, \"A Randomized, Controlled, Double-Blind Trial Comparing Two Loading Doses of Aminophylline,\"",
"      <i>",
"       J Perinatol",
"      </i>",
"      , 2002, 22(4):275-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/47/9975/abstract-text/12032788/pubmed\" id=\"12032788\" target=\"_blank\">",
"        12032788",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Asthma Education and Prevention Program (NAEPP), &ldquo;Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma,&rdquo; Clinical Practice Guidelines, National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 08-4051, prepublication 2007. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm",
"      </a>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12572 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-FF4A722CD6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9975=[""].join("\n");
var outline_f9_47_9975=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133450\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056475\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11431484\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056470\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133426\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14224883\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056480\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471281\">",
"      Usual Infusion Concentrations: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133499\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13796880\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056479\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133500\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133498\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056483\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13796879\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13796878\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133489\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133420\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133422\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133436\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056474\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056478\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056469\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056482\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13796898\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12572\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12572|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14648?source=related_link\">",
"      Aminophylline: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/11/16564?source=related_link\">",
"      Aminophylline: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_47_9976="Tinea capitis - black dot";
var content_f9_47_9976=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Tinea capitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5i85vWmMxJ5pKKpibE5zS0UUIQUUd6XFACKDml2gkDnJ7U5QcFumO5oCkhXJwc0AIyYEZymGGQM5x9aV0CKSxGM4A7n3prKM8fez2pwVmjd92dmCc9aYD5PLaPdGFVR1Hc0W+3em5Sqk8kHGf/rU5QZYNzbERPlJ7sc9qIY43mG84hA5OecUASXglOZnUhZSMHHXHTpTZbaQWqT7yVLcLzke9SybniBhUFFYtkEkqMdCKcsDySJGm9rgnCgkeWCegz09adgKSE7snCqfvbucj0NWngjaN5YcttbJI4XHtViG1WBo3v+YGTztqMCTzjn/Cq0crM7tGrD5v9WpOFB9qAJ5ZIGlEodZLZPkELEqemfrjPeqUiLvK5LEMcqnQDsc0+NxCAsqOYiCQN2Nw7Gp7ML5ErEMdvEhk4Xnp06mkBGwZLV455QN7bvLbls9Mn0qJBGFPm7GKDcMH7/bGe2Ku2tstzdGAM0qYLh0QgA46njOPaq7NuuF8lYgxYfu9uACPXPrQBAx/eh1X5SMYz1FaDQLdQXNzNMhKbVIByzt22j07Zpl5cQy6g8scEYjf5pIYxlFPQ470yzlhSKZf3qNswjDGCc/xdx9RQAah5wuY4bm18khRtj5GMjjFPtLmGwkzbBpJXXG8/KyHuPemyXBjFsgy7xnc3mKM5z2PUipIr+Fbp5ZbaOZt7ORjhvTAHTH60AVi5Cw5YkDduVxlc8nj3q1BPCjBzCyhegLbgQO5NLHcvgwTZmExD+VtGAf/ANXpS3MrpaTQRRwhJCDu3bmTA+4D6UAWtRltLmyINu8QRwyykDC7uSDj72eMZ6VFIJ7uPLoXkLARsRh9o7n0HT8qjMvn28Iu2Vdy7d5XHl445HftzSv5kds1xJOHjbiIF8ksO+30NADtVSV5I4pWkdUXMIKhV29zzUUHlRWhkXYPMJUS5JkB46Y9c9KmRdQeySZVC2jsTulUbD2wM8kUs7QxApaZ3xsr7MFow/Q8+vTFAFOaO7tjNG8DFYVBk3Iflycgn606RBLYwEyqkkzO0iKm0cfd579Tx2rSiiMMVzd3BWSCUopmUE4cjIGD19xVN5pfI8u3UBJWVdwX5lP17E9xQBWYQJfozxvHF1Ze+OmAKsGSHzIRJNIIFZirRL820dBj1J70xrW5mhErRmZ1by3yfnDeh75p0NuFh3SxLlslg54AHf25oAdEZL2W3WaVBGQ4CuNuxeuTjrT7A2RkZ55EWKI7RFtyzjsw9eeTUUs0lndk+WlxsG1H6q/H3gaSWO3a3+1I267c/NFyNnTJ9DnPSgCV8PfhHliaBBtD56HswHrUNnG7FllZkVwUeQ5Ax/KoZoFPmMhAiC5AY8k5Gfy9KessUCZSOO5A+8ZM8AjGPQUgLN15L6fDNDHHE8bbRJHu3TgjJz6Ef1qxpVnDf208isUkQ7wEB3Hp90dOOp71Rtrq4e7haBWEKghEQZVQeSOfXvViFCbdXmzAwDSo6vtAIP3aAJdSs5/s6XcjGWMvmSZBnjPU+gOOpqnBIouLmYyS/wCr3Rk8fN7mtzw6rXN9JMtyGt4ot94pGPMiDAbQp+8WzwPxrJgijTVZUWFp0ZyqRk847AjvxTAhhFqziORY5nVhIztIwDf7J/z2qeSwgju5JDPHDErARCJjICSexPcdap/Zi0whYKhXOwjjccnqTSpGSvlxAMmdhZiRk9cfjSAfNPKu8RuDNIN0jhiWf25/OmQzbrCZVg3NwXlHbnjPtTY2eKdpgqzSLk5HIUjufXitOzgtXheORZlaZUkVlQADuwYZzt4GCKAsY7R7YAxf94eqHiktogZY/l7cnP6j2pRuuJlRicrkL7c+tXoWkuTGsCNlFKmQEBseh9qAsVEvZLdZYYkj2M6vu25IIzjH+HepNQ1A3M/nRRBIFAXbjgH+I/7x6+1Wb6GaQPJbQtCVVRIqEEH369zRbwC1kiMKiW6jG6aJ1/d47oR3PNAFVLgi6R4LiWN5JuW3YZPc+9TYlHn5uYXQY4b+JicHb7+9VtTtDZXZiYIGB3FVbO0HkAnvSQWxn3srqVCmRgOx/ue5oAi5aFwkpEKHIB5Jb2pjKMb84QkcE/MR7CrNkE89ZbuItbK2ZAvB25wQKdObaWV47YbIS5KsRkgdhn2pgR28HlxzzRuC6coB3Hc/0qJWdFdmDeWf3TNtDcensatlpTI6xOHCRlcN0x3Ip+o2yRRQb7q2knuEEz+WCfI9FY9M45OKAKt0vlyCJsyAL+7JGDtNMgmLo0JclDxgLljjpilMjGUtG2SRtJbkMPX6VozDz44Te7YEiXarKm6WQn6Y4+tAFOVkuPswtYFt3gjClgx/eMD94nsaJlKTSF3MsIb5vlxyetNSNowXGPJ3FG3cKx9KiAPkuFZWUMejf07/AFoAa6SRksA4APfjbSSR9TGyFWxlQMfgKl2sNvJYMACM/wAR6Z9aWC1K3G2aRIFXkswOPyHNAFYFADn52xgA9MUVJcFXkLoU+Y7iqjAX2ooAhooopAFIaWlRSzAL1oAaM4p/HUd6TGMijOMdD7GgB+5Ao2nduHIIxQCqkAP8tDSMVVc/KvRSOlSQQtKsspUbU5YkgUwGtDtdlfco7Ajk+lAXEfmsh4bYD9O31pZZnlRTKQxHHmc5PsT7UNMHjZRCvtt6j3JoAczb4zHGI/mYHAT5ifrUMsE0TCJ42Vs9DxVi6RmYMAEkKhlCHjGOv1pY7XMIlMu8k4KkH8s+tMBoeS3QlipJBGwtyp6Zp8TfuhEsy+VIvKquWGOefp1qO6jMR2iVJEGMn1J9utNsw5kEYyAx5YdvxpAOgDpcqODvxwfmBBqeRJLaVDG8HmuSPlPIHoewqsUyWZSqxhwNucYzUrpumlTzVkiyB5pGAfegBqqftTh/LDhv73yj19sUrJNuwAzrK3y/KfnoFuXZfIDkAfNhc8/SnRRTTKWDZP3QXyABjJ56CgCdXubOK4jnR0d4giPkgoAc4+h6U7LiaOa5VEKw/ug6blk44H8zmqzBvtSm9kG0gnPUHA6fjitBY01RGcAJdJwYU3fcwMAdgBzQBktc3MshxkMRt+RRz7VKyXE7QQiJmZcIgC4P0960dM+zW0iS/apbaMny5FUZdh6jPAHSm3FrEqyy2k+4ow3/ADZZecAgUAUN0omEd2GYIeVY5x2waspCbh38qFgzEkvt+VAB04qxbhNKfzzA00qLtUtwqseQzDrkZ6U15Lm1gh+zi4KOdyyHOx2B5KD+7mgBAUt9OSS1Rprhi0RlxwmfuhR64zzVWeHyXy08ZaQbiSpAAH9c1oXNuxuDNbQGK4Vtw8rnDDqQPSorxZpFW4uP3s8e078grg/+hNnrQBSZmmjTzX2vIxLPI3B96YmwyRsoY8HKhun4mrdva+YkZ8qQNk5I/iIOSdv6VPL5UOpMqwo0bncSyFiAPUcdfSgB7xtDpFvNM0UfnFjHEuWYgd/9kUxDG1vsNoyD7oPPLY/w6mmxQyXCeYzxLGeXkdj+7HYH646VJcyqEjmMchQuNojlzvXo2D1XNAFcCOGTyZ3kRQ+RFkkgEdRnj657Va1SOOyIhs2Zo3izJvAJDYyTkdO1MlWG6nku/LkCjaQGYcr6Z6k4xT7v5WRZ5xE7ASLtPmE+gY9iBxQAsl893bNvcvC0u77KoII2j72R14qgkqPP5dtAwWRdn707mz1zRdS3MJSVZMAAmMIQMD1HpSRKJZt6yNNkguOQck9M9qAHNap9qt4riQxxuBskfoeehx0+tIXd5RBbQqNpKkJ8wfJ7nv7Gp5ZTGGMEaFAQD8g4GOnPpWhp6tHaNKSIVPyux2nPdeOvXrQBltHLhI2lGVJIhBxsLHn+lOS38oITK6CUjHG4OQeBgdefWre5pb2K4uPmYINpZuQQMBf89qfJ5kVlEDIZcYcJ/BHg5HPpSAz7+6uoJ1geRNkchYIn3M57iojcC5jmYIdwPmLHj5QM84x0qSCG42wzzbBE5Zw7ruABOMkelK9vIsW8SnevAKj5WU+hHWmBY04rbwrNE4a4VQ+GOPKwevuc4xSQXH2q4ttkTM4JLsvDuTyenWiC3mEkioGdlG6VkHAB44PpmooUEMi+VKAc/MQckexFIFqaEqrF5sceDBCwKq6c8nv64yaY0M0MKTGGMQIVHyYDNyeenX1oivJ2RyqELGcNjvU1yqiY3a79jgkPgklh69uOtK5bRTgEK3aIyNMrNyFzuAwecDqBUukW1pNcTNqE8kESnIkCkvIO4QdM9OvAqk+6a4hEcp/eShFkbqAf8mtCC8Z7e7t2l32ikgK3AIz1x+FUSiw2qyQCW0sLeK2glOTvjDM3+8569jxWbLFJaxmZ1R5mBUlScqTx9D6596tXM6ahdReXB5TCMR7HkymFzwD2yKgtHWJZQ5wJl2kYO2M57evSkMcsSfZo3jVYgECOx+Z2bP3tvp2qzczXGyO4Ty1LqscUCsBlemSB3J/GqsiQLgRFi20gFVOV9eP606G4lsNQtXtlkRsjBYYKEjBI+ooJsVZYDDBC8x3lXJ2KeVweeeuPrUivJar59tCy4wBOOwYc/p3qQxRRtKixee4JDzI5w47jn/JNVbtljtYgd5cMwyWHToAB6UDsTt5RsVNt9oNzEMMrsPL8sc8+tU4DJs2yxl7dH3NGBjJPv6UyDawkVzGEEbH5jjn+pq9pt0q3UOYwVkALs2TjHqKBEFlaXF27m22yMvzZLAYGM7c/TioZonRYAsQVJELLn9a1LQRTXIimV0hctzsyCfTA7+lRX0f7m2ZoH+0MuOo5we4/nTAqWltCtrJLdxSeTjiUHmM/7vfPAz2pRHBKk000skJ2boYgCwJ7gnt9acbh3DoJUjWcCKVT/FznPsM1TiljieYncQU2KR0PPf2oAfdN5VtHEZjhfnMRXGCetRbkiXEbZYt2Xt6A9jU0sMSNE1swnZ/mAboB6H34qOaMxwRDIdH+Ybem7PQ+lADxCxEW/wCVhwGONoHoamnt1GHinD3CH955YyI0HQ//AKqqiH5BI+5SWwQy5U/jS3MXlRoANrgFW2v1GeBQAYE2THJjIKjcAPwoqJ1e2kKbVEqkoQPm3UUwIsUhpT04ofnbj0qQEoH1NFTW6K8wVgSvfb1xQBEBwfr1qTySIfOyrKW24HUGpI2i3HzDIqDsB1FJ8vmMQpEI6c9faqsBEo+Xqv0PWlO7yQNp2hvvdaa3LE4wD0x0qRCAm2R2EbHlR2pASWi75kDvtQ5B74FIDJFGWO5reQlcgYDYqFAEGd3GOg60dYjGQc5ypzwPwoAkAWMPjax4AJHT3FSTzL9ighikPBLtn19Kjm+V9gG1sjB3ZGamMjidLq8gVlfkDbhXx3wKYDfNje2/eYeXdwe6jufemmQSwpDDGwYEszE5J+lWrZYknWe6tytuck7yVD8dBio2M0MFwqwFElwPmU7k5yMH3FICdrv7VbWy3bFkhkwNwAXaR64z2otblYpWjil8uORsn5d+ME4yO/4VW8hknRSNjj+CXt7fU9q0LjTJxGzrBIVeTy0EigTKwAPKjnBBoAhsJG+2PdQM8U6HMWwcO4HI46Airm/T5CxS2jSV1VlzIWRHzls57+3I5qqt1JHHHAkmy2jUtymVOeuc9eeKhG+4ugjqI1lJZggyNpPYdqYE9yYJrgEQl2ZjIQvHB6AE9efWp72G5gvCI32CZMSxk8kDsf8A61S30kMzeSJne2jbc2Itzog/2u/vVATtFJG+zEP8Ctlt/pSAS3jL7oo2CMflMLNgNgZzz7cU9bVVlE9pIWJYMI8HIQ8H8PepHbZAs2oWryl90cTMxRQPUdyRUnnNHFcyO/kx7SsMBUElW6/MOnTvQBHcIgeC3uGZZIvlnIb73PUevGKrC4fIjimlCQsXHy5A54+gx1qfyGFr8sU23cAdu373YZqO9uS/zRpHE0v7sqAecfxZ6fUUARRajdRkgz+bEx3SIT8rHrU8N07RQWkQxGG3HdgBcnnP/wBeoFmZZJ9qLIZMqZkXgKTk8U+0uEhEyRyffBCsR144PPTFAF+2nYXn2q6idwG3Lj5Qm0YVuPqP0qC1eL7UZ50a4djhM/Lkk9WNPtrmNjEuySe3kUPPECTtxn7mO3rSW1xJbhYYguydfM24AZcH7pyKAK8xhhaWKDzVdiVkwQ4PsKltra7kZIdNVWLEMsZcAgjuQamlaIxi4gdS20o5K7TFz1JHU1PdpBLpxYM0c0rgMCA25Oz57c8GgDMv4LmK6EUyI87pu+Vsg55wP/rU828VmITOsySbfOAYYGew/lz7UqW5uFFw+3EJxJsJY4HGT6DNOkla6SJZ5f8AR4xiEqMkE/hnGfyoAszRyS+bNcQWzS3K7mAb505yW9sjtVS/WGE5SRt0gAliVdvTphs9e9Mb7NsYKZ2njf55uCjL2461ejtftEFyiL5ZKKMy4b5iMjkfd45xQAlnHI+oMmjKVcr/AKuZ16dTycelTTiW/vi+4+fMn7+KJNu3HdieOevFVLdI2tyDBas6kqZXBI246Y9c9DUN3C8caQsJAMAyBgQc44H6UAW7OKKa5VZfJjiGQpkb7uCO3c9aWeUS6gbyOON7dXKiIfcIXoAP7tN0/TnkniuLaES2yqSYpWweOSM9uvFMhvXS8T7THvgdsBIzsXHpwOxoAdNMzyQ7Mg7vnIwo59cjGB0+lOu42uIR9mREXcXklbghsnJHYDHYdalJSK3bfFLKobZ85xsj56r680iTR3MihJCibsAqu7jpk/SgaKZkdTLCJCbckr5aNlQPQnv61PdpDc3hkdTEZkGxkI2jGAc478dKSWxuVl37jJGQZPlwMqO5FXZp/PuodyiUMFKBAPlIHQ4GDSY1Ysw6e9xbPiJFKco5+UEAdM9yRUU90fsMlvA21J1XcOpGPQfj0q5Y3rfYpUjjba6/PvPTnGR261m3eLcLPGbebexVm4yDgVMb9SpFSdIrYxwxTW4k24lCKWDY5DH37e1VISv8BKArtHmEgNjt7mtFFgUyyj95cLN/qVOQ3+1n09qdq0cxYPqKrIxXdF5DDb0+UHHf1FWSZp86OBZFGFLZZCwIOe1WVZZJyHBjmZl2oq/Kuf4QKSwhBhWRUSRFbyvJm43SEH5sZ5x+lNso2kngmtoRhOfL3H72MEk0hLc0rwS2HmFtpKZQleDtPUVmNBcIkUUgmWSQCWMEf6xW6Mv8h+Nat/5skBjkfdPJ8qxqvynHeqERlVomvUMwiPloC+Ng/u8cgVCbLktSORPL22iqyMzbZIjkfQn6U5bTz5BBHEUeIEs7YC47EmrGozRrcBokUQzMDGzDdsz0APtzk0agzPOkMsm2FVyGX5mJx6f41ZLMW6t2iDlCrR8bmBzg/wBRU7yfZ90CxIC4XcQ2ffg9s+lWZ7c2zG3lhBjXBCu33cjuw6fSqO0qwyEw33WUjt14oJRfgnFuss4LkoNqJv4RiODnv9Ke14gj5V/PwQ03QoDxwPT9adaxQvBafaY2FtuBIBxkD7x3fiKjKfO8SvEwDt5cEmeg5PzeuPzoKsUooVlMkFurtIykB84QL3Pv6c1Be+csqxToIhkZRFwAB3HrmtW1ZJHMFmgMcpI8l+4AznJqukRnYxzOVlJ2jksQw7Ae9MkozRovmRorSZf5AT0X3oeJ5rdWXG6M7NmeSD0IFWZUeEyeeDviZWePZ8p9jmmuqsrS3EyEMCoQNypIyMD0FAFRvN+yFTuCBgWy2RnoOO1OluZpVDMgw3ysyL94YwcUSBvKMqMdo+UhxyAR29aRPPAVFc+YpwqdDg0ARhQJHeMHYh6bufzoqTy98cYI2SF8F2PGO2f1ooAr0cFcH86dgU0ZzSAcqjknp2oBaMhkJDH0pyIXyRzj1pF+YljnC9RTAdGrvuPls+z5n9h71P8AaHe0ggABjiYsqE9SarlyC+wsN4wxB4xUkJjZhI5OVHyhR1/GmgEkhlJMpQRgnGDwAfapra2t5IQ8t7FG7MEKbGJUepPTFRkyz+WoCnax4A6+5qa3hT7HcM7Wx2uuFZiHI77fahoCJHS2nLRKsgV/kkfkHHXA9Kdco5YNcKqLM27OOVB749KbK5cmNNhQDagK4bHtUtm8cSyR3SglvlHmAsUA9AOuentSAhncEYCK0cfryT7/AI0s4kMUUkvVidoyMADpx2q1ZMJZJW+yQvHsKxxyOTg+x7kVHZ2jX00iEEEIWZ8EBSOgPoKALcUYdLK6muJV2kkiVPMQAdDgdvbFGoT+ajOZnkmly0ZDcgZwcjpz2HYVFEgjhkVblw5xGTGQIyO3PU81ZmjjtPKtpniMilwShyV2n5d2OMnFOwFS4VYoz5iRGSJl3b2Lb/br0FWrO7jtpjcqgluZDlQeFHqM5yDVF5ElR3ECCaTIJ3EEHqTj09KdbR+XaNO82I2bymixhpB3IPQY/OgB0zqyMAgZcsrZXPl454PQ1LHaq7D7axj82MMpU9COnX1oOC5itMzWkUgd1YYVT05HX8asW8EE0dy4YpiMkxvICFOegJ6ihsCGed2ZTwWdPLdnOFU4/pTrMKrb1bNuGLBHYA9OoA6c+lV7eFZWmmcgwrjfEuS8hJ4Ueg96ftjvTKm2KJgvEaRk7eeufpSAsuP9AEct0jxKOEZWAyTnCn26miP/AEm4RpHiaO2jBcvhSF6YGepos5BqF55UltM8cKkFIHCooxjcT25596htEj80GWNG+c/Ihwozx8x6546UAS2Qms3muoo/MtiHjG5A+zPfnj8RT7OKe28yUxQtcbAx3pzs9u2celXLK8ntGD2k0KwRvgxgkGXjliD/ACqnPfJHLthV3IJdpHQHOewUdKAILNFhVjDcSSR5yIVXDknrxUVzuZU3xISWYNKO/sfoK0Z3YxtM/krLMQxbaBIR0yB26c0tytna2Uc1rMk8yACSJwWy56tkcUAZj3MyIHhZvMkzudernoB7ccU60SHzy0hluGwPmHbI5B/pUlvB9tvWDPBCXCq3I4znk544rRgih+zyR2cluLKPCOJ2I/eZP7zH8X4cAUAU3VDauHWQxug+YjBIBz8v/wBerdxNC6s8sbCMRbYUJ+6O5JH3j9eKrC2N1Aywyu6wDcUYE7lHXkVKbiyRIkbCRycS7suwGPlXP92gaZGYoxoqvYOVj+7MGb5ic8MfaqEd5LKbe2hYiNCAmOBnPLZ96sWpuS81pDCDnD7SB+GBT0glS0k+0Lgl1I8z5W2nI3ADsOn40CKzGJr6cRvMkLscpEATx6j0q/p6qUuFeNZBsy8okZQuMYZR3b2NWYEZtPZ5PKS3SEb1hBJXnAYketR3HlW7FSsRjb7mcjcOoYY6ntzQBFpllHO8iu8O9MPvkbEauem4dwKrajeyTFpbhBKzlVE2MA7emPx/SrT2yOLW+jZJJWRvPg5ATnAHr05NMeLzUlJZTDEwmyo5PGTtXtQAri3e0dbaHzJFw8kjsQD6qBnP41Su7gmFBFaRRyR4CyW7MOe2cnmpzEBcQwrtuON7En5Qh5I45yBUr2EVxfu7zG2tFIPysXcLgkEDuPrQBnSXEzu32qRnPRt5/irVmU6a0UN9tTzLNXxF1yTkCT39fwqUXMERgktLCJ7nOGu5JTIu7/nptPyq2PXIqjqtnOJnd5EnkA3tMsgYO5Oev971FAi0Lq2t1IO/zVc5RT8oGMDPdvpVO1untYn+yyx7DlW3DBUEYOPT3PvSOsz20ZuFIlDHDYyxU8/iKbcQCKZh5JiZMYUjcCP9o9KBmrp+qTxwSQXCxMcqI0IwqEj7zDvxSxfZJFuVusnf90w4Az6+9Zt1cNPaW7hEiZieEQKhI/nT0RWmVo5WYsv72BV2qDnOAPpzmkNMuERadN5kcquIyFU5G1uMg461VO1ozukkZpD/AAj/AFQJyxx6+lTOltf3cAJAVPvY71YnFvZ7ohBJJKASBu+6fU45I9qLlWKt40TXVvCqA2gQshkABfqSxYfxelJAPKuHMUINrLJlFcneF9Mjrn19qmsrm38hyZY0uQ2Sr5yc84HYEVHtLGC5iJjdGw8wJK5Iz0oYI0ryQXcqyTBo1VfkcRkg4/hGKgCBrgPcQLNCUJ2q+MAdd+K0LyxZ7GNlfy5URXBB6seeD06VR08SaekslxHiG4Dqod8HdjsPrUJ3NGrMgvTC5CR7I7GTdKpkTftGQAueuO1Niki3+XIE253FwDzjsGHI+lPgDXU7meXyAUO9Cobao52gfhSRxwmwUMJI4zzsHDYzgZ+tVfQjlZEXt4nEM6yJbupy4UsX568+naqM1tbec5jEzDeVVmcBm9Dtx3rXulGEaN18uQ7FMhwx44yO4FR3FqIm2SSDz+run8BxwFPc9TTTE0NjlgjhyA+0EqAx+U+vWqDI0zPPsdJfvDKkqox1J7e1T2+JraaPY8m0kI/PX6evrT4IZXtsSXh+xlsvGsnO7HIx/jQhFSxc3CRxxJGZIz90cl/ViT0p0MFxFcEhFUGTeFY4Kke9NjhY3DR2wGAvmHjHyjoPz7VaR41wsU75OPvoWDeu7PQZyOKBWMy6eSedjcSM/nfPvzjn3J64plypj+QqCCg3yZDFs9lPatxtNtLSxfUfPMyoR5cTryTn5unGBz9eKzHaEi2QAhpGZwBgLGM8c9/cUxWDzPtljELiU7kZVO4ZAUDGeOgAqo8ACqTLIytJt3AZyPX8asXFmSIFaNkkyRJke2d2PpVa3uTDdCXy1L927Y9h2oAJwrMNyTHcvClvu88celFN3tHKZLbc0ecDePmz/WigCqKVW28g89qNhzjB4pDtA5OSelIBc5yD19uKfFhmGQSB2HeoQdzdacGKgFSQx7imBI5VpQEUqoGOnU0NuRs78Ef3RxTHkZurc+o706RneMM2NpOPc/hQA+FisjjzCh+8uP4j2pGVpJwFUh2I+XuOKdGjS7mjORjABHYU+FZJp0ZmAABy+7acD096YE4jljgaZLeO4juCEjkcZZSOoAp7wwW80JnJlWTllQ5Leoz2IqtEdrDypWZBIChDYKn2Hc1cNzIwuFbcoj/dhhEFIHue1FwK7DYYzaxysIxneezZ6ir1sN6+ZMXgaQEghseYw6k5OD9Kqu/mQl/Ojjk2CPZt6Ae3vT1cSbvNRofNAVDgFfyPT8KoBYzGbmaHCyxMpPmKduwf3gPy4qMBCqAhcAMRuGTnPX36VO9ukkESHbFdDcruWx5q+mO2P1qKNg24s0ccpZMOBgpzjg/SpYEm9UiYmPZOHAVyRtGRySvX6U8LbGVt0MgiwAsfmHdGf65PP6U/7HdLfTTQhJjESjOoypOOoHU8d6ctrNcRZsg+W2jDSDOFI5z25pARXLCBWKGGVZjlQzYIGep/+vVhIotqRQRWYCKHLSuGaU91DDgc9AOaNX0yG1SNopZLq5LDzHj+4CwJ289SO56VE9jaQuyC5aGLGTuQtg7emOh570AS6SHj1EC1uo1nY7trxKEO3kfMT61JaXSySySXkC3EYX/URZQs5yFG4fw9z6gVQcvcpbJFE4ljQKwfjzQDkY9PpT4Hma8EaxumXJa1hGQD7r6AUARZnS1iScbYl5AVAu89Mk9/aobWSOGQySfOdu4qcjB7DI6mppIZYy8stttJxJGB0K+46YqKKNJpBJOyqjHBYDjPfA9AKAJI51uHzIiRzZ+RmJXmrFjL9nnlkmeRHVGO0ndvI6c/jVq5W03XcMT2xhEq7NwwwXGTtI+n1qlbTKVlMcMrIv3w8mQVOOOmQT2FAFi3uoJlt57rIkt1wiMmcrzgk9+adDIPsTFbcSqzKsrhcYPJz+OcfhVWW1lmhWVFWOMEKSZMH5iRgA0lvbTSk20aeWX+XYZtuSB94g+vpQA5pYhDPF9jhJYYMjjlc+h/D9ahltZHZYWjCsCW3K2SFxzkDmni2aNITcsTFKGWMRMMhgfusO3Pr+FalihtQsZdJHlzK4VSHTAIHzHtzn04oAoaWg8uTdKjEBR5OdhLA+mOcCmX0LXN1K3nruLAFzwM+47fhU2pQLa+VeafcSyOigTkoFKMeccHkHnmoJ4JI4ZHuEaN3USKrHJZT3/lQBashbQ2UitbmZkJWWUZyuD8rA9lq9a2klxfGWRXhtkXy3OPtAyR0Bznkc8dBU1hcr/ZNvBHeMpd9xhliAiPqBJ26dO9QXDyT3KyWqEuQAMZQE9MY9MHrQIiETSSS2an/SDlFVVwswHQk1SktLoQB5cuv3NrfeXsR7VqRSR2VqDafaf7T8wg8hgiFeAMc7s5zUAkla4haS0cSqAT82AynPH40DLcVvOWa3kgLrsDqd2XZeu0kfjxVS182xuE2fuoP3khEXJTPGzn8qsC4ubaeSK0nhWENuVWcEhCDlWx1+lNgit5IneaeKKUvt287AvHbqetA0ipbxxBY2hQymUkvAE53DnAPX15pJo4YprtIVK7jjack/Qk9/Sn63GFWNomKoD8safeUccjuR+tQKCbxvLP2eKVgSMlgnvz/nNMGrCanKJ444LUHy4cI0ioE3+gOPTpz9afDHFJiLAaZ8DcTsw3of8AHvVnVEjS0kEExaKXGwOMcepHf61UnWUtFbxrNtGArDKjnpx6nn60mIsWEcKwMLiGdLpiViGB5bFevOcj+VZ1xfXW/wAxwXTgbzkjA6A9jWje6XdaesMVyqjzz8kbzqzMgyTnnj/GmPI8SR2UsjgFCHiVfvKeh3dM0ARwfad0UcFm32jAYIwyZdxzkegx3qC4murpme5YAbsNlQuCTxvI6/WtJbZhbSm5kmjhYoq7sEBRzjcOlV7aJLgwRTO8IBLfd3Bwfu7AKAIlzHJmSdfOdjtYKSceuRwfT2xTJmnupJLmT7ytgkOMntgKevrWqEtIb26M8Vw0ax+XG4IUB/8AaXp69Kz7syCzdnEFwv3AzkBoz1yAPb1pW1C7M+cRi3aUBxcEgBQMqQOv+NXjeQxM0KrOLJl+V2XHzcEnFFjbTlzBKLZPNiVxM8nEaA5wSOhPSmXlyYmaOIK8YO0KrZXnt6H60NXGma323y4j58sYBYeUoJzt9QOlQ3VyOIzIuw5bLdce4PvWTfeZ5VrFJHslhTYzKeOucEetJbs0t1DNNIFOdyPKpKuy/wAP41PLqXz6WZ0KJFcQSNKcMQeMdB6+vaiIRxxSplPs8mCTvLMPZfT1rHl1RrlSuQkm4jaB0Bznn8elWNOkkVvKCsVB3FDHnI+tTJWLU02TeQJZ5Zo5iUiJDeaMAYOBS3DQvZpK0jPMz5aIJ8igfdJI69STTrmJoHSaOLMbcY2Eqc9Sf8alvVt4YGjh/eusYZShyp9Sf8KAtcgh1KQKYoQscxynmKdqoAf4SOo7VBbxCe6TY6KRzu2htzZ54x/OoYLVzeFkYQFhlAzf59P1rZsbRFiiuItvmSZw5BCoeh5/rVOViErmWbOZZppGkaPdJ82MbgPoO1QSu1rH5b7XfzQ0OVyOeM5/pV2SCeS6GYXmKBjsAK8AevfFZcM0cVx5N1G7qFYOoUkjup9ufyppidi/qEcEVs0TTSC5By6OcDB5+hzWOFgijwSxmB6d0P8AUfrVu1miv7gyXfmSTnG1DyG/2Se3HepE8mR/3+2KJMneVxsb+6fwqkSwhghEdxHctvLEOnmB1Z/THoKoxQSTJKxjB+UMWLbQpP3Sff2qVZbhrkwsZJVmXoxLYU9GH0qNYQbuWASs9uu5Yy52DrwfzoEVCj4BzsQ85P1xkUUphkUASHPUYB4680UARqzK28NgimyyGRy20Z9O1PiiaaTagUE+vFKImkl2IN+O4oQEJ29Wjwx9DxT0YhQV6g+nFOaIuwxgYOCB0pDIqhUAxn7x9aAIyCw+7gjtU9vbiVS7yKkX8Rxkj8O9NHk74t3mEbhvA64zzj3qxcW8UF1JFIQFWQIFLZZR2OelABPHPJcwIrRyvIBtK/KMdgRTgscMEwuIg2H+V1/hkHY9iKjukP2pY40h3H5V2H73ofrTlglt4nM28wiXY5U8Fh1A96aArhDIwdYvlA3NjgH6VoHbJKj/AGqQ7yFkIGWZsdl9BxyaYGkhzBKhjgHzlWG7bnpyOmasfYYPsCzLP5l3NIojjQ5Cr33HsaLAVoLQSTwgSr5ztjbyQp7EmrITZKgQhcn/AFkpO2RvXFS3eoA3UjvZQ70kQBUbCjaMYA7gkZNNWW6ninldA8Gd5TaPlz/dA7e9AFfabwxSyIGG8rIEXBz6A9zVyaS3a4XNtE2wAOuwguP6AcU20DfYpxPKRbFHaEIASzDoG7ge/tUUhjlj/wBFI+UDLZIZjjk49BSAit3cSNcQNOMEoBGSDz2JHapIbyK0cbVWdTyjhNu5vUj2phmmDqbSdzLGpEpjXapX+tWHgY3yNLIJ441GQh2ggfwjHfkUARWzSpia3DBm3ReZ0UZJ/wAa0bRoprUR3FrNLLvw07ksFA9CPUcc9Kq+VcGyDQ/8e5zLJCG+WMhuuP6003s0Uf2iOZVcnCwjIwPVh2FAE+VJdo7gpGsikx7iSAO+T0Paq8JeW8uZ3V/OIJ5OzIAyefcU62n814nmmk2hR8rKSkgGSBx3qysttNqMF1aq9rA7DIIMgTHbHegCr9teSwuLh5kYn92sTLgjJyT+lV5byL7MtvawIZANm4n5nJPXHY9uOwq9qPl3l01vbRQfamkZQ6ZQOCeuD0qCyst0L7Y2Ei5RZAOAQeucc0AOgtZiuwhuZsRRZO53JwQh9RT0t/KSadCAsbHJTIUAcHB7nsaZGl7bSJDFIJI0/eAg5ABwCwJ561q2SQXM/l39x9nVkZWlhwwVh3KnkfhQBSb7TMy3EEUBQD925IP169fappYraa2aBIlEko3mebmRpF/hX0B7jvSLBJqDllUYjYRh9gVMddo7A49feoorSW1imaK5l5/1ijawVM5VfXOcZxQBXmsJUh3kCJI1RZSZAWdj/EB/SrEejTOl3OJx9lgiLidn3ZOeF46k+lMVCv2dbRWa63b2RmB35GMgn8eKe4ntyQYy8KMG5fOCOOew57mgB8MUU8Fwl0PKvoYwf3+QSc5J/EcCl020ePVILprRXYHz1imG5ZEzjkdMYz1NWl+wyDytoMyqWeViwLKB0J9D2Jq5b3GHkkSaKPC7UUnqvGMepoApajAgtpI3eJ7d337VXAT04HGKt+EI2mvGkTYbdInklSWQfMiDOwMeVJx29aofZ1gkllM3lqMgxDBUuORz7+lRtKIoFhkh8t0BImKjc5JyqtjII68daQE808Hk3EkjvHLKcxtGwyeeg9Oe9Z8by3lycTlJX4wxyDjgD8TSC2gjsg8yyR3e/KKyfLID7jpzVmKNEL7JiNqoJAq4KkHjPcYz1pjbJL37LBA6C2Q3EciAmIja2B82R1GeOaklMLPHJ5aRWbSBgI8sMqOdpPOfb1qKGGG3mnXUmk2FCd6jJ3HO3I7jpSR2D3EO5d4IAKqr8KepwO+f6UCsK0RZWmuTI0Q+5tX52yc5x6DvV1pyvmriG4hkgO+SIFSpIGASenTtUkczzqqvMFaMZUxfNgDqeOg4561Xs44/KDzIYlY+YVkGPlPc/Xt2oLsRbTdTPbtdQxxptjjjkQ89sZP3cZHWnWlvMZ58NCqxlTtlf77AEYDeo/KtDTorZ0VkYO0hJCsPmLYI6nt3ArFezaS8jt3YoQChDAndzkk/pQIL66e/imuLiVRchVDFurBemABgVo6JBpgsJJb28lW6kC+WETk98eg+tZEIdIiYTHskHzB+A4B4A49avQzGKKKEXUU00incAuFjbjn+ftSYIvuonj8/Epm5XMmMFMHHA4Jxwapww3AKvLsjUISrFiNyjlVVv4TXQ6fOrWDBkhZokBAY5wemB75qAW4tbWQ3EZOCWkjBxtPovtWal3NHTtscvdt9plaaWOYhv41PCt3/APr1NHbBLaKSSdYsuEXPzbARyXHcY79jU2oboI4xGu2KXL7QOGzTgIrSBYQ/lM/LozEsx7Dj7orRbENWEv7S0N07xiSSWdtgjik2pjAAfPofSsafdbMI28sXisYimwNsAIxz0zWx5Zt7kTzJN9qEgB3ngpnoSKnkks5r5p761hR0XbsTIaYkn5wPpRclJkep2tlKEu2huBDsyyoyqxY8bie+T2NZ8qTlEkFvHFFERISybcAnAJ/nW9qESsjfYkRo5QBtA5bB4z6fWooYmmh2xCRpo490kcoBD7TwPcAZqVNJamns76GdPpjSSQRhI0F5tVY1xjfnG7d068496LO1eG88pwUli3edHuJyB647GtKWzjkUzqCLWdVPryDkgfU9qIruKKzkil2RyyXO53Bw3lhcAA+lJyuUqdiV2a9tzFDJujXlcjhRx09s9jVeR0S2aVYtiJw4XgyN3P0/lUdncw25Iii/dAttXOSw7A4/Ork9yqWkiR7X553p90nsKzV09TSVmijFpUmp3UyQyQRNJFv3TngAc/Ke3p71YS2li05UUAkjZ8pJB57D19qrWt1HIs25Rvc4BGfkPrj0qTSTPNJ5L3S5QHaCvT0IJ61TM7WKs4+eNCJo5vuqGY5Byc1nSuDMUn8xGBJyF2yOCeQT6+9a8qhWkidVMiAsJnO5gT6EHFZ9vA17E8jOgDP99/vk4xgY/hrRMzaKYijjJW38xg7j7NKjbdp7qc0Eus8oyISGy4ALB2HXirNz5YvFa3AkhSMKVkGNoxg8evcGi2MJvyhRo8RsC7ZwwPfjkHpVE2ZTaSAQmIkIhLOzKp3M3ZSewNQRIokB8szrHjdGW4Y+mR0qdZlmjjt8CbBbcVQB8fX+L1pq20jxzmGRFtIGGZlOME9Ccc+3FAiqy7Jt6h0Un7rLgD1+oFFSSXF3IBtuGdEU/MTjPrwaKAKa4BYHkY65oY7iAMgd8Un8Q3dalkKI/liPocNg9TQgCN9sOHYFM/KO9RxbZJTvOF6lh2ApyAFy2wbScAE9KdOBG7rsHIGPb3oAaEM5Mm9QGbBz/D6E0A712CMkk9QM047RGYIpMo2GJYYyR1GaWOeRpRvkcqePkOCeKAGQKBIwZSXP3TjIH1FW5WiSF1iVtjgYTeDtYAHdntmls7kJFNGTIkcibJWA5IznB+poRpLxgoRAsa7S20YUe+MZpoCOISMQkW+VFIYowyB9a1I52nW3DwQs5JLoV2LjsW+lUVMUMbIR5rEhj85Cgjvgdauo20DUVlAuJG+SEqCcdCTnr9KoCO+88xrGf9ZK5/dhRwB0I+tFhDcxSFYEhWXklJD9/A6H29qa9tO9wyZ3Tb8KVfPGM4zVmBIZnkkgjkkkhjLENLggjqefx4qQKcceLuUJHLErDY6Djj1+lPmhhhtwBbyC5Y4Y7htAPQDuc+lWI/tDI1xG+yMsIMtJtIOOOD2p8kUsUyxtMPtBQsoxyB3IPvQ0Aq272peK3trQzqMtkbiPXnPWsu2eSOZbiVFKRSBnJxkjPYVqwLKYrh1YBUOGAONwPU4HvTPs8UKQjzI2N0m5DkcEHoc9+DzSAS0ZLjUbl7Jrk2y7hEHALHJ+VSOlQGZbq5la783zSgQfMF2sPXPUcVeE1gbK6aOIxSpHsw6AEnt0PJ96DpkU1nb393EYYpdxSEOE37R79F+vNAGb58otyN4iZB8karkNk84Par1kZhvmnTyQHP3sbgccjaeMVDbSp5sy20LqqMJiMKWjA6Zb09as6gLm6uUgMfmPgsJARyg5xz1oArXF/G8TR2cEa+YuHkHDA5zx6elX57T7NBYvHPCHkAIRn+7+X3T2561Ha2lsWZLeIowbAec/Kw9/8KcL0Pcx28ZilVDtQFAGdif7x560XAUyWF0koESWUpdSgVNyucYbOTx7iqs8E9tMsHlIsgYtlTuXPTKn8RxV24MYnmEzETmMqAy9JOjcjjjiq+nlPKaNpzGoTCTbSFDZyffOeOKLgSwrDLIYoZZ4lmwGjkOVDjqX9/6VN9me0tJligWfzAN6pJl4n7fh6VVnku4/Pguo/wDSersE+Ynr17irOlumzJkEsvJkJbjbzgD0x6etFwIL1raeFALR1ulZt4Z8BPoPWpYNPdrmSFGncGPzJUVgPLwed4PUCrenTpHPDqSRwvcO23bI+fLUDBOPXuDT5iJrh4xGwDOHADcgD+9xk0XGkZ16Jr2S3WCaPLBkLRgJx7+1UbaTMEscqkLuzvVeWA7fQV1cnlM5ube2itgZAwiBL8cDBz19c+9Rajcb7naxilnZis0kfzBVPG0H+760rj5TLEImiS7lmX7MAsbq3Hr1A7YPWmQiKMLHMWMEOSwQ8v1wM9B298Vp2+nstwQDDNBJkKwTarAHhTu7YB96j1S2dSWWDyrbZmMxvuMi9jz170xWZkRxRzX0NyirDbqy53NkJ6YPpmpRasY57mJZGMzlJATjIP6nn2rRttHiiuEW7KRwMVQM0g2suMjI/r2pjMIoDHarMNx6O2c/59qT0BblRYZFuIp7iIbNm3Mr4B9M1btUIeSRXYQxsCPJXoQOq5PvirskS3aNNJGzIq7AhyQoPPJ9fc02BHa8OxVVCcmRFPQgdh9BU8xo4hYQq0sl09wB8m6RVTG7PUEY7/lVGIK6qruxjHz4dd2QOwHYVNqZ8i986C4aQKoUxlSAwP8ADx2NWZVtFs3Zk2XxiVuM9STjocfUGncLGXZi6ijmi8keUPmJAyeemDTtQDpaQHbIs8p5YdEI759SKf5m2OGW8DrIwJHPBGRjI9CQadqrpctI9scIG3KUPAz2wOn4UxMryzWYsNPtkUSkOwm8wcBsYGMc7e/1pNOZRa/v5nkjnDL5a4zGwHynJHK+/wCFTXGkQvMkMEbSRCJZXYvltxOMD39qLi6hMVvaRl1ihcsZJAcMMd1HoaCLGrosSywsZJAgxnJIJB+lWjKstxIkimW3kTDynqe+R6e9YlnK13fRolokJdcfJu24x+pPWtuwsp4xNAgjLxKWZdx+ZfXHYCsXGzudMZcysZt9b2k9tDP+9lTf5cmDynp1+lVBF5VzbtCwNwhzlzuBHYH9a0obV2voLYwtPbyIZJDHkZIBzzVK6inhvGLKqRthAuC2UAwG9smnGRLjfUbd3EUksYBHlM/75ymRgc5qB4Y31WIFsuvKuy4UehI9MdvWpF229sIFkjlMwYGJSAYsN0b61NbRqZAowGkKqzjkEAdB+PencmxWjvZLS5n+0KDATgqRjHI4/wAau21zJDcCO3H+sy/TB2H+lNuxDdXf2eeOGRJnLGRg3yYOQM/Xg/hUjiAXU7SQvIwURRKhK4xSkr7FQbW5dDLJpErE/Lko0ecFfQgetYF0ssCmAKrNkspKfN3z9SOtIWe4t0K3SrO020/3lHQZ7EVFqRn/ALR+wyXKyRpNu3w4YLJtxwe4NEYjnK5VkJHlx2rsJCQHdjgH0PtWitwht0LXKMQeFC4Utnn3+hrIu7W4tJ18v5Q6AnzCNyYPPfgZ/OiORpZZJlT5id0mOeTxnHarcTKMmjo5EiiMojt5H3bA8gGNpbsPaqtyi2DwXCv5sbZEYBztdf7w9fb0oKmRIplkQnKsWGSBzzx6+1UQEaWU2pTy2fcDJxxnIKg/xetJRHKQrzx6jqDF25Iz5YUKpI9vqavSzRrLGm0J5a7lJHO4dRiq+orHKtu06wLN5exHixlkJBDOf7wFMs7vypY45wY43GFdumB/WqsLmGw/ZLhSbuOQ7y2VBO5hj5QO2QeearoqMXt9QXYwUCORnJKDqfrmrUnkI5la5VkJKx/Llj7YHTNV7tpJraRpY2knEwZ1Y7WVcYC49KoTZX8szh3t0iRNp3AL9xR3ye9LLc2puyssUlrYyLGHEQywXA+YA9+pqWJrqLTpIY8LBG5ldGGMv2B/Cm3Uo1BuY2SV0ymBwzfxbiemMgDtQQyC4srYOWgld7IyNGkzDAwOeR2PSiorNofMnhlLrEFZljJ/ixwfTtRQBnOQeAafFFtwzttGOnekVsHPG0HvShS7ytv3OoyCe9NaATBUZ2zKM5wox19yasmO1uHjjiSRJgCpQch29c1nBzkgrk8EAVIm+OXeCVf0HX60wJRAr3ewoQQNu1SOPqTSFV83zEi5dsLGOR6YFRK4YhMn94QGJ6jmrjlY7p3syZBF90senbpQA2aHyZGgLAqXAkCN8qN6e+KsXEkbQpFAsflxKN/y479T35oto/s9uGMCyTZYEycoT2/GpYrUSRfaXby1SUZQngqffP6UAQxSxwwDfgRjJG1cOzdMfQe9TxQ28by/aoPOP+s8xGxjjgEDj61JeReZcZt1WOM4VJETBZe5561EGmhXiOZYT88cQGNxHBOaYCRytE5aWNIw2RGFBAB9iORVqeYXEiyyKkEAh2sUX5io6sSOpPvzVNbaZbeCZrTdGSSrg8k5xg+/pTYZLuymnh8rYxkBeJ0yBz3pMCSMMzmXYxjcFowz5YEDgj2960BLaswMdtJJsUlSHKAsy9CeSVGO1VoTGLZkO4fOXETDJiY9wPSkgUSXkaWSvvl+VUGFBPRuTwAPWkBakkhEAXT7hCwjxJIch5XPVVBHbNV4LdPsUUkr+XN0aSRcoMHgZ7e9W4oV3L5yIFkkO5cDdheMZ6c1EdgBhRZfs5chk3ZGezL2zSAjSVPJk33aeaS0oVYeVIPO7jvx3qG/Y3dz5v7p7iddmwzZIZf4jn17VoLbm5maUZMoRnllPCSjHQADr60WyJBbonnbdyNL5TRbQ2cYUP7j06GgDMmeCC3t2mZZppAVeFfkKqO5buSe3tzVjSpY0tpN/CzHdGACGRweMf3gehqTy4VtstamSYsrK4YFFPoc9DWkX1K0IkkNuUl5Mf8AGozwMjnPuKAMy/vbmSRLm7imYbSW2nbn8v61WkaNnAuhOlvKu4qFUvkcjntWlc3byzNb2SXAeT94CxDknnPI7H3qfzY3gigv43jvIwFj2opQp1w2Oce/UUAYkS3Nw6CH5IpHJUONvQV08l0mpGKSzto7Oe3XMhL5SQAYJAP3SBnpWTJcz2kl1apMhtfMLKIyG2P6g9cUaai3ExbcuyNCSxXG4kc9OtA0a8lmtu4S4e2vvkAt2Sfll64HbPOCDVac2UlvcxvBHnoEK7Cx9B7g1as7QC3UrskL7vLUrwcYycdj096qNZwxyzSyvPujycxnKqvUDnkc0h2GKWilTy4xbqPleLnDjAwfqTVhp5A6TbgExtyqgbSTggH+tSK5Nsq2yTG0Lk+Y38B74PfJzU32RWtpFuLaQur4EqKFUD+EZzhvepuUkxUiM8e2NnPlk4jZgoyR0Hc561YtwsDhCojYoEZIxlBjqT+PNYdtqZQSAQgCM8xrznHGc1v20tteWpWWMvcMCxZGKjJ4K4HfvUsuJYvxYou0l3aOL72ORkZYkf0pbW4b7BbxK7vGHAPlg/vIPQ56ADtS20zmJHjYB1KgFxuIPTP/AOurVmJVldYWUAb1c4Gxcj73t9KnmZoo3KN5pdu8CjyNnBMBHULknr9KTRNDeW3coVkBDBARggA84PrW5pVrNqOhgzyRow4Uv1+X/GrVraC0tbm3llMSghgACePT3BrN1rmyoa3MnS7aMCeMBmWQbRlccjrx3FZ1xphtIt0k4RmYGCEZyR746AetdVFaQ/ZUlO5bk5SJA2FIJ5ye1I9nHNMksREUkSEsSBlsc9fT+dSqtinRujjbmylYKEWMh5CpkbqCR1J9qcLM20oj1GNo48E5OD5hxiug1G1je2DnzpAC29QPubh97I9Oh+tQeX9rgt38oyx2zhTsYnJHT61p7UydHU5zWbaQQIgjCnoZEHPY4I9OPrVu1git/JUzicNtxuXBcsOfYY9a6VrD7bOScRBpGeUZPHcDPp2rLlSYiKCMbVkfZ5agZGD8oBxzkY/KqU9LIn2b3Kmp6YLWMzSpL5bIp3KeSVPU57EZ6VhJdQRQvGyLIkDF4y2WA3+v0Axj3rr9a23GkWUbt9ok2/6vJB9MfT2rnHSbSriW2tyiLKcSJJGVwc/dOfarhK+5FWlYy7Sa5ihmbT9zQKxkdQAPKbPBB69fTiug0q8hKOzgBriPYZGIw7Z6/T2qsjmzvbuO3Miyyp5bgIMGM87duP1rONk0Fv8AelYx3GY1xwyjnqOFPoO9DIjeLOy0yFro3l67ooXEcaA7BjHzH8RWPqYkmnX7OqxRqNqORuynYkDvmoodXVokjfcsJwWUEk8jnJq3FrFsZjGQPIEZUkdTnpWKunrsdLcZRstzloJZSvyq7i3kYfKoyQTk896k0+5nVZZJ3/dplyOMsCensauXExEkUUMkamIMUAHyjPc+5FVbLyP3URlEk8khbbEN3y9a1euxz2syWO+jtlWQJIiu5kDsD8zdCPoAQKSeYXs4SINEHJ2MOjDHJJ65ziq1+Zbl5iEdY4cMFXqhJ5+g6cVFa28rJteJhhmBDAkj1IHrTirolydyzNbiSPm4hjc4Ty1XqMclse4xUWn2lqk8QmtXnikcGQb9pCdgG6D1z2xVueVbNYIImP2cEgMgG8gjnn19qoz29zaTgOXlGwZwcYU9OD3x2prQb11IdRtlaN5y8nnu3lF2cMJTnsB6DFTx28zXkcgTaCqvGqupV/d8dPYVaVWh09Z0YRuGIht3UEj0fjocdzVYbH8y7niVt5LKB90sOCeO39aL3JtYJLqT7VNMYcXTkkLnDE9BjGBUbyzSzI01shJDeYiqAeB2J7+1OvYxI0LI8ckuwyBWB+UDoqnvwelQyuY3tre5jQNJ8/BB2g8gg/0piYk1vHEiKIh9pkIkjhJ3NGh7H34qusRSeBkkEkW7CLnJGTyp/wDr1Ynt45ZopYpflMm3aD+8yeTge1Vp0WO4KRs7hxu+VuN/1+nancRPNHcxyW7pCU+dvKkGNjYPT8PWktoEkKxyRmZWdiZVbawYY6k84HvU1hD9ha4WUhnk2CFy2VBJGTx0PPNLGwvZLuFmzKFyoTC72B5Jz/CPzou+g7IpX6TT3cgtnEkvmduASOhJzjtTrvasNtJG9yuyPLLKoO3nLAEckZ9ajnk+2hWlcK7HMnBwWA7gVLJNNc2yyDKwuzB/3YxuIGQD1APvTIZTmtsW63BTfGp2sVOPLJ6KR3+v4UVYtpY/sUyTuVllkAEKx54AOWyDxzxjvRQBjqV3gtGSzHIA6Ed6jYFJJBypzjbShmQhjnIOR7U5GJm3JyWzkkZ696ACEFQZAM4HT0ogd0OVz5hG3PtTQT5gySMVb04B7gxhmVpGCRttyGJPSqQEEkRVkDDyzwMvxn3NWWa3a0xuCOo3GQDO9v7oH9aL0XT3bWsmS8ZI2H+Ej196bBGBLE7JtTbvVSwOe35k9qLASPARB5qSbArBdq8n3OKm1CSKSQlXMqg4ZxxnGOn9apIx3s0jsrYLBAvcdAauraIViGTJIx+aIHGxffHUn1ouATySymJ45lYIu5vm7A4xg96ntPtL3P2MiWSDaQVUj5cjOf16U7T4HhSYwqpOOFJOGH94jvinIrJtD/urm4k2o8RyduecL3z6UwJ7rz4oWjLeXAhDM0uC5YcDgVJsE0IluJ/tMiRqGVgVKA/X0rMuGeOWVI95Z2GOc7gDyT6Y9DUk1y13Aomk3XKKwYgBVK9c57kelJgSQeXBOhhlmEikjMYDhl6YHct7elU2nmuGEKcAthRt5Xnhfb6VPIgimt51uGWPAIWPl0PvjvUn22RpmFv5ULbcbpEyVPXOT0JqQLd4s1q4t0kSSJ1A8lDk7uMj6+tQRRLKsKTTrHGHZmxKf3eDwNvrUH25kgJl3b3bj5QAF65B+vapYYYYQ7SBS4CTBTkmT1HH8qALpuY38sxGRV2fKZBtZmHHOOoI9qggDXNyR5rSRW7kiUHCc9hnp6CobSVnd3RIpQPnZ/4EycDr0FPNu8aSqVJ3x/OVfapzjBx3oG2PuLu2LyGNFmTywoDDD5xzkjrQ9wLSVX3u5kiCmQ8qAPQ9hzjms1bYRx+XJIBljvx0THTJHrWnpVs0Mq27TRxuWWRBIC6ODwePyoEVY5iWmt43k2SIq5VS5XPUfjVzUooFdY4YZ18qMLGj7d23JG447/4VKhs9MeHcZCySsJWHC47YPXr+VTWdpLdQPKxPmNIHVgcjGMn6jFA7CIGnWGZrX7I5URLLEudxAx0/vHvSQQFboRX4twigDy0G3d1JPH3iPet2yhhugrTThVkYhWkIEYO3luMkEcc1BbWYuVjjcDz+iyLwxGTxn0qXJIpRZTsJlsJHiXMzqwZUYn7p6c9uK0Etzc3D3SypAqqQNxLqxA5/EdKSy01Y0nmdI8OAig53q4PPNTaciWVw8UvmGLBZwF4Vsd/rntUSl1RrCL6liGMrCkDB4oJeXIXMYOOGx7+lSPYj+ybZVzErybUYkgqe5+ntWhaacgeaQiNrbaGjAJJ3enNNuNPmSOOJEWSQEuvluTwOob6ZqOdGqpu1zkjaNJqMlvbRCGVht3nAUk/xH/PNQ3EMtjLHJC6IGXZtAOWGSNw+tbsOlX7rHcxwoyh8lV64/vN6LU8sMl0yEFUTlIwx+5k/Nx2z+tVdGSgyGBlZ0t7WyBlZMp1Use55q7pMVs2owyzBGt42+aKRiu846t+NZ32BrgxxsSZ0kWNASR8pJzgelXXikXbDc2Zlliyv7uTLA7sgPn6cVDdzWOh31omny25aG5a1jJO5lwfMB6oo6k+9Tw+GrnUJ7dLYq1tu37YSHlA6AMAcDpyK4/SoryW38yySOWYEKvmSAEd9oX06811Dz3VpGGnga3WcBysbE7ccb/lxnvWD0dzsh7yLWo2badesFaB1tWAYHB3Z6qR/erEldrSYIlo0scxLFQRk+iAetb0Nuus2udI8mz+zKDcsSEeQ8jfzn8cVMdLEVxBHdwPqNvHCzrPD8qgleMnvg5J9az3NnZLU5y7S4SJ5LmQwPMgQqicxjPfsc/0qrbW0WkztH9qkmgmIlzBgsecH6ZPrXZxwwPFBBp6+agcOUK8kY5Ytn7vt1rDmtnuLuY2/mrYGQxyrbxZeNFOWYeuOetVFkTinqQeRcSxrFb2cruzYXK/l+FU5tKN3dQSyskIiZnkG7YEKjoPeuysYhLB9uub5zYJthRShLFNvy5wOOfyrP1WwS7MkK7LCMorGNPnbOM53E9z2qkKST0OSlHmSNbpOqTxspRnXIUEdfrmud1xBc3d5PB5krqfmkJ37mA5PPP8AhXXeIo7u1eC3svKWW5XY0Sx7fLXueec+lUU0tbSzEcEcjMObrIHzL15bn6e9aQly6nPUi5OyMGCGRS15dw/M6JGiIcsgPJJA9qjmQ3KG2LNCd4DykYAU9FYd29+tb2rx4cSxTRsVi2ZQkADGDn1PvVKKzcadJbCRFZh8zyEfKzcg46ngdapTuQ6djndXWWTTorUTQ7gzCNhwTgdz2B7VhbTayeXvNqJOCsjBskDrx0rvdd8uIRWscRW5iTFyqEFenBFctJZKVltZvNM0ilUaXhYu/wCPatIu+hzyVtUGhv5lr5Kyx7ZMhiE+f2JNQSWbW8qTWrspfn0K9v19KqxmSwlZ5n3zRgMegIHb86u3ckvl27yyRqmTIs78FOOnv3FCWpN+pX1TzEVjEk4WUhhJI+Q2R1yOvrVaKd1/epl4kAVvn5kbHqPXmmefPe28cU87LZCQOoVR26nHsP51aSK3nYRxNHHEFzG2NpYDueevtWl7E7st2sR1FpFRGVQ4BwANuPugn3qO0uWlulkeTY0O4kHkLg+p61OtswkCWyyGOQhX2vkSY6n1FJf6ettcpC0DNIGx8vzBh2A9azbuaqLKdxcH7THJvaaDlskck4+7jtWe8xmRFj2JIfkC5xnPv0rcudMHlQPpcv2udpCXiVSGVuOMe3NUbwJI0kpuES5jkCDyUxuPAGFx9c1SREnbQhvZjJJbWxtoVMYCI4PGSOST3J/Sq9/Yjy826IvkrnfgjGOxPrSRqBcTC4YNGoILIMqrE8fQ5qxNAhson+0iVoQNyqvBBPA98H1q0RuRRwvbtBJGEjXYqtInzFvUg/jVqApc3LvboUigyFVyDke575NNjiSGFDl3BAU/NjOefu9KqywhbiSTfJlHCr1xnHTI6mlYLli5MtvKYI2RQ5+bI3BO/PofeqpjmkZ0h8t7dMSyPE24AH3PfPatWxs7bylkmy7SA8oxLTYI6j0HNUrv7SbphbmSKEttEaEjcB0P1+tCHIoNCn2iJRKZGkO4pboW2564z3x2p90xdHjht1jTG9QMFwO2R6e1W1LT6jK01xKjQKfIUAkuRxgEdOtWtb0220XxRHpt/fmNcJ/aEkMOTbueSB/ewMZ96q5FjHliW1IWaOa2bbnnO4nqMqcEAiit7X7We01e6GualHOVijMMy7m+1R7RswccfLjvRQFjiDEwfblST3zxUiShH+U9sZFNWNWKfMAeppRESjsF+QNjdQIWP5mZAGLORgjnjvU00T+ayhlO35OTggeuO1Fou2QeSX85QSD70eUHh2sdzkkg4/kapASzRq8yMrExMdomK7dxHU/WmkxrJOY1UYQqhYZ3fT3qa1H28yJI6qBhznCgAdce/t3prxIRF+9McQcxjeclefvAY6UwCMQvIvlhmZTkeYSS+B0I7D3q3HqYULGttD5ocys6L8zA/wAP0FRWtkzB5GnbyUT78fOOcDjsDUnlC8m22g2FCBwp5P8AM0rAS/2jIlvcKkcZjmwGdxmRAOcA9hTdMkknu9ytJIqZLbfl4H90nkVXW2DENIquysFdM4A9eOpqeQR3FsZZBFCUKthBguDxtA9eOaGwJYJxJLJG6iCOTj93xjPc/wD66g8qWZC4D7bdMyFlB256DA6VHK/nHyYISFkIOXGAR7e1X4jDYOytMwB/dFcdWHXkfw5pXAorMu23DrEVhX5Ihw0rMec+4/pVxGupLCNY7dSZJWO1QSUPuP8A69R/ZoblQ9vJDGd+w4IBY49/X1pksCuBb2cs0zK+XKHA5HYdePWkBNFajybffdQy5B/dkEmNh1yO2P61Yl1FLdWNsIg7ZAV1OUJwMg5xUN8WKxYngkhjUIXBO0EgZVgOe3500ufLDsRPubeWVQOQcEKe/b6UAWIh5iRRwJGrTfu3YDbGAOoPp7k0upJNFJGtzt2RDYSvGfYDvmqt8BE9vDBI3mYBdAeFJ/vHuQOtWYbv98iXbZhGUjDHcVxzuX69MUAi3Hot3FB9rayRLZ0CBJMMWHqR1x6Gqr4trxWdIFWLhlh+V1H94j19K0tXu7W71J7qS4kt4JgP3CZJjXH3fbHoazriSK7uraFQJk2lFP3N+Og3fT16UAzQhhtZZJJIrqMERmRFdSzheuG7E8807bAiRT2yCGKQF1BkPIHBIHaslbLy7gm23OHXDRnqmc5Unv0rZaeyZHisoZAV2h5ZGDLjgYwOOT/9ekykWb+505L5mgsvs9s6qVhWQyqTj16jJ5yKtWxNxDI0ywGB2wiI20q2OnHP9KzbaAwoZbdGeNWGU2bEyOwPUdenSrMktw4W5ktWjfhXckkE9Pu9hWbNYmhBdLbagsM5BjVmTIO4AkYGTWvdadJZyLNcbpHVCSpOGkXA249ay9PtZLuxWZI4lG4hgpDmQ9+Ov4VvW+6U/ubfftURsZjny37Y78ispux0U1dWLukWqSokg3ssigEnIw57k9B9KsXECSK0MO4yKjD91xj1Y/gKs2dhLJpcCTxSMfMIDxN8mBxs2gc89zV3S00wXNxZWaNJGUKS5z5rsOQw7DBH41z7s7lZROWttLYusLvlZmYxlG+bA6tnuo6e9ad/E4mDyNE0giLKgIwVbgeYe/AP0rXtrd11lLQxSyhlEflxKEbYD39OetSah5s8kAbTPNWN2Rwx2u0fQ4/vAdMjvWnMzLkRzM2meVpl3LNboWRsCTkCM4zhT37VShgjt9TK37O/nR/vHT5gDjufXFbdzCkF2m62nCyExGCRml2448w44wP6VT1LSvsE3nWkwubaVhEgIALsQD06Ac4o5iHC+xU0rSlg1DT57ZoViuHClyCygE/dYevFdzKs0Np5t0I5LIgCKOV+CxPIUdQMdjXH7UiiWONfstw/71452KYYdge49K6PTINQ1uwW5dYhHa/60O42uTyPp9fwpSlcuMLFqbVFLI1lawQRxONlzs+aRD2YdPwqt4h10SSpaWzRurY3JEW2uAON3oeTx0rQ07XLdFvzY2SxpMFR1z/q8YDMOOf0xUOoacDYzyWELTPC++CYIQ7Jj+IHggdaixo27WKaTRTabKLG0RdhAldycpk44HpzVnRrmKxiNrZzMLiRSHRThpCQcg98dyanso7NLCGK5YnUbllkDE/MAoGOMdAaWdLeXV72eSaCHUISJkmjBCzeqgdQDz7etT1K/Ut6bbyW8Uiw3CmSKPhYmDJO/oM1Xv44rDTpIJnYajcP+7ZkLYbuPbHatDxGdN+12N3p262S5j8xpFA2RYGQQOuSQQas6xYaTcSaY8bMfuySi1lL7lIPzHP3Vz+NNXE3ocTDodxbSahNdFLjyEG6USbguR09T1xit/RrKxtTp8k7A2c0YllRBukYjjnHT0xVS4DXGprbSGW4062kMi5fEcvOM5xzU9xBv0w2NtbJBdSM0eUcsQD/AFB7fjVCa6nGvZTS390Y7VpYnZike7DQxZJP6d6prb3M093JFaJFDjy4m3jaB7e9eiw6SdJtmh2TuXGJgGAO0cFWOeTkVyiWEdpeSmzGYWfYInO9VBB59mp7GaTkjiLyJLWez82JmDIQ8sgyWAPP41S1e+t1aOaCzii5Dfu5CcD0I+uDWrrzW8lx9kiPnSH5cO33T6+gHNc5qNmLO7nsWkjuPMbfuU4Xpwu7tW1O9zlqpIj1e2U7ZXBE7MJGcHG5Ou3HtVS8tmnk81Yf3cJMxgLFlEY6YPXr2rUiYOx82RN8IC/vW3HGORgf5NV9TiAlheJxGsibSwJKqDzj1yDWlzHlujMKDy/IuYnERb90YVyWzye/U8DFLHZyidI5FSJQoG5f4cdASO/Na2nw5a5iJ8sABBGANzk98+vvWpotw1hqqfaIBe2iMRJCGA3ZHBP09aHLTUSg2yhYXbSQxRHy1kjLJkDBBz/L3rpPDOiX+uX7RxzxRyWsbT+dPMFRQo5wP4u1UrHTXj+0SW6R7iCWkLA4JOeP8BUyxx6bI8k6K07IUQMeHY9wfT61m32OiMXbU5+5CRyyXMJMDKAiomQCxPLN6VmuI0edZJHZyoLSFslm7AjqcGtqSE4eFWg86UmQl3wrnOdue1Y6Is8pMCmRs52TDaqtjHJ68dq0hJmNSKuVbNXs5GhkdXkuF2OkQzg+/bPemw2ymeOKSUJFNtWRwudq+uB157U+426ZezysUkfYE2MnGf8AaU9frVG0k8kiSZJjI7hwIyFUKpJbI7+1aoxJI4jiWNohHMnygNkAtn09cc1NeSC3YLayh41KgSKMKGHUc9TVeaaXejcKZB5iID2zkZ9Kt3EE1rFPDcFD5fzPNtHyluQCM9T0yKBDIpJYZVLyKqq+1iHwyg/Tt61Y1Kdob2X7PJJBHOqlSGBJyOnv3rKvbJI7VJfOXY6luhyNvf3p9xG5tIUkPygBgSN2FPPPt3pWHckjsbk2y3EckaSoyklOxJyAc8ZGM16FLo8msm3vta8I3M+pSBXkliuhFFcMBwXU8gnHUda87jVvskcokLz7gsfm4VVAPBHqP6V3XibTYtV1u5vF8U6YPMRd8ZkcGNcDI4HTPQ8U+oHH+NbvULnxFdN4gtjZ3KqoFtDgrEu0eWPptxRUV9ElrrQitLtL75F2zwklZM9snqR0oq7E3OcMXyKWkQ442LyR9aekRmiCsDkMdpzgfjUS4LAdM9QakjdoCAVUnJGDyPrTESovkws/mAu3BUdcH3ojRY41Aw7t/wAs+o68ZPrTZfs3nAxq/lsBuJ5wfb8adG8e3f5QcY4UZHzY659qALEdi8fkh4GXeWBJYEyYPQen1pIsrcK0rRGNTgmQ8A9gR3qvLJ5kUCBpMxrhQeuTU1lbyzGSDj5vmKkgZx0P0FIC8gSAuG2G2mGXJztB7cjtVZSyqlzZM8e5im0dc49ancs9ojylQhcRKSTgjuQv86heO0+zA+czSmQgIoP3OgbHb+dMCzb+VN/pZV1Z8grnK7scsT+tNhSZIXaMRymNtuGTn1yfcjpS+UPJ+zz3HlxKfMiOcbyODketPnt9heOIXEe1Q4RcE7+5JNICRpYzp8QtmeG6WUgfP86qV9T9TUL7YgIUMispJfJDK59M+hxUX9n3EUhjVQZCuVyQT6k1atpoZHkkmltwyMJAix4Zzj16fhSAY1vALb7RcfuCxGADjGTz7jHSi3CWoVY9geYlRDITjH97d71NcRm4l8xj58p+ZFlPKg88+tQHdNIglwrRrjMjYyvOcZpAMuLdE1NYLN1kgnVd5KgBemQAT2PrVhYYJb1EhaVhGSVjB+VUx19PrTY2hktHj8ti25t7rjJwRgAnmr1nCkMKLMGaUxspiz9xs9A3rgUAUpNMVdQkxPDJIzZWPoCMZIJ7f1p9ksen3kX2+1RljJb5c5BzkdO1XltkghilEUbrMpRpQflR8crg/wAXXms7zXmUQNvmaKPCErjaOwz3+lAGhcyxXChrmdfOIzsVQWbjJye5zTdO0syWssqCMFCsoZjgqO4+tVY7S3tDvRmnV1I8zYQASOQccjHrUnzC9t0FqI4w24Iqlo3wMZ3dSO9ADohOl60cZHmFSDlRkHOdxb1q+llp728H2iWTzmJlZoo9yN7Oe59cVHBYSXsjBm+VyWU8KODySO30rUaC4Qy2j+YIl2+YFIRiQM/L6DHelc0USrBE8N0mLthLE2XjmTarcdAPpiryXlk5wSQcnDEliR7inzWcUccdyLkvKgVmd3DmQnp9fxrbsdEGoB4YmdIivmLI5AYZ4GR9T2rKUjaESXS1hjFpczxCJJCUzAoBByQrZHIIHXPWt/TbWaC/lSKZCLh96uYsx7lHRx24zzWTPaXWnTfZryGM+UpixH0kA53FexPrXV+HWLzIWnkS2kiEhOVGB905z+R9ua5pO53U4rqZt+bwxFEFxbW5yd+/ywRjpgcEkZxjr3q9b3F7oum77WASJNEY4I0kDSRRORulbH8R6DNR3csWpHToJ3kMRZii5O/KjAAHTHoa0otLe/0xoxIlukUYWWOB9shIPG89yfTpQgafUlgt4pUZYp7q0u7tfKe5lbb5IOcAj06fjUZeQTCKaS/vY/KwxXBJwcDkdUJGam0e0sr+/uf7cnuI4IIw0FtuLPLt+8CB17Y7VbLJZaaXAmsUZg3nQgvIxGdqEDjHqKl6mkfMp6ahtPtNxEYY7KVmtxmY5OQc8+gIrP8AstrDKILm6cyxkMHiXdExYfKDx+taEMXnWVut9pk9vYM4cyqSWuxnGMdufStaL+yrG8nOnpcTxMixpbTrhkcqc4PTuBjsc0WBdkVf7Ie7vAZ3MsZIZpJAoPUZA7Yx3qaG2Fn4q8u3Xfo1w6ssErAqXx1JPatmeGw1SO3sJN1u8du00ojQ7QMjCkj7xODxVDUI3uBN5zJDpkjM5uPufME4RfUDHQVLCLuZ17pcTS3EkpjVpmWMEfIgcvjj1GOSfSo76BNE1SOO8vHuFIdHQsQSB0OR+HbmrelTWEEf2W/ZWY26hXjQuV3DoT2Y1M9pOourRRbpcrgYI3bEC5BZj3PcetMb1ehDaxTagl9buv2e/LoYn8rMiY6Lg+uasR6Vf3975f2W2gv0UMJ5OnyH0H5kVBAzRay9xCz6nGiLLOZBhScAFgR1I9KZpWpGXVdXn1CXZYRykwRytjznP8OeOD6ilbuN6XaKhnn+zCKa+s0upJ2D7YshFONrDjp1qxEmp2dlK0b280/lvbPOxDFFPUnH8PNYgtzY68yCNUnkTcYHyVI6ge/sPatqCbT4tXE1ypiW6TY9uiEDzMHa2QcY9qr0JfmRWH2iXRX8trV3t4ViTfu2HBIIHYnnr0FZ2nTWtnNbzXluZVln8yBlZgrHaR+f+FbltptyujCa10yG5SC2ILE/Ncpn+7261R1W6lks7C1t4t1vbCOWaAr86jcSEB7YOfrSsNSQ22V/Je4thJCHiYb7lC4cgkAY9T6mucgvGguPJlMbRLtkL7ioiA67j0PXkjt0rtjJDq0c13EvlwsPPaFJSFOFI24Hfg1zGnrt0SS41W4tx9qIKblzhBnbH9elNPqS1fQ4XxrpyW+qf6LL9qE6ZYxoVx+PcH1rAisVkjMkdq0SBCvDcMe5Ofwr0xIUfTYZp0dHYbI2GBg5z83sKxdRBMP2VUaY+aV3IAqgnkfr3q1UtsYSoX1ODgt47dZpbgFYnxGQvByOmfTr+NE7TQGKI3bF4iNiREZyeM5PA/GtbU5i3kQKYVJU7yRwST09zWbLaWwtJDFEXYjbJkB2Hrgjp6fhW0feOaXuuwsNkbCYpdeZuAyDncykjo2OvsaleeSaa3EVuEkAAI6Bh61RlvJWt/swieKBiZIyRklhxgnuMCujaUXVsgd2HKIWbjAHJGAOQPWlJWKpu7sT6Yrwiaa5RTbqwDRscAnGcisi4uYDcvJM5WEAsoxkZ7L14rdIM+PPMIhjDMikDA5rltXSwN8XAYrtwQoPDeuOhrKKuzoqu0UyW4ntTH9oLKvdWJPytjgY7H0rN86J5XMpUSKobdJkE56dPzqjPJ5hFt90bgEYnCj3J7nmq0oglknY3b3LROEjJJUyKPQ/yBrpjGxxTncU3EizyTzsku4bPMdt7g+g9PxpJzZPprxrMksx/e78MrIemzaeDnrmmSOiQRkKxmUjIkxtZey4A/XNWzCyndKijOIlj/hYqOM9yOcVojHcp2KQQ2yTh8XnBV3Hy56Yp8jhDcx28ULNcRKmZCD5eOdynseKsXK2lsgli3EyZBt5EyIT3GfSoTOkAK28UJicgO0ils5HAOOgFAFZ50igjkhLsQv38YBb2HpjNIYjFDbzxIAHyHRTt2n0/GnuDGsqWJ+0xL8sjEZ2N1JHtUt4UtYonaIOrxKx2yA8Hvgd6YXNPQ9ZOlLMJLC0usnhLqHzFQ5x8pz1IrWHiu38l3bQtDDqCvyWxBKDHBya5EIfKMaNErqFZUVw2UPUE9M9DzUc1u8dskssY2swUAv1yPakBb1q9bU7i41K2toLCIYXyrWMqioOFPtuOfxoqa/sbERD+z7u6uEgjAuFSAoFXGSeTzhuDmimFjno5cFFlG7Y3PGce9OLKkcqLEWVmBWQjkY7VCucFxsAXGCe/tV6VmjtiSi7yQQT6d/arRBDIT5LSSYTfyV2+vTAq99tiuXtkVDEo++IRglgOoz+tUFCS2crZAO4Ag/wj+tX9Mklsbpvsy2xKqN7bRKcN16/0pXGZpQ3FxiMqSzcMOgqzbxvCGTbtmyRluv0FW5FjFzIbUyLkZQoBuz9P8Kbbxzi9HmeTMZP3glVsk//AF6LAMtbeVnhLBcuWRfMPTA5Jqe0a1hhzDOoupDlmPAjx0x6k/pUXlRuQZ32KGIOOQD7DqTUsNnGb5vsTRSArtDA48v1bn2zxQBXUyBHxCZkjf77jkE/5FWby6iMRhj3FhIGZX+bBxjJPf6VOnkaffbUuZHjZiPNPQjHBI9KpSxLdXCmLebpjl3ZQAfoBSCxcsyouAZol8oRnK7tpGR97P1ou3tEMD25aNyrRsVjyJPx7+lEdk0AnfzFjU4Cuo7g8Agn161aUxSqVe6kdkYlyiAsHPUjtii47FYeZco8ck0YZORGseDGp7Z6gepNXYTc3JtkNtFPBypVsHaR2Ppx68VlTo2n6mkebiZZlzJsPLDuM/Sr9skX2eWdJZVtpTggZXA7c/XsetIQtxCgX9xavtWRSuxsYPTGc9qa0M9r++mLtasxVdxyyleoB7tz+NLiK3HzXE8NoRmFTzuJ647ZB9aqXEzNfMwvGIjH7s4BZsdPbrQBaunlunZ2eWKFP3qJKvzKR/EVUYGelJG8k9pF/Z0bgRh9xlYZK4GTg9uuPWpNGv5ZVuGlV7m6kB8sPkIucZyRgnPp2rRls/Ljlmurf90pAlBO/kdx2UZ6HvjFAFDR7hWchhNtQhPLtv8AWAc9AeOe9Xv7Qguo0eQTi3iJhjEw3MuBnaF7ZPes0ak8uRZwqknCgxgqxbOQfpQs90155ky3CXAzHIxIMmT2+n0oGjZs7q1i8iRgkgbLMuOFzwMjjGK3LcR3NyZoLpTMcYJAwpHB+orlrOKR4VjEcGcltiryR/te9X21OOExwvlQgDA7d3HTBPUY9Kylc2g0nqbUem3kskytlc7kJVckkDIwPfsa6HS0uLuPfDKJHVRsJ4OBwVOOtY+k6lq6zs6zw3MB+UQucb+OinqMeldDpWpRG8g8ky2kzHaY+pTP3selYTudlJxvY0bS3ulJm1CFmRf3asv30kB6nP6mrfiBbYWyyxoUit5yhIHMoPX5uhG7ilfVFa0meSFykCsru4wZozxwOmQPXvitHwxe2dzZ2aagqjT7Xe2+ZzsMnGAR7Dp71jF9DpkkipbWkr2V/dWQSJ127pZCVWJMchM9/wCEU+4t8TwupaNIkXyI3y+9sZYkrjkA5we/FNGsmbQre3lmgaMyzzz7zg5LZjU/7IHP1qbWb1buztJDPC0qBCkNueTt5aVvocDmrEnbU0bfTzdSJe24O6PaFkXKNCcZ/PGDx3NX/tzSR6akEEivZl3azUgCRhgAsRxluTz2qHRdUki0We/1y6mVZJRNBBFCd0w6FhjnB6elM0I+TJc3cUF9cFzhbRht81jnj1woxkigJO+psXl5v0SGy0+3a2vHlFwgm5EjDlthBx0zn2rMtbuwTR7m3kRri1lm+0Jd54Mucbcn34/Crt1Dqt3M8l7ZWlxhAI1TK+R3IQfQYzVa60WSynka/u1JMivsBwVZlODs6A+v0pPYUUkXdKvLmaaOa1AhuCAlw8p8wRyHgMoHXArMe3tLq8Nu9z9uiaVojtOXYjq49BVy8i02wmUafNd29zsy82CFZyOnHTv7VVFzGfslxaXD/wBr7ynmGPYvQ53dvQ0nsEfiuh99efYLbTNPtmhtIGEiLMwDybs8BuODVvSpQGilmSB4om8ufzVKO7n7zAHjPTrVQyNqVnp93cWSPDBkXDRpks2euT3qteWMepWMs11NPAh5iFzKQuFPP4gY61DLW1jodX1a1Hh25tYYjFcSMILZSNqI2Mk7sc+uK5mF9Jubeeadri7iSNILh3Toy9WTA/Crmnrp91fWc18bu1XzPNg2fMrKBy2TkknnpWBqui3VzcwvBcu+mTzBwHfbKWyRtYDrjFU5XsJJRbSHSXbS6vaXLBbhbiPZE8oLMByAre+OcVd08/2Vp97I9iz3MVwFRWG6PI5bGe+Dj2q+1laxrp8LTlmj3F/L+Z41wTvC+oHHFLp1raOLqS5F18iGONmJ+cHoxz64HFNBLaxv6XLJfaBAdHiVJS0kSuV2lRzgE+w71xMWowpcvfGK5Mix/wBmqXXCzSE5JJHU+g5rVtBqVnp9tIszR2YBZ4mXbtDNkNz+NVZIYXnbZMwgljM8SM+5hMCRzjgHaM0OQlD7ivbra29hEhZomR8XsiHIIHzAD/a5+nFV5bMWXh22ezTzwiszGXAXJz83HJ4x9KSaN5mhhupUuNSkCtEF+6STjkjjp+NN1PR7p9Rkhup1lFnbhDHEQq88AEjgjPODU7jei0MzS7l7zTbxEgjvBHFvjMkmxUzxyD1Oc4Fc1p1q9zcNAjzSIY2aSJZArMc8H2ArotF8NSfYJbm5nhiSMqWHlhtwbIHP+faoLuzto9bgj0tsoELPPKnlqQgyyYzyfQ1V+xNn1Oa1WyEl7BFZBpbiNNw4Dqo24w3ueeKyna2hPkuW+1Rx7VCJlIh1CsOp5Paus1+zS21eQ6ccl7dZNy4Xlu3PeuctdKa2tHuZV5lYnzSOG9foa1hKxhUhzbHM30pu0lmvYpFtY8LHH93k9AO/NWbCzmvIpMySRpFypYE89dpPpjvV/UrGCSZYnjkQlMoeW2gHOWz3qTQrZpbNnabCKTEv/TQCrlK6MYQfMWLYCB5XMqO0kIJUEDa2ccg9selc3qd3/pCRrJsOTiT+Hfjpn6dqfetLLHJPHMwMT7FA4JGOD9axGSO8uizTSxqB5hZF3H64/nRTh1FUqaWKsz2sqJGqhMEuzvnqAfk49cdatbfKjiY26xQIN5L8tNnnAI68VKIbW7sFF0YoJl5MmwmXZ2LY4x7VSntGh2iSdpGBGyLG0snOCo9K6DlFt3edzFZQ+WwBdUBLfnn61ekt2itWQq6SK2yUueFYdhj9aJ28iG1OnmOKdlCzEHEofufZcf1qO1a3aJLmA3IlEZwpYAFxwQOuVweO9MaZXeJ5JXWOdR8pDSE4BPr9DSSqIbX7KkjFV+d5lfhhjnb26mrmlzTorPbhlhjjwxwGOf7pz1qOG5tTHEsmWPnF5TkHKdsgentQhMrS7TZxrbKIo2IXzM4LeoIp1ysA3JPOf3H7sBUBIHXIPcZqfU0lF3JEd7RTgfZmBADLnK59O9MSKaaGRmC5mT5zjqR2P1IFArFKSaG3umSG3EcDEADzCSD/AHt3tnOK9NvdMt9EfV9UtdHhEtr5VjpcMkfmLcOwB83B+8Tz0rzm/Ec8Fnb6fYHzARGzlSjOc85weuTXa6lpdppOiyrPfX0lxpV1B5k8lyQqEglkjUfd44BPekNGd41sYYNUvJLSFIRbJG01nGTtR3QM6jHQKxxg55NFY3iO1XSPEX7gyyWjKtwjy/fljkXeA57tzgmigXMYEECu4Qsi55w3UUHE6OFUIwIXH9agLLtRmZmU8MR1qxG8DJ84lDKuAqjO8+vtWgiOHCK6synB3DjoferdoIFkkkuDIisp/wBSMEMOgx6GqZmln2FY1KhuEUYzj1qzaxo99brL5hhHzFRz+FIAy8cbeVH5S7+JeSwfjv605AYUlV2+cN5gGdpfIxkf4UkymaZ1ZcLHlnwRuJ6Z/lTfOaG6RL2N3jVhvj6MB6UwHQN5VyzuFZRltxXg1cjtlupW2vIu9Q7Y6qPXHcntVZZGgu2MKHyC+QZxuC/X1FWpb2a3cxqo3vgs8Y+76bfagC4YWs7QyFlkG8Llk2sPYg8g+1NtxsY3EYiCAbief4ug9ah0xvtUM8UzuC2d46s+emPQZxmnw28kFs1zLthjUBA7MMPxgqD646UgHQ2+bdRcmRZeSVYbkLE8fmKp5BDTBgsB+9CoxgjoM+ntWpBIiLD9mj8x2bqxyWBPBK+vSqshmsJbuPzNjSkCT5AeSc4HpUhcr3l8WtYQhCxqM8Lg5+veljjS7iMazGKADeyIWY9PvN2IFT3KwXcilTDBbW8KhhEAXk7Buepz1p1jAk1vPcSy7Gt8BJUj+Zec4IHXPrQBG8EmnWbujxXQLqsfIdVB747HjFLaQy3cgBaSIlsvJ5e5QvUAKO3Byalmkllnhu2WP96CwRFKc9AzE8daJbjfPJm5Fvd7sfIWPA649ie1ACxw3nns1mpkjiRi7onyhSeS3oDUn2o2FjATHci5lJEyEkR4B+UKO4+tNjguv3byxr5u0lQjYXA6lvX3zWtDKZle6SULbMwVY2AwSOoCkkgc8H6UDsU5RMWnu4vMtxINkqrz5LYwoz2z/Wnw3EJidhtWRfvlXIf/AGun8NWUjlSK4W4iinaUBjmUfKfUgd6pXcjQOdqqkzLndgY2/hQMsaXqcR1AQRxBZEyGdSWBI4yueRxVm2vfMyHhcXMLsixgZ3e+fWq9jpUUjDHki4uiEjdnKhSSOQP51YgS8szIJ3kV4yR5qx/fUHqKQ0TW8jPIIYw8dyw3MXbarf4H3zWrpd1LdXU7PbwxIoGdjckegY+tZls7ebINrSRBMrtVs47ZHfNdJpWk2txZzTQwKrK435GwqSDj2PrzispW6m8Dp9KvLW1gjX7FO1v1kdyWUnoD0wOM10eowW+r6myWdvB5FpCvlrC+4TMWBLEeuOO4rzWwuJreRIykklsOTESQrj0APbPrXWabbPd3ExgZYHkjKjcSn2fHJ6duOK53GzO+L5rN9DoLLTLLxFq11FJA8On2ym4EO75mZBggn68AdKm0y0tbC0ury6QTSTbY0hIGCxOArEc7R+uDWbbxF7lrmSDbIYsQhXzLJz95s8YPP0rWtpQ9vJahY7WXUHi5IyIypwRg9Mnj8zUlW1Zbltf7Cure9tp1vL5kw0TcpAAM/KB0HXirZz9vguLGQmaaMSTS4DeQPVT6013mazFpp9rBYxSyBUvN+WUDjew7dTVex8ua6istKnllmmBNzMYyyqvPOfRiM80ME90zcMMMkdrFBfPHFKWBnlypcZxtA65Jx1qK0tried4rq3nDSylpp5RuyAAPl7g4GB6VcslRbuWW1MN95QVkRuUjwPmbNT+G743F006H/QZWZRPOxXLeqr/d6iiRG2vkV76++zwKlmLZ3UmGJnGGKkfex3IrHcRLaxWht4/OkjxgNnn+/wAcfr1rZ12K2kvzDJZF4ZXBtrjPCuB169P0rNFxPaxWH2B4o8B0SFgHLsDlif6YpJ33GtFcoXUA0hhLLm7aG4ELKZPlWNx8xI6k1DrDCTybUW6QQC6H2UyE7XXOWLDuMY4rehgS4uoXu7OW1naEBDtyqMe7GqE9layQqNQAm1DywsUisSGdWIKgUpFIrXGr7FsLSOOVLksYVuowPLdc5JGenWs7U2a3vr+1lRxIDglSce7fn6VrXelyaWlravvCXmUWNlzJGe2B2Gail1C6gkdr9LbybRlguLiLDZTPPH8zS23KUusRl0lzaRQ/ZZDbzNCIxKwG92YAEgdOKm3LDqKwTgC2gtTBKwY/KG/iI/vE/hVqZHvru8gg3CAXKXaqDxsI5LFvcZxTbWX7Z4hZLy9gaW6AwGACGNc4OehOT0o5ug9W7szry7u9TNvbTmORVKF4IkwURR698Y6Vk3NlbXutR2GjqjRtksXJAJIPB7/j71f1eGGXW4RA5lslmEQmgGDI27kkf3RnB+tRalPb2GrahKYJJJzJG0N2g2xbV7cds8UmOErqy2J4obmRbdoPLhj0uIFUGDzkgc+uMkZ6VSlmjult5kli2OxzuYruwOsg79f0qxJam71PVJopo2kiUTzSLlfMcjbt+nNR3tutnAYo9y3DRNG6eWGAzz847/hQtytErlGa0aG5ubchrgFx5cNuDi4JOfl7Bcc89qV1d7NpdQJa4wIbe1jj+UJnnB67sjFTWdzbaekY0sXcsQQyEN8ruAPmkB7DIIArTc2f9pWmsPciV2iAgjRtoiJPTA6EZPJqtEZas85v0kia6juEmjupWVSsiDMa55yfp3x1pk0Jh0ptiLJZ+blVTmRfXj09q7Xxlo1v9oF1BbSyRRiOGRQ5YzMxJVifT681xmqFbaSezV2j2sGWVVwCw/hA9Kd9SbWRy7FR5ckkbJGxYKW+ZgT2x6VVuL6KzRI45WjmZyChX5RnocfhTtQuTb3KCUbHLbVLnAAI6nHWsu5vJJLuS73rK1unlO0g/I4FbQVzknLl1M+8hYMyqsiRo21z/eY98fjUZsptwYIxij+ZZHBy3HYegGafJMtzJbXEsu2AAlm6KCO2fWoGMLQwh5rlUD7nkHzbQeBgew4561vFWOWWu4iyG6dDBEs4gcsfkJGwDPzH09qjeI3bxLbFlCh7hSEACjBOFOefpU1uBbtHEkLz5Rg5V8bWbgFj3GO1Z1ujBZTOdqx7tis+z5v8BjPFWiCXYrvJLcMZG+VlVs5boSSOuBViy0yW4gvdTjjSCO3kHz5+RcjgKvU9OtVjcMJHluJoriYllbaN2RgfMT6VNdzm4tPtlu7SMXCMoboV6HaOi4pgPsWjtw4MrMWYvtjXuR61UdILa5MdoN9vKmGM0eShyfToT7Vf0me5naZIhbO23cu5AABjkg9c8VC8InvZ55o9r25VzbMcxkD+Hd6+1AyxZXGNLuUaWKREj2ojR7dyH7xRj3BxiokfMUaLLsljbcknlkljj7uAenue9RTH7VCrshtlA8xX2bhncc8D29PSrFvdSMYf3I2k5LIp5Hp9KBGfeSFbgJYSSeeWBGW6Z9Pqa9L/ALO8QNYPBrHhSxvLm4MbTTfblT7Rs4VnUHkj2xmuBuNNAae5D2rNGQyxI+wDJyBz+WK6PW4tP8SXo1MeIbCxtZir+TclllhIAG0KOoUjAA60C6mT410zW1mbVtcsVhSR1jZY8PGpAwqkqTtwBwDRW3rHiGxuLXxBdJOFi1RoLa3h2HMnl7d1ww6DOOBnNFILI83mCCyQJIN+7LRjjaKZAVjaVfLG4jashPCUGMgqqEkP2B6D0pYUSRz5jtkghd3dh2rQRJFA+xCgcRAkhu4P+FMUGOTcHPnHhCOg9RU0sr3GR5zSInAYrtC4qCFPMQMowA2VDDOTQABJx820ktyuB1q9O0EZQRt5cy43SY3iT8e30qt5ir5nzshHAZTz7jFSrLbFyoi8yMn5BK5BBx7UAT2gRk2srNIpIZc4BB6fhTZ2kIikZpAso+dE5Bx6H0pYQEtYjJA3mvhsnPTOP8irzxzQynzrmOKB8lkCDGB049T2oaAzNPZ7cC6TeRkjABA/z0q4Y1VC97BsZgCEwTg+pHr/AI1Fdun2eNIVKWwPzox5PqMitGGzvI9QjkuIk8sRFlWRw2VK8HPf/wCtUgMN3m5S5WTYIhtAMexto6cc4PQ5qRo/PtbckeScsQrjBz6nv75qrbtJcYEC/vFALnOd4z0P86dLbpdFjPO6zA7Y3ZiTgnhQPzNAWJNOENtfxPMi3TLuARhuUZHDYHPX1pLLzYra4uFs2ktFcq58zbtb+8cdqfb21xHcSgwtbqikb0JTlv4Qe+afaQXKlIwFV/LKtHID8uD/ABe3NIC1aSR3haJo3ktSPuKcCPjhhuHakFjDDIJruSMW4AGxCBKFzgEfjUlxp6Q2STzXVu08pKb9zFUdT0B6fnSNJcTzweYrS7WPPlhdhHI5POD7++KB3KkwEkqlL+QSLuVwYzuK55JGcA+1XJoo7OKNI7j5tpUEYYsff0yOwqOZGtdQM1xJBJIZNx3DABJ64H3hmpLaT9zcgyReZES7HaPk5+Ur3ySelA7lhLl4CFSDyZJQCUkhy5HHPTPqcmr/AJfkxM8rW1yXcxs2VZl9Dj0/CqMkchvVub1hPM8Yd5BJ8ycf/X/StPTvs8buwikhEKh5J2HmBF6Dp1+gqWy4lyC286e3aRoJkMu5TEwUFR2I/hORV6BbRrrfLKFOcBnOGjPXIXuKy4ZrSe6Bd458guZB+7bvjA+vrTw1uYdrRIZyFCOQWCnqfp+NZO5tFJmnFZx2t/GpV2lWTzPMVioOcHP5dqs6rGTe3P2PzCkyDAVsK4zhhj1yeM1lL5kDt5rtDFNkEjJCY6MvHTtW1bebOsE0ckMhUlmdBuzx0YevFTNmlOKTNnwzdWkRUTQtbTRTojF9rfJjnIPfOKua18940awzWErsd2w5V4j0YH3qJ4BeLZm5eIwThozKgAKtwASO3NXbc3sOrQw3Dl74T+SXcHChVxuxisbnUlqO8H6u/h7VlgntLe+WViIJWfIX/wCv2ro4rHMUuo37+XcmRpYbCbIAkOSDk9Rjn0rmr7Tlmv7axiuhdCOQRNICFO5uc7vT3Nb2tR6rZz79cxIkaiGGVQHDD1YZ+XjA3UuhT1lddQ0uwEOhS3E3nySXiNIuw7ht6Z9ABWreSzaRMs9patan7KEdhkCQAD5j2z7daqWkN7pka3ZPmCSBgspkxHCTgKAO55PtTgbqLTI7Vkjnt1nV7l5ZTuBx/F/9amiZK5Z0S7il8PCwnjlju9hu2ESgvKA/AGOucYxXTSnz76GI2xa0Zd6lvlw/BIx7Vx8V9dx3qy2/2SJ/NSOP5OIS44OfTHP1NdpqSizeWZL1ZCUVXQAMykDqCTgdc0p6q5K0kkjE1m/Euh31ndQESNKYoY0HMpB6L7gVVnitwGt9RhkimEYSARNl2zjkkHgg9qy2ubu91mCTTbWVpY0wuJNzjB+bJ6DI9PWls9Rl+2S2+0tAJN0ls0fOOhw/r0NJFvyNe/8AtOo3mnWF9fAeW++NYM5kK/w7uh6c5rPtFDXguriKeJYrl2kUSbRGeRlR/e/litGfWop1isrC1kVZA6STwEloAOeCRyayPC0a3RmkmvGlUN5irOu3gNg7mJxtpsFta1jYnsRcXsSxXHlW8cHmtLO5aRVz1ye/OKzdQuoo2RPs8cpfIu4oBu+UA+WSexz1q9qEIuL1re6jWRj/AKsICokYnkZHVOn0pbqZ9Lub+204GTUWj8lYVj3ZOc7mPTnP4YqQ6GXbW0ttpSM8kxmmCkiaQDC8YDVdvtmk6np1tDHbXX2xS6SpHnyWY4yo/iA/OnwWttcwpBLeGfYAJUIIAK/eXHrWRKk02oqt08iW15Cdhb/WREnhQPUDr2qfkat8z3HJBp9pqflRJeKsUjRRBJMKHJ+ZyT1JPbtVmz0lY9KmudXumECAQCM4ZZiCSCPfnp60xrexOqR2jrMunxbX+0zP/Fjg47c1Qv5ptQSwsmZ33Ss6JNGMJGDy/Hryc013Jb2sVbi7g0q0lu4THI88ohER6gfwgep5NdHr15ef2ebmxtxFfRKxiVQDxg5Y5/KuU1rTktpIoLG2y3EyunzMxJOMg/dOOcelUfEurX8EPyTmcFVjkeRgOeuPfgdaW7sOW1xtzAILl47Z/MlkiV5+SUVuv4KOnFaV3qen6fLDcyW0hAU7025CEjovqO+TXHz3V3K63qRYmvBsVUbOEHTd+NQ3moXCJZ2bfKZ/nPzEbSO2PrV8juZ+1sjrbe5+23UiWLPPL5bOsaPgAdQW9COeKwdT1GC1E1rE++Mhi25cSmQgdf6Gs+3v7dALhkniaDCssLEBjntjoMday/EWrxmf5ojCoG6ErkhR6HPJpqGtgdRctzm9UlRrmbE20W6hUjOdxJ6nv25rPcy+ckJlI3ggy4G1wO2O56Vet4XugL27jSYMTHFg7SrHqcdSKgudHa21TfA7sgzhZG46ct14rqhoefNt6mJJ1jBd125kkJ5CnOBkdM5q/D5cz2SW/mR+YCbj95uWQE8Hb1HSor9plt0cgtD5hPHQqec57kkZquJIVRYlAZgMpIpxgA8A/n1rU52SC2S2v50Yx3NorYDbiFcg8D17066ghuChFzA0URMax7zk59vSoo45ooZXjZ2ZHBZFBZVVjjlqLyF7MO0NkrxybcTZJAA54PvQJhf25+wSKkTQqXwMqOORnvn0+tUJJJYoYrVkZAjBnUHaT68elb+nFPtwv7tbcxuiyLFdqxjIH3cjOT0qC8kiXS7uVQPPu3DM8Y4VQ2dhHQevHpTFYpxXW+5TzWEe/AWNl2lfRj2Iweak1ERi3RnRxFNwgjbIcr/Fj0+tVpjNLIZBIDMBuG5gRtXjA98dquRSSLFJKsoBlcMJGT5U5yMehFA7kdrIlxcNbiaQxjlWjHK4Gcfj0qW0e48gw28ZUDJaVTnPfac8VFFdLDLIYbePz2yEmRirFiMbh2PenNbqitdrDL5SfIWZwd8gHze4xQMrGOFyhuIsS4DS7ZBnaT1PYDmvTbrUptJ/4SS1tPD+nyRaUkL2Si3BMkbcF84O7rnNebiJo7pY5VQEOu4kZG0n+L8+K7PWLrRPDmrJHPqmtf2haJ5Qlt5FUoMZ2AH+E5o5RGF8Qbgy+JGE6eRHLBbziBFAELGMfKQOmM4PrRWLrN7Be6xdXmmteLbyLzLdtukLY+Yt6k9vSinYRiK4ZSF4Ldc89O4p0mYpMLgsQDux1pXJdwwwhx8oA4pgywPJ2qd2M8ZqgHHzpPMVjhiwDqeDxRCm6N2ZhhBnBPSrUEcsqySHY68Andgk/wBRVdiJPnUKChIbA4waACZVacNHtbIwdowF4HWrdrJbwRTIwilkcDAI5AHYHsarYT7L8m5H3bdmOo9c/Wrds0HlIrQpHID/AK0HBJ9D6UATRSQkJFBDKkDOCTKcEtj7oJot7fzyVLFWUlpdzg4UdNo6E1BdxyBjC5Y4bOFcED6j1pJYZQo8qI+VIwKyD06dfc0XA0ILb7WgxOhcko2eqqMYc9qZ59xDNHa20xkgTdChYDnPXk9jRbSBby3lnQBgy5jVQ0e0cHcM9uvNLfta/apfs5Bi5O3oVOecY496VgLSlbW3KxywrETudYxyrDgKT2FWlDzwFXdpQg3howDkdwfU1RhjAjjazZYp/lKs5GZPQcdwPWr4FxFGwmbdAPvHA3N2AGeozmhjuQ2987JBH9pCIrHBccL1C59Kszb5NQuDDPIj4wGK7ncdefX2PaoZJvlspIpYDEqmR4hHt2/7Ocd6WTyJp4Ht8QFVJI3gMvtg9DUiIJ1idomP2ktEyt5ZHX/awB+frVi2g/4mLSRlDblufMB2juuV9fSozfI7BYpxby4CswOdo7jHTHfNV4JppY2MYVoIs5nA4JHB+nUUAXr6QTzXZOBdIyqGV9xK+ip6gU6Bo4bhkaSOfDBg4UJtA7H1PsKpRObaJpLa62o2Yy6x5HPUe3J5NXIPJjZIZSn2oIQrOCyp6kEdRQCG3TRSSebdTSrNg7pH9zwAOmK09OmKPC8ssjzONqRmEsWQd/7p59elZa+XcSeS7J5AyGKLuV2H9z0OavQC3kikhkeUBBtyow4bP3QxPAPpSaNESrf2ENwJhNNHKVIIVAQWH8hWzNeWkc7hjLPHOF3YzgEjpkVipFs2y20PzM2BHMgfGB97+lTwuYikpSXd3KHH4AelZuJpCVjqtDngnmjcPII0JESSPvRMjG4g9BnrWnod3qKwzCO3gmtJXxKFwFZgeuMfe9O2K5fRwbv7U1sI4kCghnbDD1UKPvc966TTrjyNJR5JGERJb5YtpDgHqfSsprQ6Kbuzbt7VLxro2Zjiitk89o3xu+UdiOpz2FXdNn1OW4sxarDdPcushM5ySSOV3dR71R0V9Nu1hmuZxbzeVtiiYDZO2eUb0HpWle7h9luRF9jEG+OcA+WyOR8oHbOPzrBJnW7MtHRJdahumtrK3sptPybi6ic5YjlV29/rSxah9s1C5tNWWO2WWzDBpJdpZ9vyk+n0qtp0l40TrAVjmmtmWcF9gbHAK/3m9cVoWXmwPp2pz2dpKgxb+Y7jCg/LuYHkHPSjfQTutS5YqscstvFFBcXD2x3I24AgjnGeMn0qWwtbQXEC3hu0jurfZKEOQGU8BvbGam0DU7bVdV1O4mZYIbaBoF84gPcEAj6ZGO1ZVzq1vJCi3Cxx3ybgbZJfkkQDlyfocYp2BSurMuz2zW0In+z24uGl8wM8hbdCp+6V7HjijVry7vNVle4s44Y2VVhwdwzjiQjGSvUZ+lQXt1Y3zLJaNJaXFswuFlb52nI6g54wOuKdqmuec0MsL/Yb9o8TPgspQnr0znkmiwIuLc3EXlSWE0Yvdhj+zxvkLERkkk43HjOTSgwxWFr9glsmurknzJbiTG1euB6856dabdQvbz6ZhoLjySLiYohXzl/hznkZ9Kk8U6n/AGgLTybaG33RFPJwPMc55CkcjHWmTLRqxBHDYXF5On20lbeTfvWXBdivyqo+nc1pXiw6dpi2kSQz+eFWS4IGNp5B2+gx3rK0mS1WNYhbx3Mxm8v7Ow8vY4HLHjpzycmqNpLb/armHy2dpEaGKC3BcL/vsemPXtS3NHr1LF+kt7LFZteSbcCRZ0b5I09B355wPWmxXNzeq39nyzrpyyESTcBlI4G49s45ptvZRRW8sqs9pDDHtMTttxjneuTn8fypRdQ2zTRWtxHc6cYg+NxX5+x5+8eegzSvcnQcLm6N9c6dF9lkjmXe0cbDgIAdxb0Azkd6bf3F211fX14qrJBH9nhygfg8ksuewxz+FRRX1vZ6hIhtP+JhDukESfMz7wNob1PtTtR0u5Okvql1GYZFDJskceZLIx+6PTsMe1K3NuVs9CK8vTfwKLoMq2tuXkWGPBZjwh+voKrai02mtb2sqLPqVxFGrXMkhOwY+6F9RnJPtV3VdRsLK4tIpVAubUI7xqvMzkcd+dvqawL28WbVFj1V5kI+bahyxB7Z9BQ/IIrTUta3cRx6ysmm3DbXjPL4bcVABAxyc8jmuf193knYXdrbxW6kNIlsgYgkdj9Kr3d1/pBm0uJIoxLu3j/lnxjBPbIrprXyZ70WMM5iXyQxIIPGMuQe7HOKEtbjck1Yw5rG9t1tre5n+WONLmWCMjeq5+6XHoCD+Nc1qV0jaqr3cYgtwhkhljbMpAP5EnitjX721t5DPb2k6Wkf7v5ydznkZf8AHnHtXD6hIs9xaOZZJVBJ3Ov+rBP3eK3ir6nJU00LcupRrHbxhbjzV3K2zAAOeD7/AFpJHc2++RA7KFd3Y7jGOfwqe1ktIbQQy2+6fcUPln5duc89z7Vm6xLF9qb7NApZRlhnjHsPUU47mctI6lOYXLRqIY5kjTDHaeACc/e6D8agt2udU+05dHt3U7nlIQ/LyQT7egxk1Rv77ETQm4n2ONzrEuF3A8Eg9frVbDmdUiOLWTO5tuWdPU57n9K1ic0pNl/UV3W8CRNHIzgeV82WXPqemRVJY5ZI5o7oeS8AaYOMYYgYOff296tGO2aeMSzC2DR7twXIOeMZHI6YzioVX9w5ZlMZk2McGRnGfvAe2OvtWhJJDNcC2lfylRAW84qcL/s45656ccVEJLOOVIisjxTS5d/MKqcDpt9M55qSSOWSUIsRDP8AKu4BflH8R7Enk1EY4RvjMex4o8pIWG3OepH6cetOxO42W8eFkViSwkLIkaZ+TAwAfpxV17dXs4okZmhlfcFH8Oe4Ht0rKmljgdY4YVUTIuSvI9frTI/Me52wB5l2lSqDaAO/egZp6hdZggjMaia2Q5lUhCeQfxJHNULbUNklvG0hliDZEMgBUgZwmPf1qWNiC0uJPnUKS0eQVHBTPTJ9ewqbTIw/26P7AsVyFYwgAnZ3wp7H3Pagkr/aXeNSqrAsa7VVeAATyPrzin2s8k+XQQwxLE0Y3DhUHXjuTmormR0t4o7goMks24/MCw6Y/DrSvGouAfMkSFvuyOB8/GOV+tA0y7cS7LuKW6kklScxZMabWZRjjiu68Vf2/Fr0iWHha2vNMRE+z3E9iZpHj29S2c7u2DzXL6N/Z11dzQ3F0dEki2ojxwmQyt0YjH3ea3dSk0tUUT+NNQR2wFPlyjJHU4Bwc0c1ijidUN/ca0xubZLC72j/AEZY/IjVNuAQp6EjJ96Kl1uEQ3Un2W8bVVmQEXMoOcYyQAxJGKKdyDm/Kmkjj2KRHzjJ5OB1+lAEcAdXG92UEMp9e1OLSfeIbbjAx24poRyX2BQu3J3DNWwGs5G1kDbgPl4xj8e9WrAy3MTW9vbxyMilhJwrFe+fWoJCI0/dcOfl+Y/yp6xtDLEWVsJ8oOOOnXNSA5EDmLC+Y6DLY4yKkAaWaZlg8w8M5zgJz1A71HexSJMqkhjjjYOo9Tim+YpiK5HDgqyrgge1MDTtdPQwm5lJlCvyVP3z1+tLHLFbQ3MMyFvtB2IGY4gGfvDHU+3pVWzuZEjSzQhhlmUrwTnkk/lVmxnEmmpBuCOWMu6OPcSR0JJpsC9bqV1UujxF32xgAeWshxgc+/emXLWvlzfuJo2By0gIIL91HFR2FziKOC4VVibnLnjeT39KZc4nuJIC+LcZZ2U4DH1PrikBZP2O2tIA0jvAyjaEQgq3Yv2BFN1B3MKIXNwykxLKrAhe4yeneorOcfZ5llaeXzB5Yj3f61x6jsPT6U25uYZI44ola1EYCMhHdcfMfU9akDQlieEIpYEKu5BIB5bevzDr61FdygfaEUB7ra2XGG3MRktntgVYnsoREs1uJWyvnbc7j09fQ+mKZbrbTzxCLe8Dx53RxctgZOfYHvSAy7e2jv4JSYHSdY9w3P8Afx3Hv7dKksIvJk2MHQRrsTIOSSepB46evpVqOF382O2uVZGJcRxpuMjAj8PrUk9y8Ekk9pbGRJN0Y80FztYc/iCDg9qAIswq0xi3p5LcmZgA74Pbv65q1C6W1xHtH2WB0V0lhyzMMAZz71BdxMLS2eaUCSSRgE+9IeByc8fWqdzKsrxwxSu7r/rFIwoHbDCgEa73lzeu8NpCLaxDbVZF+9t7sf6U+WIpf/Zy0pcEFTIflAI4Ix0PJ4qlCbyNrhNLXZHEu6QoC+D7n1+laNzdxwqbeW4RrghZZJIZgG3EdBweB3oKLt4ZdJto4YpWivEUr54UOzIfb+Ejn3pmmiD7ERPMZWKnIwFPPXBJzWdJHGY02STNMV2iOIgFwOTn/GrGn2kS2qs4Sbzny+UxsIz8qnOfqaTGrmnHIYpYn0y124yCm4EP1yQfatGwvntp5LcmTYqktn7rAjPOfrUFqkCRyzERPEyABcglOfX14OatXs9vNZQnTJI57j/UshTl1HKsPU9Rx6Vm0mbRb6GhBdJewPG0SRbTnecgLngkY7+wrehtVj8qWTU2vrF8wt5p2upA4IXr+Nc5pwgTZE4V3GXGJMSHPTJ6NXUWd1ujiW4tNkZVjMWYE47MB2/OsWtbHVG7V5GpJIDHatBdPcWdltQKIwHhcn7pB5wfWtzTdWxHY6bc+TDAJSu5k5IPUkH0JriL6JlgmVoZI4kPmGeJdzorfc3kHjJq7FqkjjTpp84TaCzr+8D54ye2e1ZOK6GyndanST6XMmpPpN4kAiaTzi4wQyHncp659eajutItvPuI4b20uLbaSp8tWIAOR057YrNvbpLm1vRd2ss8+7ZvDHZnH3h6fSpNPvt1tAotIZVhJQSWygPt9z3A9TUt6FpPfuXNSu1vYIJXgS92KofYpVw2Qdqge3AqneX5F7dGQSyrIRwD8yHp1PYDGRSwSaq2qufs0zmDiJEcIY89SQOua3IZYDZB9StbZHn/AHkO3IZyD+g46daL2C3VFfTryRy8aPOJowG86Qo5BPX5R654qkN1lqMk9pavcXg4RlywUjOSCe/Y4rfvYbt7JlsrW2jmIEgVsKJEx0VckmsGa4jtQLdUulkHzxq5AVJcjcfdT6VV0JIuST6lqzLLP5f2sYPmow28H/VkDqfWr6a22oIlmtrDZO7NBPLEQz7sYP7sc4I4/wD1Vz0txEXnglspIzErM81u+CW9z0PPcY9Kt6dqZtmSWzEEN8q7QJcsG6biP9rPOfwpN2Ha+w3xNpEz2OntMJGsLZMFrgZYDpwOuTjiueupHvDZ2rsrwswNnHEcLEOm8jsfrXVapqep6pJJcXskVxJCAiwqhCE+rY9Aea0Y9F85RaQXKHUpX8yRONtvGR0B74pN9hbJOW5g2FrcXCTvaWyxTWzjz7rPLr037zwGzjpT4YmSaLy4WuFjcyQtLICjSt6nPYAmtA30NveSrFcv9hifYYYwFVgoxjPoT17ms65vItJlZXxNqdwB5G1d6Qlj0I/vACi9tCl3ZJPiym2TIksTQmchfmLnPXd9TjFZN3HZ2UBmlDefGpZpJCWaIH05+8emPxp89ndWYnM8lxutyZGUjDWwxnaATg7j2qvptnYPprGaB2uUDPN5xCifI6c85UnjHHrVbEt3uY9rPa21z593LOUdt1wiw43LngA9jxznrWpqWp6Zd3VtdfZ0t4o2DxKIGBZsEE9sn2qXQNIibXfJFrc3AaAyYZ94WX191Hp2NX764XSb5YbWSPzkt1DEASR+b7eh9aL2Eo9zh7p7jVl2WEaiE5TMmWaQjOGx6471Vg8N/ZL+0jv45FbC70PBxzg+mTiukjjks7hptMDvGoDOmAfODEbgcduD6Gq+o67aW720kiBhJuzFLmTeexbHTrx9KpNpaEOMXrI5rxIYrOJYXlmM1rkBlUBSOpwf5GuYvH8x4LoYCGPbmR+frkevvXVX0wuGeG0iaOKQ5dbo8RqOep7e1cvrqWVvHvEj/aJd3yrjYFHI2+mOa0p36nPWavZbGX9nuVd4p4GLIQ5ZXyVI5AJ7jHanafK2LqVkia4b94qM+xwp/wBnpj9arSXsl3JaxK2x5WySjZ6cA5P9aW8BFyIr8x+ekizBplyXO3jOD06cV0JHG9yjNcW73IS7aQiMAh4xjfx/EKknuVmaBiFeUjbFsP3B7gDknFWp0tyHluZ2aRnLuvljlx6AdF9D6VQFzLblyB5MiMPmKYbk9j9aYrmrpd28s/2i3cQzRKJPKm6Mfu4Hb5fenaldQXl/++kEpJCzm3TaAoPztj9fes9WT7CyXABMpEgck78dwD0IzyRUp0meK8RyrRM7jgg7UB5Ab2PWmhFa+ggjaVofJjGSFkjfkj+9g8g1HbvI3mK8geKIfLJCMAk9SfX3q9zHesklsEV2KmOOMEkHPI56fypl5PG8KkxiS4kYlwmRjoAT6UAiOeJXkhS2ummtgwwANvzdTtHp6mpYWmmE022WVZFcJjqjZxlvbB/WnsghsY47a5hdQcbi/wAxLdR7gH8qeVmtYY7UiKUojLJ5jcIO6jGDnnoetAMrXNulzaRNHEGurUM06SN8rxgjAB9evSqEQL28rtKcMysNze/cd8VeRlTSrtb3cJQ8awleAgBOc+/THvWbqEfz2zAMvy4kAUnaQeTz3NMR0GkaFqWrPMbG1a4kjw7OJQhHpnceea3NT8I61LBDINORp0Yh83UeNxHAQZ6D371w1tPPcKbSeQCNyGEjjJU5wDnqK9E1PSvCtnHqi3Vlf3h0YRQTyrchSwJwzgD0J/GlYpHGa1b6pYT/AGTUD5MyjG1SCuCuRyuRnBoq/wCNESDUPs+mxGC1ZI2gAkzvjKArI2ejEHmiizDQ5MzySIYvuR9efWkjl2j99kRdPl5qNEJcIw2g9TnpU9mYxKqylWh3bMMeOe9XuSMISecjYIxjPzH9akCXLHYDhYxg5PA96bJA0MvzsHhVshvUZ/lT5LoOpjOYlwSEHI9cfSnsBLbkxW/lTBJDHnYobuenI/lQs2XWG+AU7vmQrtGO+MVSRWxugEoZByccVbWVUXbcOxC8qcY3eoNFwLcZK36PYW6IgG2MEHDEcnOe9DTm6/1dwtvIqlSudvmZPQAVTldg8kcPmNAozFls7B6fWnxJC9wZ4WxFFjeZSSy+4A6/SjYCWF5ZnW0aJ2lZjuUdP+Aj2rRuIriRDOZoxMD5KIv3EAHQ+pI61nxuXCJboyqzZZyMMVJ/ICrVzK1u/wAp8vZkkA8qSMEDjjNIB8cxtNxto1EzHHmRnKsCOQo9femQReYtufKRHclI5CdzA+ppEkkgmgkDs0qR5LA8BeigDpwKlA+yKrW0pa4TOZMZCMeGP4ZoAfLqDLGYYppZQV2q2Aqj1LHH6U9bi7aS2+3zSAIBxGAvygdFHQ1Fb6cjQidgY1ADCEnGc8ZTk9evNVPNRJEt1QHa52ndkk56AdMetSB0VqYJGhltpTdssTPOYVCGIN6547dqjuEBtIbxGuZS+9Y8HG3HAHHcjJP4VFcwS2kKzSzsj9YlyPMf1IXuvYZpFmF0oaGBpHYFlYtwoUdCPXrSAq3SCOKPNy1277XlIBBi/wBkD16c0+EjziETyZJEdxI75LMPUYxnsO1W9StvIubeberytGHaTrGSem36DjFLqL3WpQWplgjZIm8tnxtU85AIHQUAUrS3vJY1ht1l3sxMmTtSTjjGO+fWr9oLK3VftK+SUYqseAWDAfNlumMVLdPM8D/uSqxILcW8Q3L9VUdx1yarQ2zW89qhE8Mw5cPjawI7Z6E96LgmWrG2SS5RLixxaTkhbiI5ZeMdO/UZqSK1uLqJ/sggkUMUVGj/AHjsOoGOSe+KhtI97yRFxFMqk7y33Rnlcim2wltruG4t1LybyEfBUbhxkYOSeal7GkWaUJdIIlnVhtzHIvlYYAEkAHHHPWrOmyvZXqTSwSqB86y25wyEfxeoFVodYu9Plk8iZxDMx81T97kjKn24qrLdlrqSWKzIZyAdmQyj/H6VC10LvZ3Oqu7izlElxHA5SQbopHOGDfxKB068496v6RJNIsYDsJzy7LgAp/cHfJ5rkrW6N8S1+ZGa3XEXljBU5/i7ZFb8cV3NE06IXWPqUwFPfk+tZNcuiOmE+bc6qzSGJVurWWBlGYpo48qwT3U8E+9WmuLR5WlaH/RooW2sow6yfw+x61zMurgtKtvA8UrfvTKgO5RjB4PUdM0WBUaRdTz3E3nrIshYAOMH+XWoaaNvapqyOp0u4uIDCiTRFhKFaWU5fB6jYTg4wefzro9YsoPI1Cac3SiaYKm4rtlU/wB3bwv4VzEWqaQ8NykgW6yi/Iy7JC3qOwx+tdDZaxpg/cTWkgWOICCaEAH/AGiw6Ej2rGVzeK1TQ3Tobyxe4it3tmVgDMskwUqp4DZ6k024WaxuZ9MgntLmR23LPjLqODgMeMmm3GnRLJcXGmbLmGI+Y7yna+zgE8+5NS2kGl22puZr3Ofu/LuZSOVIHQ+n400+5UtJXF0JU1C/nSO0ub+W1GNzyCIRk5x97im2OiXMsfzQQrNHucQ3B3sxHXAAzz/SqmtXoOsx3AsGi4YSxxk5VccFj696khnu4Ed7We5KuREzxptLE4ygbsCOM01Yzm3q0Rz27XkEccUCRSlyZCkuzKLyF2eufzoSIW+oNLcfvp5Bm2tpYmJPHX5emK3EtnYyJpcEdreWrK2JG3ZzwwQ/xHt7VR2Xk2rSSQIyeX/rb2WTawGPugdgB6UnpqVDXRj7W2t7rT5ry+mMEkDFfJD7I9+MhQOrE+p71PbXtiLqC+kk+z3ZhV/KDbjGc4G8jqfYUzEWI2vtPkuH4lgEKFomwTtLHv6Vm36+YMazOVm83c1vAgOQenT0z+VS5JByuTsad7HAlybaG+F3dTFpoGUBEhxzvY9DnJHsah/4lsV8HjWaPUQVkLsNxXnHvkDn5hzWPqUy2AnK2aqkzqIoWj+6oPUn0PfNR6heSPfx3FrJHIgUAQxApsJxkZ7dKLp7l8kiXXRE+qzQWuUhk8x52klykrA/Kw7+3rVOQ3MLWr6pmdLhViWIAl8dQMfhUunkW91L5kW6Zp8xSpKHPynnk8EE1V8SXEc3k6jqMMwBlCF42+Uc/MBjrxwMY5qrXZDdlqjpPDmqrJBdXLW053u0MSW7hRj0yehHpUt7qcEsl3FbzQBkjA8pI9rgdNgboehJPvWPombJJdSitpTCrhVinXCxxnu5zwcVnXk3latE9lAjweYWZEILOWPGcdge1U1ciKd7s6LWzBpWl28lgYI5ok82bccCSQ9RtHseK8vntLqJTd+SPK8wxqkoGTnnIz/Ouu1a4l+zGO+hS0jc7cKBhW9eev4VzWvaqskaG+m8yaPhAp+YKvYr0HXNOKM56Kxn69dmW1lkmtRCHTBAydpOBnOckcVxGtMkrrJDIrxbMDHDqVHYVpa1qjTWziZmVHIxlsZGePw5rE3iExrNCwiZtpDxglGx1WumMTiqyKwMu4tHAFRSGfcvy5z1/wDr0+Uqsk0Ih89Npkdg4cBvXdx7DHpUrTRXdqzxGUwwZjODgD0yOgXPNSEyQ2TxTW0DP/rNzDcSo4DY7DP9K1sYNj4I0stYhaO8hmMqHcEJIPYKwPUE9h2qnPBKuoG3hQhSSGypUI+7oc8jnjmo3uizNHLGkTpGdhJzznIC+lXC093AJSxUSREliOW9z7n15pisMlX7W1xO8hWUARiMHARupAx1TjP1pxW6S3aYRu0iLumWSQk7T6c8A+oprRs2mYVVUl1UbWyRxliSfw4qaO4ae5iuUjSeGNjulkUIHVf9kHjrnHfFAyFGubqNnhJUs4VhM2QqgZJyOx9fbmqRnYeaimLZkqG2hS3OT+HXmrykW1irK2Gnk3xl/QHBZvQHgYqNTp6XLGRJI/tBKyoj/IpBzjPU/SgCK+mhAtY9ObzIbiMCfjG75j8vsQAKYZViuZ45G2IWXay8jb0wx/WrFy6XF2z3EKIsiFl2LuMme/HU+o7VFqKTXMEJuPLt12BFVU2j5eMe9AriXVtNLqBMbRzRSDeHHAyFzu/L1qIO7lQLYwXLg+a7sSCvsB0z61KZpIrU2sESkTEKZj/yz5ycfX3pzS3cS/OZGt5lCyea3JKn6ccdPUVSE2UWi2xyNEytKCHyMhx7e4NdmNR1DT/FMNvrcmkmS7s1tryORd0ZB5T7RjncODkcisC5ubiK0MlvZTQuNolLxFo41z8q5xwc4rqNTsNL1PUm1W7svEdvcS4aeKCy3o8gUZKk8rmmNHNeNU1ddcuX1VreO7hVMC2GIwuBsCeq7cUUeK7uTUtYku3s5bd+LaKzn4ZI1QBCR1JxzmigRyqAhhnlgec0/CqNysAS2en3KZkmUKCo56561IMlNhjJIOT70ATXMqXWwh1QhQnPGBSXDDFvmVWP8RA6YqOGHMuWQSekZ+8akaArbqynbzjLDnPpQA+SXzC24OXU7iR09qUIJVTcAk4G5ecjHsPWmSMRIHEivI67WQHj8KkkSNoo5CpfHAycEY7U7ATxqDNEihI1f5WZn4c/3sdhTbeW1s7vDCWQBwMrgAEHng9aqXKoqQ4l3HBOCeAfSr8Z3uPKnRVlXe7yKMg9CMnrTAWd457iOKJXDsSFZnwSCeBgcVahtHa4Fs6hyp8uQqcnI7n6VWsI3hVSxiXblgZMcnsM+vtRpU7tfyzlh9pOWHzbVJPUYqWBZtoZLlo7O2dcANubaTuH94nsKuiMLdJEstvhd26SCT5CemCffrVExTIsrSJN5uz5+M/LnoD6GnTlYr13JWOFdvloFG3fx1HoKALVuJYZQZH8lyQwcJuXbjnOe1WIria4095L2WC1tzhU8uAbpTjt7Y5NVp457VmaSXzmDswQN8qg9MD19qhdYb/DzRSSSdfKjO0HrzjPH4VIEzg3wmdJI0uMl4gc7Nu3BKk87h6Vb0T7Vp87TNIgWNV84zcbW7A5GCaoRlJrq1jKyH7Llo0XgSc54544rRguLa7W4aXdJNLy0RJwrZ6En6A0gIDdTMtxJ9neeGOJgOhQZPXGOCO1IS0KRIrSNAuS5XkyP6HvjmpnnMbRKoeWZ8iZXYkE9j6AVUhu4ojcT79txv8ALALZ3EnPPoODzQA+zA+1zfZrqW0kcbY4lP3pD/IetR20CyyPLdSyyyofLUM2QxBxj/8AVTZrpEuUubeFyzgo0UY4Ve5z3zU8MUarLHFExuHb93GDkgdevagCtemZmaJlZJ9vJQbSyDqxxweMVqRtLbWiJPbOZl2mSXzSGjGPlA9OoJPeoPsk6XD20dwsjAbXUqMnPLBT/WtKxiYxXayt5e/EZwSWbOCAB+FTJlRJvLSGIXFzdG7uogFEqkAdM8juo9fWprMreshRZ45yCVYY4P19KzpbqPy5o5BC2VEe0AkYHfPGBntTbPUwiW/mzBiWPmKihhgD2/nULXRGiNSA3EMjhyEWUkn5fl49R2+ta2lXdgwkUpL523CDd8ufUjvWNCZblLeVT5eWIGGzgd3bjp2q3atJBMZI5zsXCmRYV5B6j8uKUkmaU20zqtPhju9SRJrtILaJPlKnJUscgAfzFPvdPjWSW7S9XBYJ5YIHmgEduM4rIs2WVWWWUyxI5KJc/JjI6DHet2xm0e4m+yyqtrEybPOdt+7POAv97IxXO27nXFKS1KIvobbUEubgs4IwE8obTg/dJ6g/Wt+61O2mjSaxsrhUbDRq2CAeMpx2qhayW+jalM7Qh7KQZlSQbiR2IGcg1qaVqck8ry6b9mtreJTn7Vt2EMOy+tRLXob0m47Ms29/DdO8g8qK0mGyQEMXUgfcI7DNbkV9aGxijsXht5YAP33lDzB6Lt/iPXmuc0xN9u93O9tNcLKd8anaXI59eOKnudStQd0ZWJ2YTRiJdzBj8u0t27mpXYqWurLmn6mttqT2jXU0NjKfMM80W9txHJIHPPp0q3daks7yQabaIyTg+axbLMf9kZwM/nWfZahbxXDSNJFqEUr/AOqLEO4/vZxgDtgU8agk41DyLC3swrsi26LmWIHq27vntTsTexph5vsiLZWa2qkDynnlzLnueeg71UumjN1KtnBJPNGoVn8wurN3JHQDP8qzDMsLeTqTQNLLtTe0hzGuOBnPy1Jp95C9ubBI4xPny/3TjBX6k8+/NGo1KIzUrq/Dol3cXBtEby3EL4hjPcEjvTrIxTXhlggIDsC0twdu4dhj1xzmtNI7Xy5raa2jkgAOFJOxWGPmJ/iJzXMePITafZJYbhLl51LLbLKWZFA45HQc4AqWuYuM+U2bbWbO5eeMkyqrnMrncSOgAz0Gal1KxjFpEILU+c2DmIEjaf6VyVsk22ETtuuFQIsTR7Bg9Qcd/rWxBq1rZ6W1vAJvtUjmJfNYsI1UckenPAzUSw99UawxfI9SuNMJuZViz+5OTjO1PbcOM1JcxW9tdr9sEsVucTLAp3CN/b3x0qzaTl9LsktJkeKSZSYeilwfvseufalZYYNRvJjENQWNzG25iAzEdQfb1pxi4q3UmdRVHfoUbibUftTSQXb+SxVsupG0f3WX/GqZ8QzSxXFutqA3m5JUDcCDzz2qw2oXVpdCE3TLJcfvC0fzE44xnHTGMVyo1GSymvlFvvW4O4sPm3N6keua2irnJOVtifxDqIuD5s0p+aPKxOuAnXgE/SuQuEiuIzLdQyMEjyv7zbtH1rR1iWXUIIFmEZt4BtdFOGb2Hr61z8qSPpUixhmCEs6FuSueM+oFbxijmqVG9yC+VhGZLeF23MAoaTcD7H0qLzbWaeOOdJ7eYrtZkHyBh2X6gc98mr+TJpceUJcqwYlgqsQBtOPbkYNP1FLI2lrCynzoY2zKgGH6EA89jkZ962TOV6mXKYJY1dXLEAJIi4AGOBj1qbUbS4uY/OlCRSqwkj80cy4wNrY+6AOnamJPDJFFtUASRYZcAbPQ+xp51Bllj82d7iCRAJF2eX0PG7HX6DrVIhoraxp8k1uksEMi78TPAuNsQwdx65weuKSIMbSAJGDGinDwk8fX1FLNDCSnk3Bl8xiWdOhHsM59sVM1vJbxeRHceXC2XR1xhc/3jnimOw+eWOaaZYYW8lQGmkfCOSQOpqnI9oJmgiNu/m7eEjI2MpHIHTJ6Zq60NqhNnCDLeuv7x3U5ZsZBUemOMmqVrGLhIrd49pUvIoiILkY5560CJkzNYPIQJoY12u0nyeWBno3cgnG2o0vYLgQWzpDDHJsH2lBucEHliKu3a3t1bxxRI81tKQsY+VyhA4wBzg98jJxWRI7WrNBIsatC+/dFHkFunU+9AmXL2GdZLV0BMCDyEKJjJ55/HvimTRXE8jwNNFneI1jbgKe3PYCtALdxWJcKI1aMTZ8z5d7DOVXnjHbjkVmpNAjKsKt9oyuGI3iTuS2enPagLDYQbI5mMbowYbgeA309PQ1JK5WGSS5Y3MQ4eRh8vqu0g5yKfLJa5QoRJdJIXfac70Hb65qnqqu8AuZo4oknbf5UIG1RnkEZ4PtVgy2ur3EgnihnMdnOyxyxqxLSY5DH3GK7O62JrEemv481s3iBN0QtydhI6MQ3UDr1rzpbkhCQERYDvjBB3O2f065xXocdg+teRq174Uuor2fDgpfpbC6yMFtjfNggDOOtDBGb4y0Bt2sTQatPqV1aeX9rF2m2QRnAR42BO5eRRVLxB4glUa9Zvp/l6jdtHDLKpKi3hjAxEqn3GDnrRRZhocCGDKi7cFT19qtwu+1liAB457iqOPerMTkoRGDvxwRUp6iLV0Ga4iOXJPPB5/Op5Z3eMRyl0yAGPr6VS5TlyUIGBVuOaSSJxE3KhVkGMgr61dwK2U5YLgJ0BON1WpHKQ2u/CCQ7lZMHAHqKbHHCdQNvlVDtsHUj8KryQSfa3giDNg4BHPHr9KYF0QKUBCgyOSxI54A65/pSW4S1dkuXU28i8EHIjY9CKSCORmjQrhFyCynO406OFNQuIrcFI5CzDzD0I7A1NgH4XymjFvuUHdlX+U443An+VWLeyl1qcKg2rFA00pVh8ir1I9qq2iTQzSxlpPLj+VwSOM9vxq3/AGlNZXTrCIAs0LW7sEyAjYyMevHWgCbUdSjiuEtorkzW6JsTJ6g9c8VJNeS2kUaCINGoYJ+7UKzdCfU8VjCCWdZnVA6KRukHDL6EVqRyRJF5dzNOsSJhCBnDH+JvQY9KAJVMMlmWlGSD5m5nbkE4Cj159KEjE0Qtpp7eJg2Aiqd7E8gg/wB3qKY8EJSNliMshBDYkwnXgoOop9raSWsWZYkQSHIkJPAbPOe5BFAGhLa6e2kvM1rF9rt852uRvUfxcHOR+FULgeVceT88M1wF+9l8t7d+hGDVWeS3kPzyALGcuhygk/L19DV5Q+oL9vZ38yNsb35OFGFQH24xUsdyZ7aeXTSkzKYkzkFcMDyCfWo1sp4rC2nMZFsCT+7wvH8XPc9OvHNQRLDJceWkMsz5G8uxBXjqcnoalsbeKTzGnmCr5vlpb4YJyDjB/Dp3pCGR5uAzyq8JyG2RBTjGcgevrU8oNuLm5s1SfY4zKxK7c9Mr2NV7RG23MHy+XHIpDBCWQkZGGx36YqFJGsd7O09vqAkHysOuR3BGc46UAaLRiC5tms3IupsEksAEY9yT0HX2qWbyLS1aXe1xd3B2rKr8KRxgY9ev41RtLa8FzDLNHHNKcBhO2Nh6jPtT2IhuJY2ijYGMsySHKhh/XsAKLDJbW5IKRyO9zMoZHjEXzKAODx6dzVm3tyguYo9hPkLMySJsZ+7EZ6H26HFNhvbS0tIjGriYII5biM+XhiSduAMkAcc9ajCx2l9EJm86Bjl5JV/egEds/oKAiaNnNLa3SwJc3AUkERnBUDHAIHvWlbvDFcrAbP7abjJLAkR9ep47VjW1vBapFO8rMXXzWU8ZyeM+nYGr8ISSW5CebCXiBiHmllHPO0Ad+PyrNo1UjfWIPZ3c11KS4Hyb1IjDYwDkn6UtpeRadbqJJ4TIAFEcJySSe3HB981ylxLcS7VhlRbROUkcDdKc4Py+tWrW1hWOVp5QJ1G4HksfRcepqJI1hPsdRpenTahqKTas0yum5wpkG0KOobn9K2beS3a1KKI0s/M3ZVF5PbA9PXFYdhPOMG4scOrAFHQ7VJxyVHU8etXJ/E08uolY7CGKVV8vzZhv2DqzAdif0rKSbOiMktzcsInWaf7HbzRpH8wPmhfmI7+opLi/n08sLWJnnBLyxxKCBjgEMM46msPStUS5MzzXc7QyMTtVtrbzxj3Wtu/1xbbTLWPTrl4HK7JpJHEgYjqOB0/OpUWjb2nMtDn49TEV3KJreTc5IEWNpXnse5rWm1FipeGQM0W07VwpI9D6+uaxVmtJZxKVk4HljaQ3XqeeeuK2rWBLhhdQpNM7JsabKhgP7uz+tD03FG70CC1jvbyC5mhkhgyGZ5PmJPbOO1XbCDyyTaQyQ2rSOSrMOgPVcfmfTrUdzbxJ5LxM6GIbpFeQ/NgYyMevHHtSzXI1BYXaWRJkXb027B03EAYxj86m6exduVm5q8UESoTI4dUMpZiFRlxyB7/XrXF22uf2dcSzpaxC4ZNsZlG/amMZ46detVdTke4upo7i+muLRFIiCDAY+m09vrTvLktyZLFmuLvy0WKWQ7Sp7qFxyO3t1q1ExlIz5NQ1GxvDKJHnZMk7xgYI54/lmrpktTsN0TOzwk4U569GGOKyp71oZ1l2LNcKxkMhkxu/2TntTG1KBZFETsyOvMb8bM+meorRxsrmSnZ6HR6BeXWnPGI2ERVWOA28nB+8PwOM0t9r8YSQWEb+fKVk8xBjYRjH16VaUpC0IbZCAmFc4L7T1GRXDaq8cNtci1BC+ZtUbsHBPrWejNW5R1Zr6zrc0Go200eBMHEg3HlGA4JPQj2rmr7UJ/toWOQzGYliIhkndycHseaguEa5K/aXe3bOGLrnp0H9Kr3NuQreUGmyAVEakIT3A7j61rGCSOWpUuye2kMCzASFnBKfMCSnOcCqdvbyN9peNCV8v94R0Udz169Ksxz5HmSrh2yqBiMKPYd8Y61bvrdVu4x5vngIo8xyFwepUrVIh6mRO8325Pn82IqC0nlYAOO1WRqNlDLdXE9qAUQIkKNxISRlT/dBAPNWhJdR2jW7x+ZDgzb9v+pOeR6mshkuIboXcrQoTGMHZnMbcE46AgdK1Rm0NswFcC5BgSQmZSccx9QoJ5796SCC0bLI2+IEn5s4BAPUjp9KbqES32rO1tM8vmgHL4UIAOckdMDBHvUiRMlusZn3Pc/KqMdm9SPvkevFOxIWtvK86O9oVUglAhCgfTPWprC4eKVkdIiDKuUVADkZIZuucdx371DZXcdnqa3E7fbViztt84AGMbue3J4FRGOWN5ZYoXhLZKpJk7f9oL64pW1uO+han+1O63JjVGcmISAjcz92x2BHeo5FEMls0qMssR4wpV2B7cdVx3NQxyTxxNPbpumYqjruztYjvnvjmr11Ki2kbpf7x5hjAgbcxxgjcDzj0+lNIm5TtElivLiKGRoIGy8u1SuDjK89epp9v9mSGY2Jnku9qjyPlbJ/iIJH3fakiuWuRFAjCQMRukzhiRyAx9BjpT71r37MsdlEqBVBZo1BYgknJ9OlOwblKJzJhC8iIXyHIwAQeg/WrmyGDUDIIgYjtMqMSDhs8hvXHeqx8yUW9spSQlQFXsRnLEf3fxqYXLW7SLbsXtgxQ+aAG6YA/CgQHz/9JZABDcMrpM6AOyD7oGP1qnKYp5y3kqrOgIU5ILD72T+BqVb2MQtGowThmjPBOey+nY8VDJJJcBvOkLSxDY8m4AEY6Be596oBbxrN5WIHlxRujZxy3y8rkdu3411fijRj4n1qfVNP1vSZLaXDA3FyUktl2gbQn+yR2rnbe0vbq081baW6wdrR2yMT7MwA6VJHo+rxtu/su680Kxy1s7844C8daYy34mvI9T8QzTWV00tjFBHEblyELsihWkII5yR9aKb8QCI9beBo4o5WtbQhAu0xt5aknp3Oc0UCscJQCQRg80UhHNZoC75Zkt1laTdg7cZ5psezDDDBiBgA4zUceG2ICR/eP+FWp4nX5CVYLggjrirAjWXEu8Elt4Iz0q80jQ+Q8Dny58khTnn0PtVYIDd7Z02oByVHNSNOsabI0BhLZw3Ue49KpAOQyiOcgBXjBbpwCeMipfJeKVSj7o1Cs4Xgjv3qsUN1eYhYpHt6seg9zT1DkAtKoKj7xOTge9JgSo/2iQxyjYilpJcNg9eM+poXzPOFpACI5vmIUhiB/Sq58yCIsyB2JzkjcrD2NWLZ5I5S9mybJtsToAA2M9gf50gEj823kTl3jYeWcdJAD6f1q9G6yXDqzwAtjYzKw83HYj+tRyqTM0tyhKW6BV38EZPoKakvl3sYiRbxRnCyDhSe31FOwFtLPZNE0IY7mwYMjfHg85H8qsypA6NB+9+yq+7zGY/uvRSPUnmqCGVblpVtvMbDK6nAyvrn1/wqKJJbm7a3tNp3Hec8KMfxHPGaQF+706MXLSQSW8hSNmkBJI47DPerVvLayacCtuPPK5kBwFbjjaOu4cEmsuILIVgzKGjQB5mHCr6fQH+dWoPMhu4YSs3mKnMpIGAe4444yKQDkV43tpUVriZ1aWWROGjwcZP+JqaeHZCkgEMqj5jIDh+mT8v06fSolKRWUo0+5ADht8p+UyHsPw5py3Ed5Fby39vNLFjaZIlxgYyV9OcZ+lKwFe2RZLs28zR7NwABc4lPXO716VfluTIwtbIxyygbppWGFQ9/mPp0BpbSKGHR7ksIpLGX94A56HsB6HI6d8U3TYpL1H8kxSxRN50mFCPgjn2IzjFCQCTulykQ+eSA8P5RypYDAOPTtVMwrFbvJdBt5JEfAXL+jnrjHT1NLHcXM8DQRIXjUgGVm2FVJxtxwCc1eENtIoL5bzwT527DKqjByPT3oYCRW93czyXNvHKryKrKWRUCsMYyOw44q1GJrq+S4aWKS4QGScFSTCCeSQRz9BVOUzPDIiyOtqqDc8pGMHAULn0I5qhLfXNne3M93bwTOyGNdrkIvON5x1P1pAmaEepyLMYYVZdkuGEihVxg8knkdjirE0c9vZF4Z0eOb5YS2cdcbgT05/Ko5LKOV3muL1sy2yYd4yyyMcfLuHTGKqwSG3b7NcLGfMYDY4JVVViSR9e/Sgdy6LG4hVJnLxG43Kx4KlQfmCvnjJ9q0I7n+z7WQ6csTEuI1D/M5HXr7VmGM26n7Al1cROPMBlHEYyDuUdABirU0QubJvPZjJIzyO5br7N6ZwMfWpaKizQtde1mxi+yJOjRXG4nA3Ek9efUdKW3u3F8BNMrKGESpEAC5Az346nr3qgZIo9Ot/s48kR48xgCVQnkZPTBPFS6u6tZNcRNbRzDLS7QQPXJz0J6VHKaKTtua948MCl5llDMRiSAYCv3Bz+VJF5jtzI8UUuJA8uHKr3Y45ByOlc7BdQRqLW6YxxSpu84MxDgjKnaerdt1WdKupobKUwnCYZWYvnjPTHrScSlPubM016sshdYJ7aM5Usm0vjn861NP1K6hyqu2Cu7Ea5IyOBnv71zEetCAKsiTwxCPdu3sV3npx6mmNfXFxDFPGxcEBm34UkdMY9v1pciZftbbG/ea/fxspjeLh9hkIzgVduPE88KRJJHHKsbb3t4xjecce5Ge1clb3VvPbKZ5mSZyxJAO1sZ4/2ailntWuitsrYk2tGpBYrnrz3pKlqJ1nY1XnF9OLy4HlSSMxCF8IoA4BI+tXJrkjyFTcY4yUM6S5KkDnA61hOTNBHFAszx5BO8fcbuF5/Srq20tpZpLNKbe5ZyQQQVI7jpRJ8o4Nsnt7VLu8leZljVzneRhSR2Iq4ulILZmF0ohVvv7cH5Tn/OKzLvWIo/NtoyjuqCMuV5YgkgD0HPWqn2y6MsfmvFMbbB2PwDnjA96lJt6mnPFI0E1yQXM7iOOQIdjSkH5s9v/r1zc99JcskLgKWkLMgGACTjPtVyKaS5nlezKxThchc/L1wT9azZJLiFpDMiyfvcidG4LDncD39KtQszGdR2J9TIbVGSGaMi32gFySM5Az/POKsRzSxXSKkJZ2J8mdCVJGMYHqvcCoG1K0hvY7pUlKgr5sD/ACs/+yW7d6b50tvJeJNAxg2Hy2Z9+wntitUjJsie/NxcmOZVSRSRlflxjk5/xq3NcTi0jnm8t1lf5Q2CMDA69sHvVGGS5mtII/sqsj5Krw5YAfw/lTrmyuhsmmhMUky+dy21THn72OmOnSlyjU7GrvgmWZ2mEEgUnagyj47DHSsmKOaR0t2nVCkoMfmthXXnlvYf1rOMtwZZWDM84fG6P7o5x+NaYUm4kuLuFvkUhnjTlmP97tmqSsS5XHy2NtfPdyFjbXeSscxcGNnHPQdjg81nELY3ZQqtw6gt+9GVLHtu9DzilNwskwGmRtIxQIyhT0OeT6dfpWldtBHZNDEslxG6rESFBVXIPzqPYjAz60yGZbTRXcaC1jJmV9jknHB6KPWp9Sa7e2iBDrIWOyQkndjklW+vaq1utzod5M0kRW4thgHjC5PO4A+hq5bTzLp0dxLK8UEUhEcCn5CSeTzwM+tPURWLNam1ufmnhaN0KM3ViPm/EZBqRJfKslESxl1YKkoT50BGMMT3JPWn2v2je5uNsFuAQisgODjPB6Zx3quBJFcyI7oxuThhIMlu/OP50IbRaja2splRlY3SD5A6jaHB7+vepZba4u5XuZYYBDComuJYiFz7Y9BVWK1K2zyRQwmUny1ZDuZhjn8ffpUWk4nVxMnmbeOG+8Ac9On1psEP+xgytNMMRyJm3XozHPAbFOvTEYmaL7xG7lCQOx47VYaWeW8DQmO3SUjarEEAD1PWqkW/7bNc3U0Y8w/vAWwZUzzjjuO9CEQXziCW1juGLqsQAYED3+Yf0qSTTHnjkAe3LbyyqmFB4zjPf6VWifdcXEZLmDaQVC7m25+UEnuOOadDG9tLMHlLzIp2KWHy8ckjvgVVgNHStTvtLilSK8ktY2yz+W5VvTj0xmmS+J9civWe21q/mtNx2sJmBwOpI7Vp6DFpV3Zatq+pQLc29hDHN9lQMBLKx2gueu3uQO9Q39hZ61ZXV54Yga01W3jL3NijErLERy8OedozytJjMC9uJbjVTdPLcXRUKS9yct0wMn0HaitfxpYw2XiBoLZFgtPslsWROgJjDE/ic0UxanF0UmaWsgHRn5iTz7VOku1t0Z9yG61VxzU9sQCDjLDpVIC6J0miY3O5mHC47VEVXz/3eXi4Jz39/rSxuF34RSMHqelRLMiryrZOM1YDpYkSc4JCdgOuPemwszHCl93cdqtaeEAeVod0rHKZPQd6keO38uGZHIleQo8bcKPfPpQAxjlBGWcxKAvGcAn+dWBYrLMXsyEXg/MThMfrS24MTtBuUKclCW3Be/8Ak0iN5Cl5UJkkGQygYI+g707ASxtHPJMSZPMEZzGZBtBHXB/pUMKFPLZdojlz5SDIzx1z9adYiRAyXEZYSDlnHygf571LaLDBLkyIWQblOcqo7Y9/egB9nLtjYBgJyMsoO4ADsAenfI70tuI5nkilkVIzlw2dik54B9KrwC4muGKI0shbcrrIFIB659cip2RTZtbG33FnWRTn5lBPIPtQBpRzWa2olkhYT/eYK+0MpbkqehPHSoJLhTH5l1CWWZg8aznJbBI6j8M1mmM2auWl3eWx2jbuTP8AdBq7YzR+WpaR5nt22Qr5YYHcctx3AHSpAkt47Z7WKLyxDIQ2WkfaoB5zjvkcVHBNdxxyfZlxAGEqp5mVbHAAFOlL3bNsjIYJl964JbJwPY/pUltZhEEKo0sjcptyHRhzggcde9AEMCLd6lF51vK5fJMUce3kdR2GBk8064by4/MjViCSiIODg8ckdfpVpy90JZIbXYxA+Z32MgGdwU+p7nFPaaxgcFZZzeE5y33CeNoB6njjI6UARzteajbq19tisbKEeVDwHkJP8PHzNzz9KddXk5iEMVnDbW+MEoocop9zz+FMljnjj2GaMhm2Fo8tz2x6cnGallaBo284XK3CsE3B9ykgdwKlgVbqYssMflsiwkpA2cCX04P8XfNPjhlVXnuLQz3CON4uDjIz1GOOtXZr8zFGUJc3RJ3K0WEQA8gDucAZ6daXU76S9vUtLNMrtxt3fIB/EUA6DPNIBJpLa8nZjC8VyX8totxQYIycdvw6irM93ZJdWfkvv8mIxncvyhz0XnqB69zTY7+2t7xVuWe5kKhRIwOHzwWz2OO/tTHtorm7AtmhgQZmj8xxyVPAGP4vrQMhtvLVmjmZnkDOyFcp8rdV29NuajuJZLe8j8pFBkwSpjxt6DcAf50yGcM6ajM5eZXOSx5BPIKgdqtknULtI7hwr797s7bjsbHc9Oh4NANkN806yw2reSiKhTzkUA4zkEnufrVqwaNbn/R4A1tK4j89/nPTDcH72SevPQVnTWltCsZJ3xSszDL8xJu4B+vFWLiFp3QpdSTLb+XEkgyAC3O1QcdB6UCuy5YfZ7ZNs0MVzFtMZacEHeDwUOO3p61WlulgZoGcxwtMVVkj4X2APTnirDwzNpiXCFp7xGkmBDgeWA2Dwf4s88Vlw3c/kzHYkgb/AFgZgM85BBPv6UWKuRazCyzbpbhzcA5mUD7hHTgfzq0PNV2mvjuMX7tUQ/dx39+KfAYLaFzDbi7uXXaWKHEqN1AU8kg8bvQVnQ7QHiS224LqJGc5x2Xn+nWgVzVeMOn+jbiZJSfLfjLH1x0GO5qrGgeR4Hd2u2Yx2+1gVQZGSP1qxp1wsayyRMqxbdrRycblPGQvU49DTraytWQrcszRB/LZhgEnPGT246UnoUm2i1Ym6kgjiQn7KrlNyMVUk9wOoOK1BKGtPIliY+TlCVBYsfcd+nJrEeSBGjaGZy7AiRNhKKAeMHPXHeiG6vo7u1RWV0BbG0bTtbg54z+dZON3qaxlZWL1vapcTGSUkk43fJjnnp+lV5LeAxPHBG7ylysjschh64PQj0rYmmWVGMxMUszBSXX75HGSO3H4VSvS6SwW8U6CJxuwcgAj1/xpIbM6eNI5rgwQFVVVRpSSwbHUn0PSi1niOlTacypIs7qSOAVI6FffmnNaSJG0zMNrhtu1iAwBxn3OTUFwsvmxmGCTZEQRKnUdxk9zWyMmEbIS0ksNs164ZljnVyXGcE56ZAHFUXjxO0cYmV5WICeXk7e3Hb61oyiTUPMNyz4ckCQZ+Y/xFz2zUYmSznljuIfMghwqOnUevzdcHpQSU7aKXfHbiVnWdTnZgFRnqD65xn8ak8uCW2livrho5LQHOSzB+en+zzwMVZeCxmtVmw6XAjJ3CT5QxOD09cg4qhq14Zn33dpby3gjVH8snbhRjLf7XHNMB0+7FvLEroNituVRtLDI4554qS6uWieGKNRtUgEKcq5PXcO9R2JlFqqRzlECnEcfJOeSMGrZS3GPIlddqq0jvhmMjdNgHYgUhlS0tVVphEZTMjnzGh+Qsh6EZ7Anp0xSzbJbULLcbYRuZ5IVyzMOc7RjP17c0zUGmaD7RO6m63KiKjBQuB3XvTLa2ne+RZJkSeNm4VTjB53E4wPSrRLJ0ktZLaX7X+9luHVpLgDOxPU+/Qc1TAnt4gqyORFMwUEkjb16dOTVqUQ3ULBVS3dYwZI1HBfJJGPQ8cdqhe7jgmKW254zGnmQqScr1KqfXNMRJd3iBSjyjZK2JdoyD6Mo/SopZYJ5o0l3RzeaEbIwMcAH61DcSRXW0QWREkUeHZFJOcn16cED8KklXerRkxSjapjZQFZR6E9+aSQEt+s0EUizSSW62rsYZY1ADA+uO56fSs+zuZQpmSOMjyiCkYCge+PUVeubswWwhmlUx3CuhlYFtseOgJ77uD7Cq0ywm6ifytwMauUxsBGMZz255p2AdOxt2/dzeZDJtkQSY3gE9+wI9aj1OKSSSRfORoYujbiQ/rg/jToUE0U0rRDaAQzgfMgB6kHtUrxtp8kmnXUflPHiTzCN2E4II9CQRxVARRW6iOP7Q4gdz5bDachRyc88mkvIFUpJNveU4O1lGHHYn2qw6pfS3ksNx5ixISiSL82AOP69Kpx3CwRAtE5e5j8sM3PfnHvQBueFZ9cjMs3h2F7iQNtnjW2EiFSejL0IzinWfh3xfbX8d5a6VqUU8DmQyLCVIJPQH09vSodE1e50PVba5s5SZQSjQIpLTLn5kK+/rV3UV8T+XJLBp2rW1u58xdzSsdpyQrH29aTuBleLLjUbjV5RrMMcOpyxx+ZvQw4AXAGPTGKKxbqSeQrNczNJIFDq0rl2YdMc0Ux3MsjHakp3WjbWIhKM88cUhBzS0AORyO9WYlWSJnPUfw+tUycVMjhQFABJ45qkwJrcfKRySeNvtVpAsKjzt2JBgADJUetVwpgCB1bdng54NWJg0e0I7eWwBkHUCtAFd/MdSgV1X5VIULQlwDcqNzRpnGc96ZK21xJkLEegA7VdW9hntoYo7crfRgqZU5Eg6gkeooAijt3Eszb9235WUNnOfQ0yHyHYowwuM+ZtPIHbHYVNa3zTQ3C3FwFG3KhkHzH296jtiGvFSGDIBxtU4LD0NAEtkXvbgRRwZtsYMaHBABzx+Jp4cxOw81kjjPzb0wSQeOD0+lMhmmWO5VCkQWRZACMs2OwPXHsKkvLqWZt8iPK8igkFeo9D9KAH3twl5HvCxsoUZBBJJYc9OBjFSRTstnCxiDogcCVeNucYIx6VFay3P7qOMqFdgFeQYCY9D3z70RskYELHI3NvZQFB56A5pWAm/tZkumkR/MyN0kJ43nBG0/7I496sadG1+lvFaI2+LMpx8pOOTgjkgY6VCkNusAkYtBOADA7Lu3AnnPpj0NWo5vLjWeV1kEJIVwuN+eCB6jnpSsAxlQTpJHLvWVsqGYYyP4c5469KnC3ABhLR29ykRInL7gqvwwJ5x6YA6mobiRI7hIUWJLeUZjRiCYyw64HvTJriJ4ds95Ex3dBySQecduMfrQA3R2hjMczMyMp2sg4BXHIz/ez+AxT7kXBnuJCZZ48/JI4BYEngEDjPFOjaNJXgkjVjIR+5ZFYgg+gP170amt3NDFb2avLt5Rg4Jwei7QeoGaTQBbBntrkzSxllYKGblmwM5BHbjBpmrzhBHBG0EQeMuPKUjcD/AAkdc1LDE9tAlteSGKILyUjBdyRwCM8elVJRMqTxwxLhF25fAKg8AA980rANS4uQwmu2+0ps2bEyMHbgcjoQOcVHdW/niT+z5ALWOTKjzMAkjkhjgk+ta1taSkwJCIxFliGlkCBXVfvM3dcZAFUNVETXiRWBkhI4fzNuCT3X049aLAWY7h5riOCUeXHhYyQQGC4wVHHTvmo4YS0cjW+IzC2I5WlPmZHAXA6nk8Yqe5aC1vlktjOzwxgFiBudzjJUdsCmI1umJLRjNcSgtmQFT5meoHrjv7U7ATWMUV0rCW2jbzQMBCC8Z9/YDJJ7U+aDy4Z5bmQx25G62VBnaxOF4JyQcdRVNZ3htPstnva5uZCJo3+VkA9+4PX2pshuEitVvFk+zwphSg5XGcfUc0WAspfXE8YjgEI8iPcWYj90SfmOB1BPbk0y5hVxawIkYwru1xg4JPb14NU5GX7QXW3b7Sr745D0Of4j2q1ctKlhvmZFljYKiiPlxnPOO2cc96QFi2ufsvl/ZN6TImd6ZX5v4lz6UQJJceUIZtpgIuHK4dY+eST3HI61VImuojLblUYH/SFxxtYhSwHc59Ku2qzpYS6X9nggkiRi7DO6UA5/ec8/QdKQFQSre6hDKYw0Ms5HlwDBDEYDfngYq1EPJvJZGbz90hDKGBUMvBbHqPU1FAXUWohVbVwflkZQUY9WAB61HbXb/aVEMBhiCZ3BBuk5yT7c9BQO5fE0os33ERsZMtK+1SuRg8Dt04qSy1GG1IdFPmKRsMq/OuP4v8/lVO6dEuZp2aYIx8wRMBhx6bu3b+VFvLbtaS3MkixSxOAiqpYbWyOvtxUyV0WnqdJeXQuvKkuCskT4ZjHgkZ7Vn6ldpJZAY8i3I27i24qmfQd6ogwxzwI02GuDkyplUj9MDvnP4VVYyQu8bEqm7cFkGGPPTOPxqFE0cy+8T2+Ekk82EhSDuyy9xyO/fFRz6ncGKD7YwnGSqSc4xnIwPpUsuYTIYZkaORDIro6gFvSor+djHaAeTbpZpsURkAoSc5Pq2fWquIbfSXSQhMxTJOVdguQdp4Py9jmqcA8mxd52CW3mfOwUM5GT8h59KvE7njFyJTLEm4bugGcjB/pTGhUCTaMxSLnHl569TnqfrVJkMqW6W00a29pKxinRmcMdqxPnoD3I4696jmnWVR9iQxmBCH3HO/JOSR6+1XLySFbeCOEeXaw8NIi5256MAe+aprd28vmSiFBLsAd/MZS0i9CD6nuDxzVElDTZnijIkjcxCRRJIDtAB/h9iRmrVwHCgvHLMXkyioCgAHQZ9Rmlvzdt5+I2WKZlaaNAcSEAkZXuRmiOSV4UlluPNtFcRxqJMFWI647dAfehIBtqWEk2XYXaMHikHBBPUH396kg1AwTxyJdmFfKdZVkBZZWzyCO45/On6r55mSaC2KQlVR5VcZ6c7WIxg9RxVeEI0TMscd3LEDJLFLHtypzghs9fb1FUSye40xbrT1hWeCW7gXeHjfKzIRnn1IrLhi8hoYo2DzM25gMrtBH3TnH1FaFjFdy2i48xrtgGTaBtdT03N244NVdQIu7v5UZot4UqHyVH90evOcGgCa6MbXEHlzSNO2BIN23I6DHoQPrUN0txbEefPGRI7qSRlsr0yP606NpZCt0AC7ktG2znKnCn0P0HpUrQR3TKjSr55Uldh435AzjPJJPTsaaQDVhE+nRo07sYl3RQlRymeSvoc9u9Nm8t3RYpI2CgBpDnDEdQc9/TFPQJDMo1BsBE8sEEfLj+Ee/XJ+lV4pIo4XNuriNJFbzCdyxDpz/tHPNMCY3kDSzohe3VpQVWT7xTjqfrzTdQuUuJ5grecqybd2fnfIGDz24xUU3yrBPIoaGTcqsVIDAent3qmyoYlw+4g7BwcnufwoAtLNDC6CdAxXOSCAoBGOfUjJpb2by3WG3BNsjqyjcW59QaS0KzQpbrErHJdDKPlIHXPtVez81bmJLUONvOYeS2T+n0oEdP4J1OWafWhbXFvb6xPGPsc07BATu+dQx+6xHQ1cj0vxzHeLP9qu1dWy0z6iFj+pO7GKy9A0zT5rTV7zWYXuYtNRXMCP5bzMzYAZv4QO+KfqWjafqmnz6h4XE6mCIPc6dLIWaNf+eiE/eQdweRUspFHx9NaXXiiea1aJwEjWR4l/dyShQHZfYtnmirfi7SYLTX1trTMES2kD7RlhuZAxOfck0VqoaXJOKp3amnrSj0rmGJSAYpxGKSgBKEBYErzig5zQCR04oAuRu9ysMZKgbgNx7VZkgVZ5LfzCdgJB7Nxnis1ZMKVwCDV6xm371kkVFA4yOlaJ3AVXSeKKDgHJIbH6U+0kMYmVSQ0XKNFgHNGNkOGfDdANuQR7GoZQqRF0CFhjNUBcjAmRYJkdZH+YEryR606OK3laZzIsPlcBGBLNnv9ajdXZLc28peRlyzE4GPQH2pqb2LSPKEeTIUnuR79qAEKSrO5SBnRFwCeeKsreLLGieQEPGWjbB9Oc1AZnaRoFMkchAA5wCfeljt908cFqpkldecnkN6UATmIfYPLZlVBNy+/qOmCPSrsLwDw7LBEkEimcBWeMB8gZGH6/h3qpGke5WKiN1zGUlGdxPUkjpzUDL5VzJlcwMQCy84PrjpQBpXMr3FjbKzXTTPg3Tbchk4xgD0xzWrJu0mG2lspWCND58LzhXzgkHrkDB7ViadfvYyTFHxC0fllQ2GOferIujNpMVmEEkELGZdwO6ME5xnuCeelAD4x9thllWNYyVJ2KpfDHqzH+EegqncQ2tu/lSbpLuIkZChlPoBjrx3q9bajbWySskPl7sgvk4Y+49PaqdusvkxOjiBiNu/7zIpPBA7DmpAkLeUY4ms137S0io4WSNT/CPeq6Txi7gGnxvBNIwZgeePbFXdYYxebLIGSdgI1kVt3mL3IpjSLcpHb3A5RhwowQTxgP2A64oAsQ3lzNqP2u5V0IIYSx9Sc4yw6CjWraM4ha5lijA3yAKSzOed2Ow9xTLiGe1jljuJIGbmSNl5DkcY9zj1FJaTvI+SzFpEEZUyEvIvqD0OPT2p2ETvevNBBZvOBGkZldNvzPjGFBHqcGqiPaJqkUlwEP7wvLuUjHoCfXtUiiRbprK1m2oykBwvzOB6E8g1FfNIwit282GSM/PiPl2HYUmMfM/nzma4Ecaz5/eSEn2wAOnbmn20WbqMqiQ7FPzGbJKgdj6e1JFcrJMkk9uskeVILnKIOd2VP9Kbqqi5ulkVYxHuXycfdkGOBg9+lAEk8s1wg063DMZSGK8b29AD19T70HzIo4pHlaGMkho5G+6w4Gfc+lRwQ3uo30mowTCG7iO8rK3zZxwO3HBHFMvjsEkV7btbtwzMw4QnJyB3zx0oAluLmW4mZo7kCKLBERyFUHqenTjuajeSaXfCCsofG4L97aOQdtWbC9sYoWWEyw3JhbEKqGSQngM2eQT6dqrRiSEPuVBAE+RFcLz1IGP60AX/ACPLmZ7aW3LzQ7YniY77fbgkFe5PQ1UhtUe1ciGSQsGDSIpweeG9j1+tNW5toLX7Yysl7MQS6/wqPb8OtMtrm4lmcJNuSTJyrEAg9wPbHelYCWeC5mt4rcR3Fwq7pMO4XoOAAefqO9T20TzW4uHbyYIUxhVByyn7uD2B7npRrZF1bxQPDm8hh5Zvl/FvfHSoNMhtk00ymJpVMipK7vjchU5QKe4PO7NKwFQedcPH5okKNhi3mfezk4x+FSwuZE8mJlSI/Khb7wzyeP60W1mLuMxWzmQgcZPzsBkhsfTiqNo06Sxzq0jSq+5nfnDdOnSiwXL00tvHJGwYrIiiNQwABX/63rWjDPKU+VTNLu3/ADDPT+IZ7etZl55sl8xuLXFkHVSQB8u7Pft9KuWqxwKrR3DXEYVk3DrnphR6d80mrFJks1t9oMm8IHxv2RMDn1OM4GfSrNqmmNZXcn21IryEB4YJ4zmYdGAbsfY1lrD5tysCBvPml2Bg+dh54x1I96bLOkSiOU41CLDRswwoIP3cdyfepcSlIuwTxXCMduwTPtCiTOG7f8Bqdbi9ilWS4KicgJA+8sF7BSnQjqcVRvrq4mvPtjWxikkJLQquANuN2McfhUDCW4UTWFpOi8q7iQkkgHJPpgGmkK9zRd4IZbuC2c3LL8qMgxkYyc5461mXLtEkS3ZDIXBChsbB33LjJ+tJBOIQ0dq4imjH3i+Q4z2PT8TV14m1CZ4rKQSXLyLH5MrDBOCchugGfpVCGvJKLdJ4n8pFcmIFgcgAde5zUcVrPEYPLtnQyPlGAIjkHoB7c1pyT3VhGyappzp5KApJOgyFP8BA6Kx796z7W8Wa4SSMFEEgYQl/kjz6egHtQhMNQknspEgtjLC2SrZTKE5zkA+mT+VZb2glSaQ3CxyuTGqBThxg8kdqu/2pI9pM6Ts95HM2Ipl3xmNuOPQg/nmoIZpL658+cBLiKPCrHGBkA4A44/OqSETTTP8A2dBbMxtz90SgZBXHoPU02WI26m0iEewlHlmz8pA9Dx61HHJbrJtZYZYC7BATsdDwGDfTtUMaPPeW8UhdoIk+Z85Jj3cnB6j2p2Asu8D8AI7xEJHKrbV4bqR7+op0pdtlzGEtZ0kMZ+zRck92JPWqURg+0SO8gjRQFUKpIZQeuAeDV64fAh1S6t2kjWTb5fmfLInqxBypJpgUwtuIGeVTPcli0QY8bT/y0OO+e1Kpb+zp7UJE7kDkHGwYyeenPvTGgiaSWRdsDzfcEh4QYznNRxzMlzFE7yNGwwWlxjPuB1oAs3El/KYxcRrPlBHHIyHYq4/h/wAaSKCNLj/iZrPIkAG5oMABex/E96illmgcpFI3l/6pkcYOPp2+tV58FHDpOvOAc9vQ+tAi3PAk9vDLZx7FP7skueT15z3NQskSoFs/M3KTndxlvSo45U+zhxB+6iA3qW69t1Pto5LqVt8jDONyYy7YH6UAX9L1W50a7kkskiBeLZNBIgljmUnJDg1BpN1PYams+lu0N1CxZXVc5B6qV6be2DWv4a02J5Jri9gad4pEt47cuVE88hxGrEfwjkn6V2GirNLf3un3KaPdQxqXSOK3ESzbeWCMBuBxnBJ5xWlON2TKTWxiXN3c6xqLX14tskzoiMIkIGFGBgHp0orV1PT4bHUAluztbuiyxMerIwyN3v2/Ciu5QVjm5meOmgHmhqQda8c7B9IfakooAKSlpT0oAbxnmpV+UbsVA1Sx/eFXHcC4TOsAbPD8bSKaWMYWN16H5s1JcE74+e1R3HMyZ9RVgDs/kqmTjP3QKdHNNHEfl3W7NkEjvVuHi4GKr6px5Q7ZPFJgSiG5fcdokZk++x6KPbvUcYnQhlY75Dww7N0p90zf2hCMnHlDv7VNZquzO0Z89O3vQgLSzSwyJb3cbRoFIUbclj/eNR7FkQrDIsaxnLF+Cz1HdMftly2TuE/B7jmopebhM85fJpgXryZTexiIRSliEKuNo5HQ+hpLyR49QxKTD5mDshPbHT3FR6d8145bk7geaguSTA7E5bzetAE0c9wu9o3kaOM72UrjA6HFX3+z29z5cMnnLKv7xwcllOOoPTHtUG9v9NG448jpn6Vc2r/wiJbaN3m4zjntQAajHNE0Ua3RlmSIscRb1KDoSF7etVt+zy5MbrlCHjVGJ+brkdvfFWwTFpF8YzsIlCgrxwVOR9KzLFmjhjMbFTtJypx2NAGpHGZ5MXEyoXYSyo5G7J/iGeKr+e1nJHkPDJG4AbylYlcnmM9BxVnSFWe9zOokzEM7xnt71DfKBaQgAYErYHpzQAqRpcLM8SCeNRw45bH+16NUeoPJYDy8q6IwUh5MSA7cjcP1zUOoMY7+5WMlFaKHcF4B+taYjR9UO9FbKoDkZ49KAK0dlFD5cwmSUSKXeE/M4wMnI7A9aLW8Q7Z1gjaExPBHvwDGSMBgD6etVbUBp7/cAdq4Gew5pfDaiTU1SQB1+ztwwyPutUgJcA2EcTSyQyy8mRYzloxnuT1J9Kk0+7t5LZjORcnus4JWIDk7Tnris1wPsQPcscn1rYnJXS5ApwGxuA7/AC96AK1oGjniuEIJWQO0jj5Uz0yx4AGB7097t4zbbZYUSQuSPLBHsT65NLaOy2l1GrERrsYKDwD649aragxOpNkk4jXGaAJLdJryycKV2H51yBu3Dg49BjFFtAbC6uLJgyyrGGfLZXPckfj0qHW5HieUROyArztOM/KKkuma5+xNcEyt6ud3cetAFlrq7aNWlCZRSHd4tu9c8e54/Ko0nZrfhoZAEFyI3HzAcjGcc4qz8R3ZfEWxWYIIUwoPA4FUr4BJbYKNubE5xxSW4DIpGtbkTRMoifG5kOCG6A461YmEDvtD3EFvJyylwxlPUuvscUvhxQ90d4DfIp5555qXRo0m8QaQkyrIjTKrKwyCMtwR6UwISyxIc3E4WWMsu07Qy/wkg9eetRXMkjwQCcb53AWN1UIyr3B9amijQ3s2UU7ZGA46D5qg05Vmn1DzQHxDkbhnHNSxosEGcrPAsTzx4OcEM2ByCO3HemM7tI5RMebEq+Y8f3Bu5Pv+FUnAW/UKMDjgf7wrobjjV5YxxGttOVUdB9BSshmHJJL50SxmWSSR2bacld3TeBj07VPKZJowdOZo2D4k2t5YT1zk81VSWT+09P8Anb8/epLr5rhQ3I9D/vVZIwmxQW9tbZaST/XyNkZ9lHp3zVtltTbxSJIG+TbIgUIoxwCSepI5qlYAFbkkZI3YPpwakvQGuJlYZUImAeg/dikwNRb2eDRrmKeJbiNmUCUPuChQfkPtz+FY0W1HcpFKinq4bLIv16YrQ8Pux8PuCxI3v3pumgfZ9S4HJP8AI0kN7FbMV7qKRKZDZ55KptYjuAP73vUskbeR5Nk7xWrtn984AIycc8d/1p+gn57X3kXP5GsnVf8Aj4Ydh0H4VaEaIl0uOwuBGXe6kVYozL0jPVn46nHFQW+6CO6SWKVLYxlEI4bJxj3I9Kr9RMDyAAQPwrYlJNhJkk/MvX6CmBmXNkRE0m2eZDwhRMAn/wCsKhtJBBbTKRveXAfIyAvPJHqO1W7iRxbMA7YE64GfpT3HzN/ut/OgCgZVjUC0/eOG4kc5LY6YHoKc0scokVXZXdcfKOXPXB+pq3Zxp5anYueecVm2X/H7B/11oEWHtlTdGJY2Ix+9yevp9BSedGY5PNkeTEmSin5WboWzVi0AJv8AIB+T+tUZEUMmFAyPSgCVreRoEQO8m4/ukC9fU59KktjvkR2Z0lHytIvcehpZyTdxqSSojGBWlBGgKYRR8h6CtIK7Jk7I2/DE8Fs89tNN5aSMkiXC/P5EyHKSEdxyQfY12loIoXkuPL0ezeVSJLuC7MwG7hjFF1DHJxnpmvObYAPJgY+QdPrWvZgBwQBmuyFNdDm531NnV7oXl27wxskKqsUKnqqKMLn370VWPeit7LYzcmf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A round patch of alopecia with overlying scale and \"black dots\" at the sites of follicular openings is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9976=[""].join("\n");
var outline_f9_47_9976=null;
var title_f9_47_9977="Biliary cysts";
var content_f9_47_9977=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Biliary cysts",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/47/9977/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9977/contributors\">",
"     Mark Topazian, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/47/9977/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9977/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9977/contributors\">",
"     Elizabeth B Rand, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/47/9977/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9977/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/47/9977/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biliary cysts are cystic dilations that may occur singly or in multiples throughout the biliary tree. They were originally termed choledochal cysts due to their involvement of the extrahepatic bile duct. However, the clinical classification was revised in 1977 to include intrahepatic cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Biliary cysts are associated with significant complications, such as ductal strictures, stone formation, cholangitis, rupture, and secondary biliary cirrhosis. In addition, certain types of biliary cysts have a high risk of malignancy.",
"   </p>",
"   <p>",
"    This topic will review the pathogenesis, clinical manifestations, diagnosis, and management of biliary cysts. Cholangiocarcinoma, gallbladder cancer, and a detailed discussion of type V biliary cysts (Caroli disease) are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43881?source=see_link\">",
"     \"Epidemiology, pathogenesis, and classification of cholangiocarcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/43/40633?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cholangiocarcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25114?source=see_link\">",
"     \"Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2902?source=see_link\">",
"     \"Caroli disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of biliary cysts has been estimated to be 1:100,000 to 1:150,000, with even wider ranges reported [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/3\">",
"     3",
"    </a>",
"    ]. The incidence is higher in some Asian countries (up to 1:1000) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/4\">",
"     4",
"    </a>",
"    ], with between one-half and two-thirds of the reported cases occurring in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Biliary cysts are more common in women, with a female to male ratio of 3:1 to 4:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ]. In the past, the majority of cases were reported in children, although more recent series report equal numbers in adults and children [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1464909\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A classification scheme for cysts of the extrahepatic bile ducts (choledochal cysts) was proposed initially in 1959 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/2\">",
"     2",
"    </a>",
"    ]. It was expanded in 1977 to include intrahepatic cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/1\">",
"     1",
"    </a>",
"    ] and further refined in 2003 to incorporate the presence of an abnormal pancreaticobiliary junction (APBJ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Role of an abnormal pancreaticobiliary junction'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The classification scheme defines five types of biliary cyst (",
"    <a class=\"graphic graphic_figure graphicRef80937 \" href=\"UTD.htm?26/27/27056\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/5,7,8\">",
"     5,7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I cysts account for 50 to 85 percent of all biliary cysts [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/1,3\">",
"       1,3",
"      </a>",
"      ]. They are characterized by cystic or fusiform dilation of the common bile duct. Type I cysts are further subcategorized [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/7\">",
"       7",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Type IA is defined by cystic dilation of the entire extrahepatic biliary tree and is associated with an APBJ. There is no dilation of the intrahepatic ducts. The cystic duct and gallbladder arise from the dilated common bile duct.",
"     </li>",
"     <li>",
"      Type IB is defined by focal, segmental (often distal) dilation of the extrahepatic bile duct. Type IB cysts are not associated with an APBJ.",
"     </li>",
"     <li>",
"      Type IC is defined by smooth, fusiform (as opposed to cystic) dilation of the entire extrahepatic bile duct. Typically, the dilation extends from the pancreatobiliary junction to the intrahepatic biliary tree. Type IC cysts are associated with an APBJ.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type II cysts account for 2 percent of biliary cysts. They are true diverticula of the extrahepatic bile duct and communicate with the bile duct through a narrow stalk.",
"     </li>",
"     <li>",
"      Type III cysts account for 1 to 5 percent of biliary cysts and are also known as choledochoceles or intraluminal duodenal duplications. Type III cysts are cystic dilations limited to the intraduodenal portion of the distal common bile duct (",
"      <a class=\"graphic graphic_figure graphicRef81700 \" href=\"UTD.htm?0/14/231\">",
"       figure 2",
"      </a>",
"      ). Choledochoceles can be lined by duodenal or biliary epithelium and may arise embryologically as duodenal duplications involving the ampulla. As many as five subtypes have been described [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/9\">",
"       9",
"      </a>",
"      ]; however, most commonly they are subdivided into type IIIA cysts (in which the bile duct and pancreatic duct enter the choledochocele, which then drains into the duodenum at a separate orifice) and type IIIB cysts (a diverticulum of the intraduodenal bile duct or common channel) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/10-12\">",
"       10-12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Type IV cysts account for 15 to 35 percent of cysts. They are defined by the presence of multiple cysts and are subdivided based upon their intrahepatic bile duct involvement. Type IVA cysts have both intrahepatic and extrahepatic cystic dilations, whereas type IVB cysts have multiple extrahepatic cysts but no intrahepatic cysts. Type IVA is the second most common type of biliary cyst and can be differentiated from type IC cysts on the basis of a distinct change in duct caliber at the hilum, or a stricture at the hilum [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Type V cysts account for 20 percent of biliary cysts. They are characterized by one or more cystic dilations of the intrahepatic ducts, without extrahepatic duct disease. The presence of multiple saccular or cystic dilations of the intrahepatic ducts is known as Caroli disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2902?source=see_link\">",
"       \"Caroli disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several theories of biliary cyst formation have been proposed, and it is likely that no one mechanism accounts for all biliary cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cysts may be congenital [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/13\">",
"     13",
"    </a>",
"    ] or acquired [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/14\">",
"     14",
"    </a>",
"    ] and have been associated with a variety of anatomic abnormalities. A genetic or environmental predisposition to biliary cysts is suggested by reports of the familial occurrence of cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/15\">",
"     15",
"    </a>",
"    ] and by the increased incidence in some Asian countries.",
"   </p>",
"   <p>",
"    Developmental anomalies associated with biliary cysts include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Biliary atresia",
"     </li>",
"     <li>",
"      Duodenal atresia",
"     </li>",
"     <li>",
"      Colonic atresia",
"     </li>",
"     <li>",
"      Imperforate anus",
"     </li>",
"     <li>",
"      Pancreatic arteriovenous malformation",
"     </li>",
"     <li>",
"      Multiseptate gallbladder",
"     </li>",
"     <li>",
"      Hemifacial microsomia with extracraniofacial anomalies (OMENS plus syndrome)",
"     </li>",
"     <li>",
"      Ventricular septal defect",
"     </li>",
"     <li>",
"      Aortic hypoplasia",
"     </li>",
"     <li>",
"      Congenital absence of the portal vein",
"     </li>",
"     <li>",
"      Heterotopic pancreatic tissue",
"     </li>",
"     <li>",
"      Familial adenomatous polyposis",
"     </li>",
"     <li>",
"      Autosomal recessive and autosomal dominant polycystic kidney disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Congenital cysts may result from an unequal proliferation of embryologic biliary epithelial cells before bile duct cannulation is complete [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Fetal viral infection may also have a role, as reovirus RNA has been isolated from biliary tissue of neonates with infantile biliary obstruction and biliary cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, cyst formation may be the result of ductal obstruction or distension during the prenatal or neonatal period. In a sheep model, bile duct ligation in neonates led to cyst formation, whereas duct ligation in adult animals led to gallbladder distension [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Role of an abnormal pancreaticobiliary junction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired cysts may be the result of an abnormal pancreaticobiliary junction (APBJ), also called pancreaticobiliary maljunction. APBJ is a rare congenital anomaly, with a prevalence of 0.03 percent in one population-based series from Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/20\">",
"     20",
"    </a>",
"    ]. It is present in about 70 percent of patients with biliary cysts (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77946 \" href=\"UTD.htm?20/7/20607\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef57937 \" href=\"UTD.htm?5/35/5682\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62324 \" href=\"UTD.htm?10/15/10495\">",
"     image 2",
"    </a>",
"    ) and may be a significant risk factor for the development of malignancy with the cyst [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/21\">",
"     21",
"    </a>",
"    ]. In addition, patients with APBJ without biliary cysts appear to be at a markedly increased risk for gallbladder cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    APBJ is characterized by a junction of the bile duct and pancreatic duct outside the duodenal wall with a long common duct channel (at least 8 mm, and often over 20 mm, in length) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. APBJ may result from failure of the embryological ducts to migrate fully into the duodenum. In support of this hypothesis is the observation that the ampulla of Vater is diminutive or flat in patients with APBJ. In one series, the papilla was displaced distally in the duodenum of patients with APBJ, with the distal displacement of the papilla corresponding to the length of the common channel [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A long common channel may predispose to reflux of pancreatic juice into the biliary tree since the ductal junction lies outside of the duodenal wall and the sphincter of Oddi [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/25\">",
"     25",
"    </a>",
"    ]. This can result in increased amylase levels in bile [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/26\">",
"     26",
"    </a>",
"    ], intraductal activation of proteolytic enzymes, alterations in bile composition, and theoretically biliary epithelial damage, inflammation, ductal distension, and cyst formation. Elevated sphincter of Oddi pressures have been documented in APBJ [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] and could promote pancreaticobiliary reflux.",
"   </p>",
"   <p>",
"    APBJ may be usefully subdivided based upon the presence of an acute or right angle at the bile",
"    <span class=\"nowrap\">",
"     duct/pancreatic",
"    </span>",
"    duct junction, the presence or absence of a dilated common channel, and the presence or absence of a dominant dorsal pancreatic duct [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/6\">",
"     6",
"    </a>",
"    ]. This classification system reflects anatomic issues of importance to the endoscopist and surgeon. Proteinaceous plugs or stones within a dilated common channel may cause ductal obstruction and pancreatitis, and cyst resection alone may not resolve the patient's symptoms. Surgical sphincteroplasty or endoscopic sphincterotomy may be required in the treatment of such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1465186\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic features of choledochal cysts are variable, ranging from normal bile duct mucosa to carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/3,29\">",
"     3,29",
"    </a>",
"    ]. More commonly in children, there is a densely fibrotic cyst wall with evidence of chronic and acute inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/3\">",
"     3",
"    </a>",
"    ]. In adults, there are frequently inflammatory changes, erosions, sparse distribution of mucin glands, and, not infrequently, metaplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/3,30\">",
"     3,30",
"    </a>",
"    ]. Malignancy, when present, is most commonly found in the posterior cyst wall [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/29\">",
"     29",
"    </a>",
"    ]. In the case of type III cysts (see",
"    <a class=\"local\" href=\"#H1464909\">",
"     'Classification'",
"    </a>",
"    above), the cyst is usually lined by duodenal mucosa, and less commonly by bile duct epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with biliary cysts will present before the age of 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/31\">",
"     31",
"    </a>",
"    ]. Infants with biliary cysts commonly present with conjugated hyperbilirubinemia (80 percent), failure to thrive, or an abdominal mass (30 to 60 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/3\">",
"     3",
"    </a>",
"    ]. The triad of pain, jaundice, and an abdominal mass is found in 11 to 63 percent of infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24519?source=see_link\">",
"     \"Approach to neonatal cholestasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, chronic and intermittent abdominal pain is the most common presenting symptom (50 to 96 percent) in patients older than two [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/3,32\">",
"     3,32",
"    </a>",
"    ]. Intermittent jaundice and recurrent cholangitis are also seen frequently (34 to 55 percent). Other manifestations include an abdominal mass (10 to 20 percent), pancreatitis (20 percent), and biliary lithiasis (8 percent). Pancreatitis and ductal stones are more commonly encountered in patients with type III cysts (choledochoceles). (See",
"    <a class=\"local\" href=\"#H1464909\">",
"     'Classification'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Rarely, biliary cysts present with intraperitoneal rupture, bleeding due to erosion into adjacent vessels or portal hypertension, and secondary biliary cirrhosis due to prolonged biliary obstruction and recurrent cholangitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/31\">",
"     31",
"    </a>",
"    ]. In addition, type III cysts can case gastric outlet obstruction due to the obstruction of the duodenal lumen or intussusception.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A biliary cyst should be considered in adults when a dilated portion of the bile duct or ampulla is identified, especially in the absence of biochemical, imaging, or endoscopic evidence of obstruction. A high level of suspicion is required for diagnosis, particularly for type I cysts, which may go undiagnosed unless considered in the differential diagnosis of patients found to have ductal dilation. On the other hand, acute or chronic biliary obstruction may cause marked biliary dilation that mimics a type I cyst. Such patients usually present with jaundice or elevated serum liver tests, have a readily identifiable obstructing lesion such as a stone, stricture, or mass, and their biliary dilation often improves after appropriate treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/33\">",
"     33",
"    </a>",
"    ]. A careful evaluation for an abnormal pancreatobiliary junction may help with diagnosis in indeterminate cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466123\">",
"    <span class=\"h2\">",
"     Imaging modalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple imaging modalities are available, including transabdominal ultrasound, computed tomography, endoscopic retrograde cholangiopancreatography, and magnetic resonance cholangiopancreatography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1465578\">",
"    <span class=\"h3\">",
"     Transabdominal ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cross-sectional imaging with ultrasound or computed tomography may suggest the presence of a biliary cyst. An ultrasound is often the first imaging modality used for the evaluation the biliary tree and may show a cystic mass in the right upper quadrant. However, it will not detect type III and type V cysts. It has a sensitivity of 71 to 97 percent for diagnosing biliary cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/34\">",
"     34",
"    </a>",
"    ]. Factors that may limit the usefulness of an ultrasound include the patient's body habitus, the presence of bowel gas, and limited visualization due to overlying structures.",
"   </p>",
"   <p>",
"    Communication with the biliary tree must be demonstrated in order to differentiate biliary cysts from other cystic lesions. In patients identified with cysts by ultrasound, this is often done with other imaging modalities. However, an ultrasound was able to show continuity of the cyst with the bile duct in 13 of 14 patients (93 percent) in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1465585\">",
"    <span class=\"h3\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike ultrasound, computed tomography (CT) can detect all types of biliary cysts. It can demonstrate continuity of the cyst with the biliary tree, examine the relationship of the cyst to surrounding structures, and can evaluate for the presence of malignancy. It is also useful for determining the extent of intrahepatic disease in patients with type IVA or V cysts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18950?source=see_link\">",
"     \"Computed tomography of the hepatobiliary tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Computed tomographic cholangiography has been used to delineate the anatomy of the biliary tree and has high sensitivities for visualizing the biliary tree (93 percent), diagnosing biliary cysts (90 percent), and diagnosing intraductal stones (93 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/36\">",
"     36",
"    </a>",
"    ]. However, its sensitivity is lower for imaging the pancreatic duct (64 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466042\">",
"    <span class=\"h3\">",
"     Endoscopic ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasound (EUS) can demonstrate extrahepatic biliary cysts and provide detailed images of the cyst wall and pancreaticobiliary junction. In addition, unlike transabdominal ultrasonography, it is not limited by body habitus, bowel gas, or overlying structures.",
"   </p>",
"   <p>",
"    Intraductal ultrasound (IDUS) has been used for the diagnosis of early malignant changes in a biliary cyst [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/37\">",
"     37",
"    </a>",
"    ]. This technique is likely to be more sensitive than direct cholangiography for detecting early malignancy in the cyst wall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/43/40633?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical manifestations and diagnosis of cholangiocarcinoma\", section on 'Endoscopic ultrasound'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/36/33353?source=see_link&amp;anchor=H13#H13\">",
"     \"Intraductal ultrasound of the pancreaticobiliary ductal system\", section on 'Cholangiocarcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466049\">",
"    <span class=\"h3\">",
"     Hepatobiliary scintigraphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatobiliary scintigraphy using radio-labeled dyes can be used to demonstrate continuity of cysts with the bile ducts. This nuclear medicine examination uses technetium-99m-labeled hepatic iminodiacetic acid (HIDA), which is injected intravenously and is then selectively taken-up by hepatocytes and excreted into the bile. The cyst will initially be photopenic, followed by filling of the cyst and delayed emptying of the contrast into the bowel. HIDA scanning is useful for extrahepatic cysts, with a sensitivity up to 100 percent for type I cysts. However, it is inadequate at visualizing the intrahepatic bile ducts, with a sensitivity of 67 percent for type IVA cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/38\">",
"     38",
"    </a>",
"    ]. HIDA scanning may also be useful in cases of cyst rupture, since excreted contrast may be seen within the peritoneal cavity in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1465593\">",
"    <span class=\"h3\">",
"     Cholangiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct cholangiography (whether intraoperative, percutaneous, or endoscopic) has a sensitivity of up to 100 percent for diagnosing biliary cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/40\">",
"     40",
"    </a>",
"    ] and previously was a commonly obtained test. Type III cysts (choledochoceles) are often first suspected during endoscopic retrograde cholangiopancreatography when a dilated intramural portion of the bile duct is seen endoscopically. The dilated segment may become much more apparent during contrast injection, ballooning in shape as it fills with contrast. Large type III cysts may be apparent on CT or upper GI series where they appear as a filling defect in the duodenal lumen.",
"   </p>",
"   <p>",
"    Cholangiography allows for preoperative evaluation of the biliary anatomy, can identify an abnormal pancreatobiliary junction, and can detect filling defects due to stones or malignancy. However, it carries with it a significant risk of cholangitis and pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. Patients with cystic disease are at greater risk for these complications compared with the general population due to the presence of long common channels, dysfunctional sphincters, and dilated ducts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39705?source=see_link\">",
"     \"Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23959?source=see_link\">",
"     \"Post-ERCP septic complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/39/37491?source=see_link\">",
"     \"Percutaneous transhepatic cholangiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1465614\">",
"    <span class=\"h3\">",
"     Magnetic resonance cholangiopancreatography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance cholangiopancreatography (MRCP) does not have the risks of cholangitis and pancreatitis associated with direct cholangiography, and in many cases it is the test of choice for diagnosing and evaluating biliary cysts. Its sensitivity for biliary cysts is between 73 and 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/44\">",
"     44",
"    </a>",
"    ]. However, MR is less sensitive than direct cholangiography for excluding obstruction. The data are variable with regard to its ability to diagnose an abnormal pancreatobiliary junction. Some studies have found that it identifies an abnormal pancreatobiliary junction in over 75 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/44-46\">",
"     44-46",
"    </a>",
"    ], whereas the rate has been as low as 46 percent in other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=see_link\">",
"     \"Magnetic resonance cholangiopancreatography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466114\">",
"    <span class=\"h2\">",
"     Diagnostic approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic approach varies greatly based upon the age of the patient, presenting symptoms, candidacy for surgery, the type of biliary cyst, and the laboratory and imaging data that are available. A key element is consideration of the possibility of a biliary cyst in a patient found to have a dilated bile duct or cystic liver lesion. Cross-sectional imaging with CT or MRCP is typically the first step in diagnosis.",
"   </p>",
"   <p>",
"    For types I and IVA cysts, the absence of a distal obstructing lesion is often best confirmed by endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound (EUS), as these endoscopic tests provide direct visualization of the ampulla as well as the peri-ampullary bile duct and pancreatic duct. For types II and IVB, confirmation that the cyst communicates with the biliary tree may be obtained by hepatobiliary scintigraphy or ERCP. For type I and IVA cysts, the distal extent of the cyst and the anatomy of the abnormal pancreaticobiliary junction (if present) should both be assessed prior to surgery by MRCP, EUS,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ERCP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CANCER RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biliary cysts are associated with an increased risk of cancer, particularly cholangiocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/47\">",
"     47",
"    </a>",
"    ]. The incidence of malignancy varies with age and with the type of cyst. In a 1983 review of all published series of biliary cysts, the incidence of cancer was 0.7 percent in patients under 10 years of age, 6.8 percent in patients 11 to 20 years of age, and 14.3 percent in patients over 20 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/30\">",
"     30",
"    </a>",
"    ]. In a systematic review from 2007, the incidence of biliary cancer was in the range of 10 to 30 percent (16 percent in the largest report) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/47\">",
"     47",
"    </a>",
"    ], with a mean age at diagnosis of 32 years. However, an incidence of cancer as high as 50 percent has been reported in older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of the cancers occur in type I and type IV cysts. In one series, 68 percent of the malignancies occurred in patients with type I cysts, and 21 percent occurred in patients with type IV cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/49\">",
"     49",
"    </a>",
"    ]. Patients with type II cysts and type III cysts accounted for 5 and 2 percent of cases, respectively. Cancer in patients with type III cysts may be limited to those with choledochoceles lined by biliary, rather than duodenal, epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/50\">",
"     50",
"    </a>",
"    ]. Type V cysts (Caroli disease) have also been associated with a 7 to 15 percent risk of malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/5,47,51\">",
"     5,47,51",
"    </a>",
"    ]. Multiple studies have described molecular changes that occur during the evolution to malignancy, but their role in diagnosis or management is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of an abnormal pancreatobiliary junction (APBJ) alone increases the risk of malignancy. In one study, the increased incidence of cholangiocarcinoma in biliary cysts was confined to patients with an APBJ [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/21\">",
"     21",
"    </a>",
"    ]. In addition, APBJ appears to increase the risk of biliary and pancreatic malignancy even in patients without a biliary cyst or ductal dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. K-ras mutations and p53 overexpression have been demonstrated in the biliary mucosa of such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/56\">",
"     56",
"    </a>",
"    ]. Gallbladder cancer is the most common malignancy seen in patients with APBJ who do not have a bile duct cyst, and prophylactic cholecystectomy in patients with APBJ has been advised [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cited statistics likely overestimate the risk of cancer in biliary cysts because most series include only symptomatic patients presenting with complications, including malignancy. To calculate the true risk of malignant degeneration, the incidence of asymptomatic biliary cysts in the population should be used as the denominator, a parameter that is unknown. If patients who developed malignancy at least two years after initial diagnosis of their cyst are studied, the incidence in adults appears lower (4.5 percent rather than 14.3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, evidence clearly points to a 20- to 30-fold increased risk of cholangiocarcinoma in biliary cysts compared with the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/47\">",
"     47",
"    </a>",
"    ]. This evidence includes the occurrence of cholangiocarcinoma in patients as young as 10 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/48\">",
"     48",
"    </a>",
"    ], the occurrence of synchronous and metachronous biliary cancers, and the subsequent development of cancer in patients with incompletely resected cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. The possibility of cancer should always be considered in an adult with a newly diagnosed biliary cyst.",
"   </p>",
"   <p>",
"    While the carcinoma risk is decreased in patients who have undergone cyst resection, these patients continue to be at increased risk of carcinoma compared with the general population. Postexcisional malignant disease is seen in 0.7 to 6 percent of patients and may be due to remnant cyst tissue or subclinical malignant disease that was not detected prior to cyst excision [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. Malignancy may develop in portions of cysts that were left behind at surgery, at the anastomotic site, or in the pancreas [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/57,58,60-62\">",
"     57,58,60-62",
"    </a>",
"    ]. In addition, patients previously treated with biliary bypass, rather than cyst resection, may have a higher risk of subsequent malignancy than unoperated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to management depends upon the type of cyst. In the past, some patients were treated with internal drainage via a cystenterostomy. While effective at treating symptoms, the procedure was associated with significant complications such as ascending cholangitis due to reflux of enteric contents into the cyst and biliary tree, anastomotic stricture formation, and most importantly, a 30 percent postoperative risk of malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Because of these complications, patients requiring treatment now generally undergo cyst excision with hepaticoenterostomy.",
"   </p>",
"   <p>",
"    Regardless of the type of cyst, patients with ascending cholangitis require treatment with antibiotics and drainage. Drainage can often be obtained via endoscopic retrograde cholangiopancreatography or percutaneous transhepatic cholangiography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24790?source=see_link&amp;anchor=H8#H8\">",
"     \"Acute cholangitis\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22905?source=see_link\">",
"     \"Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/39/37491?source=see_link\">",
"     \"Percutaneous transhepatic cholangiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466497\">",
"    <span class=\"h2\">",
"     Type I, II, and IV cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical excision is recommended for type I, II, and IV biliary cysts, with the goal of removing all of the cyst tissue when possible. The approach is advocated because of the risk of malignancy associated with these cysts. In addition to decreasing the risk of malignancy, the excision of cysts can reduce complications such as recurrent cholangitis, choledocholithiasis, and pancreatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7896043\">",
"    <span class=\"h3\">",
"     Extrahepatic cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the case of extrahepatic cysts, resection is usually followed by hepaticojejunostomy for reconstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/48,65\">",
"     48,65",
"    </a>",
"    ]. The use of an appendiceal interposition graft has also been reported in children, but the value of this technique has been questioned [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. In some cases, excision of the cyst may be complicated by its relationship to nearby structures. If dissection of a cyst from the portal vein or hepatic artery is technically difficult, some surgeons advocate leaving the posterior cyst wall intact and performing a mucosectomy (removal of the epithelial lining of the cyst) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/48\">",
"     48",
"    </a>",
"    ]. The mucosectomy is performed in an attempt to decrease the risk of malignancy.",
"   </p>",
"   <p>",
"    The relationship of type I cysts to the pancreatic head can also complicate cyst removal. The intrapancreatic portion of type I cysts can generally be treated with intramural dissection of the bile duct down to the pancreaticobiliary junction without pancreatic head resection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/68\">",
"     68",
"    </a>",
"    ]. If left in place, the intrapancreatic portion of a type I cyst can be associated with subsequent malignancy or stone formation in the cyst remnant [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/69\">",
"     69",
"    </a>",
"    ]. The lower resection margin depends upon the distal extent of the cyst. Various methods have been proposed to determine the cysts lower border, including intraoperative choledochoscopy of the distal bile duct, intraoperative ultrasonography, and preoperative endoscopic placement of a nasopancreatic drain with intraoperative pancreatography [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical resection effectively treats symptoms and appears to decreases cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/57,58,60-62,70,71\">",
"     57,58,60-62,70,71",
"    </a>",
"    ]. The most frequent long-term complication of hepaticojejunostomy is stenosis of the biliary-enteric anastomosis leading to cholangitis, jaundice, or cirrhosis. This complication occurs in up to 25 percent of patients over time [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/72\">",
"     72",
"    </a>",
"    ], and patients should be monitored for evidence of stricture formation with annual serum liver tests. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7896057\">",
"    <span class=\"h3\">",
"     Intrahepatic cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrahepatic cysts are frequently difficult to treat. These patients often undergo excision of the extrahepatic cyst with wide hilar hepaticoenterostomy. However, symptoms often persist due to the intrahepatic cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/73\">",
"     73",
"    </a>",
"    ]. Segmental hepatectomy is an option if the intrahepatic involvement is localized. If the intrahepatic involvement is diffuse, a percutaneous hepaticojejunostomy may permit repeated stone extractions and dilations. Finally, surgical unroofing of intrahepatic cysts has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/74\">",
"     74",
"    </a>",
"    ]. In rare cases, a liver transplant may be required. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7896191\">",
"    <span class=\"h3\">",
"     Abnormal pancreaticobiliary junction",
"    </span>",
"   </p>",
"   <p>",
"    In addition to cyst excision, cholecystectomy should be considered in patients with an abnormal pancreatobiliary junction because of the increased risk of gallbladder cancer. Patients with an abnormal pancreatobiliary junction and a dilated common channel may also require surgical or endoscopic removal of stones or protein plugs from the common channel to treat recurrent pain or pancreatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7896153\">",
"    <span class=\"h3\">",
"     Alternatives to surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with type I, II, or IV biliary cysts who refuse surgical resection or who are poor surgical candidates, lesser interventions (such as laparoscopic cholecystectomy or endoscopic retrograde cholangiopancreatography) may treat symptoms caused by gallstones or sludge. There is no proven effective method of screening biliary cysts for dysplasia or intramucosal cancer. If screening is attempted, an intraductal ultrasound is probably the most sensitive test for detecting early malignancy in the cyst wall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/36/33353?source=see_link&amp;anchor=H13#H13\">",
"     \"Intraductal ultrasound of the pancreaticobiliary ductal system\", section on 'Cholangiocarcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466518\">",
"    <span class=\"h2\">",
"     Type III cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type IIIA cysts (choledochoceles) are often amenable to endoscopic sphincterotomy, which allows for the drainage of bile and stones. Because malignancy has rarely been reported in choledochoceles, endoscopic biopsies of the cyst epithelium may be considered after sphincterotomy to determine if the cyst is lined by duodenal or biliary mucosa, and to exclude dysplasia. Type IIIB cysts (diverticular choledochoceles or intraluminal duodenal duplications) may be resected surgically or endoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/75,76\">",
"     75,76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466490\">",
"    <span class=\"h2\">",
"     Type V cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with type IVA cysts, the intrahepatic cysts in patients with type V biliary cysts can be difficult to manage, and some patients with type V cysts will eventually require liver transplantation. The treatment of patients with type V cysts is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2902?source=see_link&amp;anchor=H7#H7\">",
"     \"Caroli disease\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1466662\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biliary cysts are cystic dilations that may occur singly or in multiples throughout the biliary tree. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biliary cysts are associated with complications such as ductal strictures, stone formation, and cholangitis. In addition, certain types carry a high risk of malignancy. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Cancer risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The classification scheme for biliary cysts takes into account cyst location, cyst number, and whether there is an abnormal pancreaticobiliary junction (",
"      <a class=\"graphic graphic_figure graphicRef80937 \" href=\"UTD.htm?26/27/27056\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1464909\">",
"       'Classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Role of an abnormal pancreaticobiliary junction'",
"      </a>",
"      above.) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9977/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Infants with biliary cysts commonly present with conjugated hyperbilirubinemia, failure to thrive, or an abdominal mass. Chronic and intermittent abdominal pain is the most common presenting symptom in patients older than two years of age. Other manifestations include intermittent jaundice, pancreatitis, and biliary lithiasis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic approach varies greatly based upon the age of the patient, presenting symptoms, candidacy for surgery, the type of biliary cyst, and the laboratory and imaging data that are available. (See",
"      <a class=\"local\" href=\"#H1466114\">",
"       'Diagnostic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with type I, II, and IV cysts usually undergo surgical resection of the cysts due to the significant risk of malignancy, provided they are good surgical candidates. (See",
"      <a class=\"local\" href=\"#H1466497\">",
"       'Type I, II, and IV cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with an abnormal pancreaticobiliary junction and no biliary cyst should consider prophylactic cholecystectomy given their increased risk of gallbladder cancer. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cancer risk'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7896191\">",
"       'Abnormal pancreaticobiliary junction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with type III cysts (choledochoceles) can often be managed with endoscopic sphincterotomy or endoscopic resection. &nbsp;(See",
"      <a class=\"local\" href=\"#H1466518\">",
"       'Type III cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intrahepatic cysts may be difficult to resect, and some patients with type V cysts may require liver transplantation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2902?source=see_link&amp;anchor=H7#H7\">",
"       \"Caroli disease\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/1\">",
"      Todani T, Watanabe Y, Narusue M, et al. Congenital bile duct cysts: Classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 1977; 134:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/2\">",
"      ALONSO-LEJ F, REVER WB Jr, PESSAGNO DJ. Congenital choledochal cyst, with a report of 2, and an analysis of 94, cases. Int Abstr Surg 1959; 108:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/3\">",
"      Lipsett PA, Pitt HA, Colombani PM, et al. Choledochal cyst disease. A changing pattern of presentation. Ann Surg 1994; 220:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/4\">",
"      O'Neill JA Jr. Choledochal cyst. Curr Probl Surg 1992; 29:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/5\">",
"      Singham J, Yoshida EM, Scudamore CH. Choledochal cysts: part 1 of 3: classification and pathogenesis. Can J Surg 2009; 52:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/6\">",
"      Komi N, Takehara H, Kunitomo K, et al. Does the type of anomalous arrangement of pancreaticobiliary ducts influence the surgery and prognosis of choledochal cyst? J Pediatr Surg 1992; 27:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/7\">",
"      Todani T, Watanabe Y, Toki A, Morotomi Y. Classification of congenital biliary cystic disease: special reference to type Ic and IVA cysts with primary ductal stricture. J Hepatobiliary Pancreat Surg 2003; 10:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/8\">",
"      Cha SW, Park MS, Kim KW, et al. Choledochal cyst and anomalous pancreaticobiliary ductal union in adults: radiological spectrum and complications. J Comput Assist Tomogr 2008; 32:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/9\">",
"      Kagiyama S, Okazaki K, Yamamoto Y, Yamamoto Y. Anatomic variants of choledochocele and manometric measurements of pressure in the cele and the orifice zone. Am J Gastroenterol 1987; 82:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/10\">",
"      Tanaka T. Pathogenesis of choledochocele. Am J Gastroenterol 1993; 88:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/11\">",
"      Sarris GE, Tsang D. Choledochocele: case report, literature review, and a proposed classification. Surgery 1989; 105:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/12\">",
"      Scholz FJ, Carrera GF, Larsen CR. The choledochocele: correlation of radiological, clinical and pathological findings. Radiology 1976; 118:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/13\">",
"      Howell CG, Templeton JM, Weiner S, et al. Antenatal diagnosis and early surgery for choledochal cyst. J Pediatr Surg 1983; 18:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/14\">",
"      Han SJ, Hwang EH, Chung KS, et al. Acquired choledochal cyst from anomalous pancreatobiliary duct union. J Pediatr Surg 1997; 32:1735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/15\">",
"      Iwata F, Uchida A, Miyaki T, et al. Familial occurrence of congenital bile duct cysts. J Gastroenterol Hepatol 1998; 13:316.",
"     </a>",
"    </li>",
"    <li>",
"     Lu, SC. Biliary cysts. In: Textbook of gastroenterology, Yamada, T (Eds), Lippincott Williams and Williams, Philadelphia 1999. p.2292.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/17\">",
"      Yotuyangi S. Contribution to etiology and pathology of idiopathic cystic dilatation of the common bile duct, with a report of three cases. Gann (Tokyo) 1936; 30:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/18\">",
"      Tyler KL, Sokol RJ, Oberhaus SM, et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 1998; 27:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/19\">",
"      Spitz L. Experimental production of cystic dilatation of the common bile duct in neonatal lambs. J Pediatr Surg 1977; 12:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/20\">",
"      Yamao K, Mizutani S, Nakazawa S, et al. Prospective study of the detection of anomalous connections of pancreatobiliary ducts during routine medical examinations. Hepatogastroenterology 1996; 43:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/21\">",
"      Song HK, Kim MH, Myung SJ, et al. Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone. Korean J Intern Med 1999; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/22\">",
"      Funabiki T, Matsubara T, Miyakawa S, Ishihara S. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch Surg 2009; 394:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/23\">",
"      Misra SP, Gulati P, Thorat VK, et al. Pancreaticobiliary ductal union in biliary diseases. An endoscopic retrograde cholangiopancreatographic study. Gastroenterology 1989; 96:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/24\">",
"      Li L, Yamataka A, Yian-Xia W, et al. Ectopic distal location of the papilla of vater in congenital biliary dilatation: Implications for pathogenesis. J Pediatr Surg 2001; 36:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/25\">",
"      Matsumoto S, Tanaka M, Ikeda S, Yoshimoto H. Sphincter of Oddi motor activity in patients with anomalous pancreaticobiliary junction. Am J Gastroenterol 1991; 86:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/26\">",
"      Kato T, Hebiguchi T, Matsuda K, Yoshino H. Action of pancreatic juice on the bile duct: pathogenesis of congenital choledochal cyst. J Pediatr Surg 1981; 16:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/27\">",
"      Iwai N, Tokiwa K, Tsuto T, et al. Biliary manometry in choledochal cyst with abnormal choledochopancreatico ductal junction. J Pediatr Surg 1986; 21:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/28\">",
"      Craig AG, Chen LD, Saccone GT, et al. Sphincter of Oddi dysfunction associated with choledochal cyst. J Gastroenterol Hepatol 2001; 16:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/29\">",
"      Weyant MJ, Maluccio MA, Bertagnolli MM, Daly JM. Choledochal cysts in adults: a report of two cases and review of the literature. Am J Gastroenterol 1998; 93:2580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/30\">",
"      Voyles CR, Smadja C, Shands WC, Blumgart LH. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg 1983; 118:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/31\">",
"      Singham J, Yoshida EM, Scudamore CH. Choledochal cysts: part 2 of 3: Diagnosis. Can J Surg 2009; 52:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/32\">",
"      Singham J, Schaeffer D, Yoshida E, Scudamore C. Choledochal cysts: analysis of disease pattern and optimal treatment in adult and paediatric patients. HPB (Oxford) 2007; 9:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/33\">",
"      Aggarwal S, Kumar A, Roy S, Bandhu S. Massive dilatation of the common bile duct resembling a choledochal cyst. Trop Gastroenterol 2001; 22:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/34\">",
"      Fulcher AS, Turner MA, Sanyal AJ. Case 38: Caroli disease and renal tubular ectasia. Radiology 2001; 220:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/35\">",
"      Akhan O, Demirkazik FB, Ozmen MN, Ariy&uuml;rek M. Choledochal cysts: ultrasonographic findings and correlation with other imaging modalities. Abdom Imaging 1994; 19:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/36\">",
"      Lam WW, Lam TP, Saing H, et al. MR cholangiography and CT cholangiography of pediatric patients with choledochal cysts. AJR Am J Roentgenol 1999; 173:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/37\">",
"      Yazumi S, Takahashi R, Tojo M, et al. Intraductal US aids detection of carcinoma in situ in a patient with a choledochal cyst. Gastrointest Endosc 2001; 53:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/38\">",
"      Huang SP, Wang HP, Chen JH, et al. Clinical application of EUS and peroral cholangioscopy in a choledochocele with choledocholithiasis. Gastrointest Endosc 1999; 50:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/39\">",
"      Sood A, Senthilnathan MS, Deswal S, et al. Spontaneous rupture of a choledochal cyst and the role of hepatobiliary scintigraphy. Clin Nucl Med 2004; 29:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/40\">",
"      Keil R, Snajdauf J, Rygl M, et al. Diagnostic efficacy of ERCP in cholestatic infants and neonates--a retrospective study on a large series. Endoscopy 2010; 42:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/41\">",
"      Sugiyama M, Haradome H, Takahara T, et al. Anomalous pancreaticobiliary junction shown on multidetector CT. AJR Am J Roentgenol 2003; 180:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/42\">",
"      Wiedmeyer DA, Stewart ET, Dodds WJ, et al. Choledochal cyst: findings on cholangiopancreatography with emphasis on ectasia of the common channel. AJR Am J Roentgenol 1989; 153:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/43\">",
"      Metreweli C, So NM, Chu WC, Lam WW. Magnetic resonance cholangiography in children. Br J Radiol 2004; 77:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/44\">",
"      Park DH, Kim MH, Lee SK, et al. Can MRCP replace the diagnostic role of ERCP for patients with choledochal cysts? Gastrointest Endosc 2005; 62:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/45\">",
"      Kim MJ, Han SJ, Yoon CS, et al. Using MR cholangiopancreatography to reveal anomalous pancreaticobiliary ductal union in infants and children with choledochal cysts. AJR Am J Roentgenol 2002; 179:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/46\">",
"      Kim SH, Lim JH, Yoon HK, et al. Choledochal cyst: comparison of MR and conventional cholangiography. Clin Radiol 2000; 55:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/47\">",
"      S&oslash;reide K, S&oslash;reide JA. Bile duct cyst as precursor to biliary tract cancer. Ann Surg Oncol 2007; 14:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/48\">",
"      Todani T, Watanabe Y, Toki A, Urushihara N. Carcinoma related to choledochal cysts with internal drainage operations. Surg Gynecol Obstet 1987; 164:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/49\">",
"      Todani T, Tabuchi K, Watanabe Y, Kobayashi T. Carcinoma arising in the wall of congenital bile duct cysts. Cancer 1979; 44:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/50\">",
"      Ohtsuka T, Inoue K, Ohuchida J, et al. Carcinoma arising in choledochocele. Endoscopy 2001; 33:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/51\">",
"      Dayton MT, Longmire WP Jr, Tompkins RK. Caroli's Disease: a premalignant condition? Am J Surg 1983; 145:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/52\">",
"      Elnemr A, Ohta T, Kayahara M, et al. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer. Hepatogastroenterology 2001; 48:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/53\">",
"      Sugiyama M, Abe N, Tokuhara M, et al. Pancreatic carcinoma associated with anomalous pancreaticobiliary junction. Hepatogastroenterology 2001; 48:1767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/54\">",
"      Sugiyama M, Atomi Y. Anomalous pancreaticobiliary junction without congenital choledochal cyst. Br J Surg 1998; 85:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/55\">",
"      Funabiki T, Matsubara T, Ochiai M, et al. Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation. Keio J Med 1997; 46:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/56\">",
"      Hidaka E, Yanagisawa A, Seki M, et al. High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater. Cancer Res 2000; 60:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/57\">",
"      Kobayashi S, Asano T, Yamasaki M, et al. Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction. Surgery 1999; 126:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/58\">",
"      Watanabe Y, Toki A, Todani T. Bile duct cancer developed after cyst excision for choledochal cyst. J Hepatobiliary Pancreat Surg 1999; 6:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/59\">",
"      Ono S, Fumino S, Shimadera S, Iwai N. Long-term outcomes after hepaticojejunostomy for choledochal cyst: a 10- to 27-year follow-up. J Pediatr Surg 2010; 45:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/60\">",
"      Eriguchi N, Aoyagi S, Okuda K, et al. Carcinoma arising in the pancreas 17 years after primary excision of a choledochal cysts: report of a case. Surg Today 2001; 31:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/61\">",
"      Kurokawa Y, Hasuike Y, Tsujinaka T, et al. Carcinoma of the head of the pancreas after excision of a choledochal cyst. Hepatogastroenterology 2001; 48:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/62\">",
"      Tsuchida A, Kasuya K, Endo M, et al. High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation. Oncol Rep 2003; 10:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/63\">",
"      Tao KS, Lu YG, Wang T, Dou KF. Procedures for congenital choledochal cysts and curative effect analysis in adults. Hepatobiliary Pancreat Dis Int 2002; 1:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/64\">",
"      Saing H, Han H, Chan KL, et al. Early and late results of excision of choledochal cysts. J Pediatr Surg 1997; 32:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/65\">",
"      Stain SC, Guthrie CR, Yellin AE, Donovan AJ. Choledochal cyst in the adult. Ann Surg 1995; 222:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/66\">",
"      Wei MF, Qi BQ, Xia GL, et al. Use of the appendix to replace the choledochus. Pediatr Surg Int 1998; 13:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/67\">",
"      Delarue A, Chappuis JP, Esposito C, et al. Is the appendix graft suitable for routine biliary surgery in children? J Pediatr Surg 2000; 35:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/68\">",
"      Ando H, Kaneko K, Ito T, et al. Complete excision of the intrapancreatic portion of choledochal cysts. J Am Coll Surg 1996; 183:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/69\">",
"      Nakano K, Mizuta A, Oohashi S, et al. Protein stone formation in an intrapancreatic remnant cyst after resection of a choledochal cyst. Pancreas 2003; 26:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/70\">",
"      Tocchi A, Mazzoni G, Liotta G, et al. Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients. Ann Surg 2001; 234:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/71\">",
"      Takeshita N, Ota T, Yamamoto M. Forty-year experience with flow-diversion surgery for patients with congenital choledochal cysts with pancreaticobiliary maljunction at a single institution. Ann Surg 2011; 254:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/72\">",
"      R&ouml;thlin MA, L&ouml;pfe M, Schlumpf R, Largiad&egrave;r F. Long-term results of hepaticojejunostomy for benign lesions of the bile ducts. Am J Surg 1998; 175:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/73\">",
"      Singham J, Yoshida EM, Scudamore CH. Choledochal cysts. Part 3 of 3: management. Can J Surg 2010; 53:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/74\">",
"      Yamada T, Furukawa K, Yokoi K, et al. Liver cyst with biliary communication successfully treated with laparoscopic deroofing: a case report. J Nippon Med Sch 2009; 76:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/75\">",
"      Chatila R, Andersen DK, Topazian M. Endoscopic resection of a choledochocele. Gastrointest Endosc 1999; 50:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9977/abstract/76\">",
"      Antaki F, Tringali A, Deprez P, et al. A case series of symptomatic intraluminal duodenal duplication cysts: presentation, endoscopic therapy, and long-term outcome (with video). Gastrointest Endosc 2008; 67:163.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 651 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-194.187.108.93-5353394DC6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9977=[""].join("\n");
var outline_f9_47_9977=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1466662\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1464909\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Role of an abnormal pancreaticobiliary junction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1465186\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1466123\">",
"      Imaging modalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1465578\">",
"      - Transabdominal ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1465585\">",
"      - Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1466042\">",
"      - Endoscopic ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1466049\">",
"      - Hepatobiliary scintigraphy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1465593\">",
"      - Cholangiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1465614\">",
"      - Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1466114\">",
"      Diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CANCER RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1466497\">",
"      Type I, II, and IV cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7896043\">",
"      - Extrahepatic cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7896057\">",
"      - Intrahepatic cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7896191\">",
"      - Abnormal pancreaticobiliary junction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7896153\">",
"      - Alternatives to surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1466518\">",
"      Type III cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1466490\">",
"      Type V cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1466662\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/651\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/651|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/7/20607\" title=\"diagnostic image 1\">",
"      Abnormal pancreaticobiliary junction I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/15/10495\" title=\"diagnostic image 2\">",
"      Type I biliary cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/651|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/27/27056\" title=\"figure 1\">",
"      Classification of biliary cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/14/231\" title=\"figure 2\">",
"      MRCP endo choledochocele",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/651|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/35/5682\" title=\"picture 1\">",
"      Abnormal pancreaticobiliary junction II",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24790?source=related_link\">",
"      Acute cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24519?source=related_link\">",
"      Approach to neonatal cholestasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2902?source=related_link\">",
"      Caroli disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/43/40633?source=related_link\">",
"      Clinical manifestations and diagnosis of cholangiocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18950?source=related_link\">",
"      Computed tomography of the hepatobiliary tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22905?source=related_link\">",
"      Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43881?source=related_link\">",
"      Epidemiology, pathogenesis, and classification of cholangiocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=related_link\">",
"      Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/36/33353?source=related_link\">",
"      Intraductal ultrasound of the pancreaticobiliary ductal system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39705?source=related_link\">",
"      Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/39/37491?source=related_link\">",
"      Percutaneous transhepatic cholangiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=related_link\">",
"      Post-ERCP pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23959?source=related_link\">",
"      Post-ERCP septic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25114?source=related_link\">",
"      Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_47_9978="High-output heart failure";
var content_f9_47_9978=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   High-output heart failure",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/47/9978/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9978/contributors\">",
"     Michael M Givertz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9978/contributors\">",
"     Amir Haghighat, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/47/9978/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9978/contributors\">",
"     Stephen S Gottlieb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/47/9978/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/47/9978/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/47/9978/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with heart failure (HF) have systolic dysfunction with a low or normal cardiac output and elevated systemic vascular resistance",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diastolic dysfunction in which an increase in ventricular stiffness impairs ventricular filling during diastole. In rare circumstances, the cardiac output is elevated and calculated systemic vascular resistance is very low.",
"   </p>",
"   <p>",
"    High-output HF is characterized by an elevated resting cardiac index beyond the normal range of 2.5 to 4.0",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    per m",
"    <sup>",
"     2",
"    </sup>",
"    . Ineffective blood volume and pressure, chronic activation of the sympathetic nervous system and renin-angiotensin-aldosterone axis, increased serum vasopressin (antidiuretic hormone) concentrations, and chronic volume overload gradually cause ventricular enlargement, remodeling, and HF.",
"   </p>",
"   <p>",
"    As will be described in this topic review, a number of conditions lead to an obligatory increase in cardiac output, which can be associated with HF in some patients. However, these conditions are rarely the sole cause of HF; in most such patients, the high cardiac output provokes HF in the setting of reduced ventricular reserve from some underlying cardiac problem. Thus, the presence of high-output HF should prompt a search for another underlying cardiovascular problem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSICAL FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several characteristic findings are usually seen on physical examination in patients with high-output HF. The heart rate is typically between 85 and 105 beats per minute, but it may be higher with some causes, eg, thyrotoxicosis. Examination of the systemic veins may reveal a cervical venous hum, heard best over the deep internal jugular veins, particularly on the right side. Less often, a venous hum may be appreciated over the femoral veins.",
"   </p>",
"   <p>",
"    Examination of the arteries may display signs related to increased left ventricular stroke volume. The pulse is usually bounding with a quick upstroke, and the pulse pressure is typically wide. Pistol-shot sounds may be auscultated over the femoral arteries, and a systolic bruit may be heard over the carotid arteries. Although these findings may be seen in other cardiac conditions, such as aortic regurgitation or patent ductus arteriosus, in the absence of these conditions, these signs are highly suggestive of elevated left ventricular stroke volume due to a hyperdynamic state.",
"   </p>",
"   <p>",
"    Cardiac examination may reveal an enlarged heart with a midsystolic murmur in the second and third left intercostal spaces, and a third heart sound, which is due to the increased rate of ventricular filling.",
"   </p>",
"   <p>",
"    Patients with chronic high output also may develop signs and symptoms classically associated with the more common \"low-output\" HF; specifically, they may develop pulmonary",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic venous congestion, while maintaining the above normal cardiac output.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHYSIOLOGIC CAUSES FOR HIGH CARDIAC OUTPUT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of physiologic circumstances that can substantially increase cardiac output:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Excitement, anxiety, or stress",
"     </li>",
"     <li>",
"      Exercise (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=see_link\">",
"       \"Exercise physiology\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"     <li>",
"      Fever",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pregnancy is associated with both systemic vasodilation and increased preload due to a rise in blood volume [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/1\">",
"     1",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    ). Fever increases metabolic demand and produces vasodilation, especially in the skin. Resolution of the fever is accompanied by a reduction in cardiac output to normal. A hot, and especially humid, environment also increases cardiac output through mechanisms similar to fever [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CAUSES OF HIGH-OUTPUT FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The disorders contributing to high-output heart failure include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Systemic arteriovenous fistulas",
"     </li>",
"     <li>",
"      Hyperthyroidism",
"     </li>",
"     <li>",
"      Anemia, including the anemia of chronic kidney disease",
"     </li>",
"     <li>",
"      Beriberi (vitamin B1 or thiamine deficiency)",
"     </li>",
"     <li>",
"      Dermatologic disorders (eg, psoriasis)",
"     </li>",
"     <li>",
"      Renal disease",
"     </li>",
"     <li>",
"      Hepatic disease",
"     </li>",
"     <li>",
"      Skeletal disorders (eg, Paget disease, multiple myeloma)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other potential causes of high-output HF include obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/3,4\">",
"     3,4",
"    </a>",
"    ] and carcinoid syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link\">",
"     \"Clinical features of the carcinoid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Systemic arteriovenous fistulas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arteriovenous fistulas may be congenital or acquired; acquired cases may be iatrogenic or traumatic. As a result of such malformations, blood from a high-pressure artery is shunted to a low-pressure vein, thereby decreasing systemic vascular resistance. A compensatory increase in the heart rate and stroke volume ensues, and total plasma volume is increased. The elevation in cardiac output associated with these fistulas depends upon the size of the communication and the magnitude of the resultant reduction in systemic vascular resistance. The blood flowing through the fistula bypasses the capillary circulation; thus, for capillary perfusion to be normal, the total cardiac output has to be increased by the quantity of blood flowing through the fistula.",
"   </p>",
"   <p>",
"    Physical findings in patients with high-output failure from arteriovenous fistulas depend to some extent upon the underlying disease and the location and size of the shunt. Patients with sizable arteriovenous shunts have a wide pulse pressure with brisk arterial pulsations; the heart rate is usually slightly increased. There may be swelling, warmth, and redness, and a continuous \"machinery murmur\" with a thrill over fistulas located near the surface. Transient maximal occlusion of a hemodynamically significant fistula usually decreases heart rate, raises arterial pressure, and lowers venous pressure; this has been termed the Nicoladoni-Branham sign [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the presence of an acquired fistula from trauma, the overlying skin is warmer and the increase in blood flow to the affected limb may result in an increase in size compared to the opposite limb. The chronically elevated venous pressure may lead to cellulitis, venous stasis, edema, and a chronic dermatitis with pigmentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Congenital fistulas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital arteriovenous fistulas result from arrest of the normal embryonic development of the vascular system. In fact, these fistulas are structurally similar to embryonic capillary networks. Congenital fistulas range from cutaneous hemangiomas to large channel communications that can distort a limb [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/8\">",
"     8",
"    </a>",
"    ]. Some patients have multiple fistulas and the clinical presentation can be varied [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One congenital abnormality, hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease), is characterized by hemorrhagic telangiectasias involving the mucous membranes, gastrointestinal tract, and skin of the lips, nose, and finger tips. In about 15 percent of afflicted individuals, arteriovenous malformations occur in the lung and may be associated with massive hemoptysis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the liver is less frequently involved than the lung, those patients with both lung and hepatic involvement may develop clinically significant arteriovenous shunts and high-output failure [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. In some patients, high-output HF is the first manifestation of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/12\">",
"     12",
"    </a>",
"    ]. Historical clues to the diagnosis include epistaxis, recurrent gastrointestinal bleeding, unexplained hematuria, hemoptysis, or family history of bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20429728\">",
"    <span class=\"h4\">",
"     Treatment of congenital fistulas",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of high output failure in patients with hereditary hemorrhagic telangiectasia poses a clinical challenge and is of limited benefit. In one study a patient with hepatic arteriovenous microfistulas and high output failure was successfully treated by selective hepatic artery embolization, leading to prompt symptomatic improvement, progressive decline in ascites and hepatomegaly, and normalization of cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/14\">",
"     14",
"    </a>",
"    ]. However, in another case report, hepatic arterial coil embolization temporarily improved cardiac function, but resulted in progressive hepatic failure [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/15\">",
"     15",
"    </a>",
"    ]. Surgical therapies include liver resection, enucleation, and hepatic artery ligation. Liver transplantation has also been used successfully to reverse high-out HF in Osler-Weber-Rendu disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29816?source=see_link&amp;anchor=H17#H17\">",
"     \"Hepatic hemangioma\", section on 'Management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=see_link&amp;anchor=H7830667#H7830667\">",
"     \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\", section on 'Arteriovenous malformations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatments for pulmonary fistulae include embolization, surgery, or lung transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/4/12358?source=see_link&amp;anchor=H1576056#H1576056\">",
"     \"Pulmonary arteriovenous malformations: Treatment\", section on 'Therapies'",
"    </a>",
"    .) Embolization therapy has also been used to treat intestinal lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Giant cutaneous hemangiomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giant cutaneous hemangiomas can also promote the development of high-output failure [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/17\">",
"     17",
"    </a>",
"    ]. Hemangiomas are the most common tumors of infancy, and seldom cause more than a cosmetic problem. Fifty percent of cutaneous lesions are present at birth; the remainder usually surface by two months of age. In rare cases, high-flow arteriovenous shunting in giant cutaneous hemangiomas can lead to the development of high-output failure [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44665?source=see_link\">",
"     \"Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several therapeutic approaches to the patient with giant cutaneous hemangiomas and HF. Arteriography with selective embolization has been shown to reverse the failure in select cases [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Administration of corticosteroids has been shown to be effective in mild cases, but less effective in severe cases [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/19\">",
"     19",
"    </a>",
"    ]. Other options include surgical excision and radiation therapy to susceptible sites [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25546?source=see_link\">",
"     \"Management of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Hepatic hemangiomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;In rare cases, involuting hemangiomas involve the liver and produce arteriovenous shunts and high-output failure in a condition called hepatic hemangiomatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/21\">",
"     21",
"    </a>",
"    ]. One review of 27 patients with hepatic hemangiomatosis observed that 23 had concurrent cutaneous hemangiomas and 25 had HF [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/21\">",
"     21",
"    </a>",
"    ]. The diagnosis was suggested by the clinical triad of multiple enlarging cutaneous hemangiomas, hepatomegaly, and HF. Almost every one of the infants studied died of the disease or its complications. In one patient, hepatic artery ligation was performed after arteriography, and effectively cured the patient. Nonetheless, this approach remains untested in adult patients, since it may cause fatal hepatic necrosis. Later reports have described successful treatment of hemodynamically-significant hepatic hemangiomatosis with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    or urgent liver transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29816?source=see_link&amp;anchor=H17#H17\">",
"     \"Hepatic hemangioma\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Acquired fistulas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired fistulas are usually posttraumatic or iatrogenic. Traumatic causes include bullet or knife wounds, especially in the thigh. Iatrogenic fistulas are surgically constructed arteriovenous fistulas used for access to the circulation in patients undergoing chronic hemodialysis.",
"   </p>",
"   <p>",
"    In one report of 15 patients with upper extremity dialysis fistulas, temporarily closing the fistula lowered the cardiac output by 0.3 to 11",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/23\">",
"     23",
"    </a>",
"    ]. In a prospective study of 96 dialysis patients, ultrasound assessment of vascular access flow (Qa) and cardiac output demonstrated high-output cardiac failure in 10 percent of patients. Risk factors for heart failure included upper extremity fistula and Qa greater than or equal to 2",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/24\">",
"     24",
"    </a>",
"    ]. Anemia and volume expansion due to salt and water retention may contribute to the high-output state. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37063?source=see_link\">",
"     \"Heart failure and hemodialysis arteriovenous fistulae\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H12\">",
"     'Anemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Left ventricular hypertrophy due to hypertension and premature atherosclerosis are common in patients with end-stage renal disease. This substrate can increase the susceptibility to the stress imposed by an elevated cardiac output. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=see_link\">",
"     \"Myocardial dysfunction in end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Arteriovenous fistulas with high-output HF have also been described in patients with Wilms' tumor, renal cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/25\">",
"     25",
"    </a>",
"    ], and aortocaval fistula [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Arterial puncture for cardiac catheterization is an increasingly common iatrogenic cause of arteriovenous fistula. However, high-output failure is rare, with a reported incidence is 0.01 to 0.02 percent of all catheterizations and a clinical presentation ranging from two days to several months postcatheterization [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/27\">",
"     27",
"    </a>",
"    ]. Most of the patients in whom this fistula develops have undergone separate ipsilateral arterial and venous punctures. Surgical repair of the fistula is associated with resolution of the cardiac failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6231?source=see_link\">",
"     \"Acquired arteriovenous fistula of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other cases of iatrogenic arteriovenous fistulas associated with high-output failure include an iliac arteriovenous fistula after lumbar disk surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/28\">",
"     28",
"    </a>",
"    ] and a patient with high-output failure following transjugular intrahepatic portosystemic shunting (TIPS) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/29\">",
"     29",
"    </a>",
"    ]. In a prospective study of 15 portal hypertensive patients, hyperdynamic circulation worsened immediately after TIPS, with a progressive adaptation over two months [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical therapy is an effective approach to close off or ablate arteriovenous fistulas when this is desired and feasible. In the series of patients with high-output dialysis fistulas described above, surgical correction of the fistula resulted in improvement in HF symptoms in 13 of 14 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/31\">",
"     31",
"    </a>",
"    ]. Transcatheter embolization has been successfully used in some cases of multiple site congenital malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid hormone is a potent regulator of whole body metabolism; an increased circulating level of thyroxine produces an increase in metabolism accompanied by a reduction in systemic vascular resistance and an obligatory increase in cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/34-37\">",
"     34-37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23062?source=see_link\">",
"     \"Cardiovascular effects of hyperthyroidism\"",
"    </a>",
"    .) Thyroid hormone also increases the intrinsic contractility of heart muscle and myocardial oxygen demands and consumption [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/38\">",
"     38",
"    </a>",
"    ]. The heart rate is increased and pulse pressure is widened.",
"   </p>",
"   <p>",
"    These changes can precipitate HF in patients with underlying heart disease which may be caused in part by a hyperthyroid cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/39\">",
"     39",
"    </a>",
"    ]. An additional cause of HF in patients with hyperthyroidism is atrial fibrillation with an excessively rapid ventricular response. Atrial fibrillation, which is often paroxysmal, occurs in about 10 percent of hyperthyroid patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=see_link\">",
"     \"Epidemiology of and risk factors for atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hyperthyroidism, even in the absence of high-output failure, is associated with palpitations, due to both tachycardia and more forceful cardiac contraction, and exertional dyspnea, which is due more to respiratory muscle weakness than cardiac failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The physical findings in patients with hyperthyroidism are similar to those in other causes of high-output HF including tachycardia, which is present at rest, during sleep, and during exercise; a hyperdynamic precordium, indicative of the increase in cardiac contractility; systolic hypertension with a widened pulse pressure; brisk carotid and peripheral arterial pulsations; a loud first heart sound; atrial fibrillation; and occasionally a \"scratchy\" midsystolic murmur (Means-Lerman scratch) heard along the left sternal border, resulting from the rubbing together of the normal pleural and pericardial surfaces. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other findings on physical examination are associated with hyperthyroidism and include exophthalmos, stare, fine tremor of the outstretched hands, and a firm thyroid gland with or without nodule formation. The skin may be moist and warm as a result of cutaneous vasodilation; blood flow to the skin in hyperthyroid patients can be increased three times or greater than that in euthyroid controls due to enhanced endothelium-dependent vasodilation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important to be aware of apathetic hyperthyroidism, a condition in the elderly population, in which many of the usual manifestations of thyrotoxicosis may be absent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/41\">",
"     41",
"    </a>",
"    ]. Such patients may present with unexplained HF or unexplained atrial fibrillation. Clues to thyrotoxicosis in the elderly include unusual alacrity in the presence of a widened pulse pressure and either atrial fibrillation or unexplained sinus tachycardia. Hyperthyroidism is more likely to lead to HF in older patients who often have underlying cardiac disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31124587\">",
"    <span class=\"h3\">",
"     Mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enhanced sympathoadrenal activation may be one of the mechanisms by which hyperthyroidism creates a hyperdynamic circulatory state [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/35,43\">",
"     35,43",
"    </a>",
"    ]. In support of this is the finding that the metabolic and circulatory changes in hyperthyroid individuals are similar to those in normal volunteers during epinephrine infusion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/35\">",
"     35",
"    </a>",
"    ]. Furthermore, administration of sympatholytic agents such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16950?source=see_link\">",
"     reserpine",
"    </a>",
"    , guanethidine, or beta blockers to hyperthyroid patients can decrease the heart rate, cardiac output, and pulse pressure toward normal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, sympatholytic agents alone do not completely normalize cardiac parameters in hyperthyroid patients. Thyroid hormone possesses strong, positive chronotropic and inotropic effects even in the absence of autonomic innervation. Thus, there may be an independent role for direct thyroid hormone activity. One study demonstrated the positive chronotropic effects of thyroid hormone on the sinoatrial cells in isolated rabbit atria; the rate of diastolic depolarization was increased and the duration of action potentials was decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/44\">",
"     44",
"    </a>",
"    ]. Other animal studies have demonstrated that thyroid hormone also has a direct positive inotropic effect; the enhancement of myocardial contractility in hyperthyroidism may be due to increased accumulation and release of calcium by the sarcoplasmic reticulum during excitation-contraction coupling or by the stimulation of myosin with a higher ATPase activity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10632?source=see_link\">",
"     \"Excitation-contraction coupling in myocardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic volume overload, hypercontractility, and tachycardia enhance the development of cardiac hypertrophy in hyperthyroid patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/35,42,46\">",
"     35,42,46",
"    </a>",
"    ]. Direct activation of protein-synthesizing processes by thyroid hormone may also contribute to myocardial hypertrophy. Studies using radionuclide ventriculography have found that hyperthyroid patients have an abnormally low or absent increase in left ventricular ejection fraction in response to exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/39,47,48\">",
"     39,47,48",
"    </a>",
"    ]. It is possible that this decrease in cardiac reserve could ultimately progress to impairment of ventricular function and the development of HF even at rest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31124594\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate treatment for HF due to hyperthyroidism is to return the patient to a euthyroid state, usually with an antithyroid drug or radioactive iodine. The restoration of euthyroidism typically leads to normalization of the heart rate, arterial pulse pressure, cardiac output, and left ventricular ejection fraction, and a reduction in left ventricular diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21143?source=see_link\">",
"     \"Treatment of Graves' hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Beta blockers may be beneficial by slowing the heart rate, but they should be administered cautiously since there may be a further reduction in myocardial contractility [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/49\">",
"     49",
"    </a>",
"    ]. Beta blockers are particularly helpful in patients with sinus tachycardia or atrial fibrillation due to hyperthyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia, even when severe, rarely causes HF, and, when it does, it is likely that the high-output failure is superimposed upon some cardiac abnormality such as valvular heart disease or underlying left ventricular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/50\">",
"     50",
"    </a>",
"    ]. The loss of hemoglobin is partly compensated by the increase in cardiac output and widening of the arteriovenous O2 difference.",
"   </p>",
"   <p>",
"    As an example, in a seminal study of the hemodynamics in anemic patients, right heart catheterization was performed and found that normal cardiac hemodynamics were maintained in patients with hemoglobin values as low as 7",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/51\">",
"     51",
"    </a>",
"    ]. Furthermore, when the hemoglobin was less than 7",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    cardiac output increased and HF did not occur. Only in cases of severe anemia, ie, hemoglobin less than 5",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    does HF develop in the absence of underlying heart disease.",
"   </p>",
"   <p>",
"    Chronic anemia may be an important contributor to the development of heart failure in patients with end-stage renal disease. Although unproven, the correction or prevention of anemia in this setting may help prevent myocardial dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=see_link\">",
"     \"Myocardial dysfunction in end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Presentation &mdash; The presentation of patients with anemia depends upon the time course of its development. Slow development of chronic anemia is well tolerated and frequently overlooked for some time. Iron deficiency and the anemia of chronic disease are the most common causes, but a specific etiology must be identified and corrected where possible. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link\">",
"       \"Causes and diagnosis of anemia due to iron deficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Physical examination &mdash; On physical examination, the skin, mucous membranes, and conjunctival membranes are pale. Arterial pulses are bounding and the pulse pressure is widened. A mild systolic flow murmur is frequently present along the left sternal border and heart sounds, particularly the pulmonic component of the second heart sound, may be prominent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=see_link\">",
"       \"Examination of the arterial pulse\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mechanism &mdash; The mechanism of HF in anemia is not completely understood. Decreased left ventricular afterload secondary to reduced serum viscosity may play a role [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/52\">",
"       52",
"      </a>",
"      ]. Additionally, severe anemia can result in left ventricular volume overload and increased stroke volume that can alter left ventricular function [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/52\">",
"       52",
"      </a>",
"      ]. As an example, one study obtained serial echocardiograms in 124 patients with sickle cell anemia and found progressive chamber enlargement and increased left ventricular mass [",
"      <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/53\">",
"       53",
"      </a>",
"      ]. Moreover, the left ventricular systolic time interval and the left ventricular pre-ejection period were higher in the sickle cell group compared with same-aged controls, suggesting a decline in left ventricular function with time.",
"     </li>",
"     <li>",
"      Treatment &mdash; The management of HF associated with anemia depends upon the type and severity of the anemia. Diagnostic tests for determining the type of anemia should be carried out immediately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"       \"Approach to the adult patient with anemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The treatment for HF due to chronic anemia should be specific for the cause of the anemia, eg, iron, folate, vitamin B12, or erythropoietin in patients with renal failure.",
"   </p>",
"   <p>",
"    If the anemia is more acute or the patient is sicker, more rapid therapeutic measures may be required while the work-up for the cause of the anemia is proceeding. Bed rest and oxygen by nasal cannula are appropriate. Transfusion of packed red blood cells must be done cautiously and slowly to avoid further volume overload and worsening HF. One-half unit should be given over three or four hours, and the patient should be monitored for dyspnea and signs of pulmonary edema. Diuretic therapy, beginning with an intravenous loop diuretic (eg, 20 to 40 mg",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    ) can be used to treat volume overload. Vasodilator therapy has no role because of the marked reduction in systemic vascular resistance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Chronic anemia and HF due to other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic anemia may play a contributory role in the development of HF. In patients with HF due to other common causes, there is evidence that chronic anemia is associated with the progression of HF, but anemia is also associated with a number of common comorbidities. There is conflicting evidence regarding whether anemia is an independent cause of HF progression and worse outcomes, or if it is simply associated with overall disease severity. The role of erythropoiesis-stimulating agents to treat anemia in heart failure is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1705?source=see_link&amp;anchor=H14#H14\">",
"     \"Impact of anemia in patients with heart failure\", section on 'Effect of treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Beriberi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beriberi heart disease is due to severe thiamine (vitamin B1) deficiency and is most common in Asia where the diet consists of a high intake of polished rice which is deficient in thiamine. In the United States, thiamine-enriched bread has virtually abolished the disease except in malnourished individuals (eg, alcoholics) or those on fad diets [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/54\">",
"     54",
"    </a>",
"    ]. Beriberi can also develop in patients on prolonged diuretic regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/55\">",
"     55",
"    </a>",
"    ] or in patients receiving enteral nutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=see_link\">",
"     \"Overview of water-soluble vitamins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Beriberi disease is classically divided into two types [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/57\">",
"     57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A \"dry\" form, with neurologic manifestations, including peripheral neuropathies with both sensory and motor components",
"     </li>",
"     <li>",
"      A \"wet\" form, with cardiovascular involvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Seven diagnostic criteria for classic beriberi heart disease have been proposed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Three or more months of thiamine-deficient diet",
"     </li>",
"     <li>",
"      Enlarged heart with normal sinus rhythm",
"     </li>",
"     <li>",
"      Dependent edema",
"     </li>",
"     <li>",
"      Signs of neuritis, pellagra or both",
"     </li>",
"     <li>",
"      Minor electrocardiographic changes such as non-specific ST-T changes",
"     </li>",
"     <li>",
"      No other identifiable cause for heart disease",
"     </li>",
"     <li>",
"      Response to thiamine therapy or autopsy evidence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Laboratory diagnosis of thiamine deficiency can be made on the basis of an increase in thiamine pyrophosphate effect (TPPE) or a decrease in blood thiamine concentration, or a decrease in red cell transketolase activity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31124566\">",
"    <span class=\"h3\">",
"     Mechanism of beriberi",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism for high-output failure in beriberi is multi-factorial. Thiamine deficiency initially presents as a high-output state secondary to vasodilation and an increase in blood volume [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/59\">",
"     59",
"    </a>",
"    ]; this is followed by eventual depression of myocardial function and the development of a low output state [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/60\">",
"     60",
"    </a>",
"    ]. The high cardiac output is due to reduced systemic vascular resistance and augmented venous return. It is not totally clear what causes the marked reduction in systemic vascular resistance, but it may reflect direct vasomotor depression [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is possible that the development of HF is due to the superimposition of impaired myocardial function. Postmortem gross examination of the heart shows dilation without other changes. Histopathologic study shows nonspecific changes, including myocardial vacuolization interstitial myocardial edema in the early stages, with myocyte hypertrophy, fibrosis, and cellular infiltration in the chronic phase [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A biochemical lesion due to thiamine deficiency may contribute to the cardiac failure in beriberi. Pyruvate and lactate are important substrates for oxidation and energy production in heart muscle, but thiamine deficiency blocks their utilization. Specifically, thiamine pyrophosphate is needed for the decarboxylation of pyruvate and its subsequent oxidation in the citric acid cycle. As a result of thiamine deficiency, pyruvate and its precursor lactate build up in the blood; increased blood lactate level has been used in the diagnosis of beriberi, but is nonspecific. Thiamine deficiency also inhibits the function of the hexose monophosphate shunt, contributing to insufficient oxygenation of the tissues. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=see_link\">",
"     \"Overview of water-soluble vitamins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31124580\">",
"    <span class=\"h3\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients in Asia generally present with fatigue, malaise, and edema (wet beriberi) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/59\">",
"     59",
"    </a>",
"    ]. In the United States, severe malnutrition, peripheral neuropathy, and evidence of a high cardiac output are more common (dry beriberi). Anemia may be present, a result of iron and folate deficiency, and there may be hyperkeratinized skin lesions and painful glossitis.",
"   </p>",
"   <p>",
"    In addition to the characteristic clinical picture, laboratory studies show a reduced thiamine level and increased serum pyruvate and lactate together with a low red cell transketolase [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31124573\">",
"    <span class=\"h3\">",
"     Treatment of berberi",
"    </span>",
"    &nbsp;&mdash;&nbsp;With appropriate treatment, eg, up to 100 mg of thiamine intravenously and 25",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for two weeks, the cardiac index and heart rate are reduced and there is an increase in systemic vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/62\">",
"     62",
"    </a>",
"    ]. Treatment of concomitant nutritional anemia may also be required.",
"   </p>",
"   <p>",
"    In the United States, the association of thiamine deficiency with chronic alcoholism may result in the concomitant presence of alcoholic cardiomyopathy and a depression in left ventricular systolic function. Such patients do not respond well to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    , diuretics, or vasodilators; a diagnosis of thiamine deficiency must therefore be considered so that specific therapy with thiamine can be given. The initial loading doses of thiamine are in the range of 100 to 500 mg intravenously, followed by 25 to 100 mg per day orally for at least two weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35672?source=see_link\">",
"     \"Alcoholic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    -associated thiamine depletion maintain their ability to absorb thiamine and respond to thiamine repletion with improved left ventricular function and effective diuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/55,63\">",
"     55,63",
"    </a>",
"    ]. Magnesium may have to be coadministered with thiamine, particularly in magnesium-depleted patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/57,64\">",
"     57,64",
"    </a>",
"    ]. In animal models, magnesium depletion alone leads to a blunted response to thiamine supplementation and loss of thiamine from tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/65\">",
"     65",
"    </a>",
"    ]. The mechanism for this relationship is unknown, although it has been proposed that magnesium depletion may interfere with the activation of transketolase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dermatologic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large increase in cardiac output may be associated with some dermatologic disorders such as active widespread psoriasis, exfoliative dermatitis, or Kaposi's sarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"    </a>",
"    .) The elevated cardiac output results from substantial cutaneous dilatation and an increase in blood flow to the skin since the widespread lesions are warm and red. As in the other causes of high-output HF, the increase in cardiac output itself rarely causes heart failure; it is more often a contributing factor to an already impaired cardiac reserve resulting from some underlying cardiovascular disease. Chronic inflammation may also provide a pathophysiologic link between cardiomyopathy and psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment is that of the primary skin disorder. As the lesions heal and warmth disappears, there is a concomitant reduction in the elevated cardiac output.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, high-output heart failure in patients with chronic kidney disease most often results from an arteriovenous dialysis fistula and anemia (which is now less common due to the widespread use of erythropoietin) superimposed on underlying heart disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Volume expansion due to sodium and water retention may also contribute to the high-output state. In acute postinfectious glomerulonephritis, for example, edema (including pulmonary edema) and hypertension can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/68\">",
"     68",
"    </a>",
"    ]. These changes are due primarily to volume expansion as the renin-angiotensin-aldosterone system is suppressed and serum natriuretic peptide concentrations are markedly elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/69\">",
"     69",
"    </a>",
"    ]. These changes are reversed with fluid removal, eg, with diuretics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Cirrhosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cirrhosis of increasing severity is progressively associated with systemic vasodilation increased cardiac output, low blood pressure, and signs of reduced tissue perfusion (such as low urinary sodium excretion and increased plasma levels of the \"hypovolemic\" hormones renin, aldosterone, and vasopressin) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/70-72\">",
"     70-72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17608?source=see_link&amp;anchor=H2#H2\">",
"     \"Hyponatremia in patients with cirrhosis\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The increased cardiac output is primarily due to splanchnic vasodilation and the development of intrahepatic or mesenteric arteriovenous shunts. Intrapulmonary arteriovenous shunting is also observed in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/73\">",
"     73",
"    </a>",
"    ]. The development of cardiac failure is insidious in these patients, but most die from hepatic failure prior to symptomatic heart disease. Treatment of hepatic failure, which is often best achieved by liver transplantation, may normalize the cardiac output. In one study, the cardiac index decreased by a mean of 35 percent after liver transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/74\">",
"     74",
"    </a>",
"    ]. Noninvasive tools are being developed for monitoring these perioperative changes in cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Acromegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure is not uncommon in newly diagnosed acromegaly [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30776?source=see_link\">",
"     \"Causes and clinical manifestations of acromegaly\"",
"    </a>",
"    .) In a review of 102 such patients, 10 had overt heart failure at the time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/77\">",
"     77",
"    </a>",
"    ]. Compared to those without heart failure, these patients had an increase in left ventricular mass index that was largely due to chamber dilation, a reduction in left ventricular ejection fraction (42 versus 66 percent), and a significant elevation in cardiac index (4.3 versus 3.5",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    per m2 versus 3.1",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    per m2 in controls).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Skeletal disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high cardiac output has been noted in patients with polyostotic fibrous dysplasia (McCune-Albright syndrome), osteitis deformans (Paget disease) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/78\">",
"     78",
"    </a>",
"    ], and multiple myeloma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7978?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Paget disease of bone\"",
"    </a>",
"    .) It is presumed that there are multiple minute arteriovenous fistulas in the bony lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/80\">",
"     80",
"    </a>",
"    ]. Extensive bone involvement (more than 20 percent of the skeleton) is required to increase the cardiac output to the point at which it may contribute to high-output problems.",
"   </p>",
"   <p>",
"    An additional factor for the increase in cardiac output in Paget disease may be increased cutaneous blood flow resulting from local heat production by the increased metabolic activity of affected bone. There appears to be a linear relationship between the amount of skeletal involvement and cardiac index in patients with this disease. In one study, the subgroup of patients with more extensive skeletal involvement had lower peripheral vascular resistance, higher stroke volume, and greater hydroxyproline excretion (a marker of bone turnover) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The high-output state is usually well tolerated for years. As with most causes of high-output heart failure, clinical manifestations are not typically seen in the absence of underlying heart disease. In most patients, treatment of the Paget disease with a bisphosphonate or calcitonin leads to normalization of the cardiac index within six months [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Between 20 and 24 weeks of pregnancy, the resting cardiac output is increased to about 6 liters per minute. Increased blood volume, the presence of the placenta acting as an arteriovenous shunt, and increased metabolic demands may contribute to the elevated cardiac output in pregnancy. In addition, systemic vascular resistance is reduced and maternal heart rate rises by 15 to 20 beats per minute. The left ventricular ejection fraction is unchanged. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with an underlying cause for a high cardiac output, such as an arteriovenous fistula, hereditary telangiectasia, or anemia, are more likely to develop high-output heart failure during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/83-86\">",
"     83-86",
"    </a>",
"    ]. In addition, multiple pregnancies in a patient with underlying fistulas may progressively exacerbate vascular malformations and lead to the development of heart failure despite a history of previous uncomplicated pregnancies.",
"   </p>",
"   <p>",
"    The treatment of high-output failure in pregnancy depends on the severity of the heart failure and its etiology. In mild cases, bed rest and a loop diuretic may be effective but often no specific therapy is necessary; the cardiac output generally normalizes between two days to two weeks post-partum, although one study demonstrated a gradual fall in cardiac output from 7.4",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    to 5.0",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    at 24 weeks post-partum [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/87\">",
"     87",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1577?source=see_link\">",
"     \"Management of heart failure in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some cases of arteriovenous malformations, surgical resection or embolization of the fistula has been performed during or immediately following pregnancy with resolution of the heart failure symptoms. In more severe cases, emergent termination of the pregnancy has been required [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Miscellaneous causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other causes of high-output heart failure include polycythemia vera, morbid obesity, cor pulmonale, carcinoid syndrome, multiple myeloma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/88\">",
"     88",
"    </a>",
"    ], beta-thalassemia intermedia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/89\">",
"     89",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/19/6454?source=see_link\">",
"     anagrelide",
"    </a>",
"    used for the treatment of chronic myeloproliferative disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/90\">",
"     90",
"    </a>",
"    ]. Symptomatic therapy for the heart failure and treatment of the underlying disease is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20429951\">",
"    <span class=\"h1\">",
"     GENERAL TREATMENT CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy is aimed at correcting the cause of the high output",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    low systemic vascular resistance and can sometimes dramatically reverse the heart failure. Specific therapies are discussed above. This approach should be more useful than standard therapy employed in typical low output heart failure (eg, angiotensin-converting enzyme inhibitors and beta blockers). Vasodilators will be of little benefit in a patient who already has an extremely low systemic vascular resistance, while",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    is of little benefit if the ejection fraction is near normal and the patient is in sinus rhythm. In selected patients, dietary sodium restriction and judicious use of diuretics is advised [",
"    <a class=\"abstract\" href=\"UTD.htm?9/47/9978/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although high-output states are uncommon as a sole cause of heart failure, they may contribute to heart failure in patients with underlying cardiovascular disease and reduced myocardial reserve. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinician must carefully consider the possibility of an associated cause of high-output heart failure in patients with physical findings that suggest an increase in cardiac output, including warm extremities, wide pulse pressure, bounding pulses, a hyperkinetic heart to palpation, and a systolic flow murmur. These findings may be less striking in patients with overt heart failure. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Physical findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appropriate laboratory and diagnostic tests help to define the particular cause of the elevated cardiac output. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Causes of high-output failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of high-output heart failure is aimed at correcting the cause of the high output",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      low systemic vascular resistance and can sometimes dramatically reverse the heart failure. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Causes of high-output failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In selected patients with high-output heart failure, dietary sodium restriction and judicious use of diuretics is advised. (See",
"      <a class=\"local\" href=\"#H20429951\">",
"       'General treatment considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/1\">",
"      Carbillon L, Uzan M, Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 2000; 55:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/2\">",
"      Nielsen B, Hales JR, Strange S, et al. Human circulatory and thermoregulatory adaptations with heat acclimation and exercise in a hot, dry environment. J Physiol 1993; 460:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/3\">",
"      Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001; 321:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/4\">",
"      Kasper EK, Hruban RH, Baughman KL. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol 1992; 70:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/5\">",
"      Yun D, Heywood JT. Metastatic carcinoid disease presenting solely as high-output heart failure. Ann Intern Med 1994; 120:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/6\">",
"      Meijer WC, van Veldhuisen DJ, Kema IP, et al. Cardiovascular abnormalities in patients with a carcinoid syndrome. Neth J Med 2002; 60:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/7\">",
"      Velez-Roa S, Neubauer J, Wissing M, et al. Acute arterio-venous fistula occlusion decreases sympathetic activity and improves baroreflex control in kidney transplanted patients. Nephrol Dial Transplant 2004; 19:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/8\">",
"      Szilagyi DE, Smith RF, Elliott JP, Hageman JH. Congenital arteriovenous anomalies of the limbs. Arch Surg 1976; 111:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/9\">",
"      Chan P, Lee CP, Lee YH. High output cardiac failure caused by multiple giant cutaneous hemangiomas. Jpn Heart J 1992; 33:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/10\">",
"      Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998; 158:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/11\">",
"      Pick A, Deschamps C, Stanson AW. Pulmonary arteriovenous fistula: presentation, diagnosis, and treatment. World J Surg 1999; 23:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/12\">",
"      Montejo Baranda M, Perez M, De Andres J, et al. High out-put congestive heart failure as first manifestation of Osler-Weber-Rendu disease. Angiology 1984; 35:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/13\">",
"      Danchin N, Thisse JY, Neimann JL, Faivre G. Osler-Weber-Rendu disease with multiple intrahepatic arteriovenous fistulas. Am Heart J 1983; 105:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/14\">",
"      Broh&eacute;e D, Franken P, Fievez M, et al. High-output right ventricular failure secondary to hepatic arteriovenous microfistulae. Selective arterial embolization treatment. Arch Intern Med 1984; 144:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/15\">",
"      Hisamatsu K, Ueeda M, Ando M, et al. Peripheral arterial coil embolization for hepatic arteriovenous malformation in Osler-Weber-Rendu disease; useful for controlling high output heart failure, but harmful to the liver. Intern Med 1999; 38:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/16\">",
"      Cag M, Audet M, Saouli AC, et al. Successful liver transplantation for Rendu-Weber-Osler disease, a single centre experience. Hepatol Int 2011; 5:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/17\">",
"      Vaksmann G, Rey C, Marache P, et al. Severe congestive heart failure in newborns due to giant cutaneous hemangiomas. Am J Cardiol 1987; 60:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/18\">",
"      Hosono S, Ohno T, Kimoto H, et al. Successful transcutaneous arterial embolization of a giant hemangioma associated with high-output cardiac failure and Kasabach-Merritt syndrome in a neonate: a case report. J Perinat Med 1999; 27:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/19\">",
"      Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001; 137:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/20\">",
"      Musumeci ML, Schlecht K, Perrotta R, et al. Management of cutaneous hemangiomas in pediatric patients. Cutis 2008; 81:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/21\">",
"      deLorimier AA, Simpson EB, Baum RS, Carlsson E. Hepatic-artery ligation for hepatic hemangiomatosis. N Engl J Med 1967; 277:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/22\">",
"      Markiewicz-Kijewska M, Kasprzyk W, Broniszczak D, et al. Hemodynamic failure as an indication to urgent liver transplantation in infants with giant hepatic hemangiomas or vascular malformations--report of four cases. Pediatr Transplant 2009; 13:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/23\">",
"      Anderson CB, Codd JR, Graff RA, et al. Cardiac failure and upper extremity arteriovenous dialysis fistulas. Case reports and a review of the literature. Arch Intern Med 1976; 136:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/24\">",
"      Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/25\">",
"      Rodgers MV, Moss AJ, Hoffman M, Lipchik EO. Arteriovenous fistulae secondary to renal cell carcinoma. Clinical and cardiovascular manifestations: report of a case. Circulation 1975; 52:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/26\">",
"      Sigler L, Guti&eacute;rrez-Carre&ntilde;o R, Mart&iacute;nez-L&oacute;pez C, et al. Aortocava fistula: experience with five patients. Vasc Surg 2001; 35:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/27\">",
"      Sy AO, Plantholt S. Congestive heart failure secondary to an arteriovenous fistula from cardiac catheterization and angioplasty. Cathet Cardiovasc Diagn 1991; 23:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/28\">",
"      Santos E, Peral V, Aroca M, et al. Arteriovenous fistula as a complication of lumbar disc surgery: case report. Neuroradiology 1998; 40:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/29\">",
"      Braverman AC, Steiner MA, Picus D, White H. High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting. Chest 1995; 107:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/30\">",
"      Colombato LA, Spahr L, Martinet JP, et al. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996; 39:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/31\">",
"      Engelberts I, Tordoir JH, Boon ES, Schreij G. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis. Am J Nephrol 1995; 15:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/32\">",
"      Abushaban L, Uthaman B, Endrys J. Transcatheter coil closure of pulmonary arteriovenous malformations in children. J Interv Cardiol 2004; 17:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/33\">",
"      Hsu CC, Kwan GN, Thompson SA, van Driel ML. Embolisation therapy for pulmonary arteriovenous malformations. Cochrane Database Syst Rev 2010; :CD008017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/34\">",
"      Wilson BE, Newmark SR. Thyrotoxicosis-induced congestive heart failure in an urban hospital. Am J Med Sci 1994; 308:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/35\">",
"      Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/36\">",
"      Lewis BS, Ehrenfeld EN, Lewis N, Gotsman MS. Echocardiographic LV function in thyrotoxicosis. Am Heart J 1979; 97:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/37\">",
"      Riaz K, Forker AD, Isley WL, et al. Hyperthyroidism: a \"curable\" cause of congestive heart failure--three case reports and a review of the literature. Congest Heart Fail 2003; 9:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/38\">",
"      Buccino RA, Spann JF Jr, Pool PE, et al. Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest 1967; 46:1669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/39\">",
"      Forfar JC, Muir AL, Sawers SA, Toft AD. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. N Engl J Med 1982; 307:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/40\">",
"      Ho WJ, Chen ST, Tsay PK, et al. Enhancement of endothelium-dependent flow-mediated vasodilation in hyperthyroidism. Clin Endocrinol (Oxf) 2007; 67:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/41\">",
"      Thomas FB, Mazzaferri EL, Skillman TG. Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity. Ann Intern Med 1970; 72:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/42\">",
"      Siu CW, Yeung CY, Lau CP, et al. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart 2007; 93:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/43\">",
"      BREWSTER WR Jr, ISAACS JP, OSGOOD PF, KING TL. The hemodynamic and metabolic interrelationships in the activity of epinephrine, norepinephrine and the thyroid hormones. Circulation 1956; 13:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/44\">",
"      Johnson PN, Freedberg AS, Marshall JM. Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. Cardiology 1973; 58:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/45\">",
"      Goodkind MJ, Dambach GE, Thyrum PT, Luchi RJ. Effect of thyroxine on ventricular myocardial contractility and ATPase activity in guinea pigs. Am J Physiol 1974; 226:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/46\">",
"      Di Bello V, Aghini-Lombardi F, Monzani F, et al. Early abnormalities of left ventricular myocardial characteristics associated with subclinical hyperthyroidism. J Endocrinol Invest 2007; 30:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/47\">",
"      Iskandrian AS, Rose L, Hakki AH, et al. Cardiac performance in thyrotoxicosis: analysis of 10 untreated patients. Am J Cardiol 1983; 51:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/48\">",
"      Kahaly GJ, Kampmann C, Mohr-Kahaly S. Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid 2002; 12:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/49\">",
"      Dalan R, Leow MK, Leow MC, Leow M. Cardiovascular collapse associated with beta blockade in thyroid storm. Exp Clin Endocrinol Diabetes 2007; 115:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/50\">",
"      Anand IS. Pathophysiology of anemia in heart failure. Heart Fail Clin 2010; 6:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/51\">",
"      Brannon ES, Merrill AJ, Warren JV, Stead EA. THE CARDIAC OUTPUT IN PATIENTS WITH CHRONIC ANEMIA AS MEASURED BY THE TECHNIQUE OF RIGHT ATRIAL CATHETERIZATION. J Clin Invest 1945; 24:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/52\">",
"      Metivier F, Marchais SJ, Guerin AP, et al. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant 2000; 15 Suppl 3:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/53\">",
"      Balfour IC, Covitz W, Davis H, et al. Cardiac size and function in children with sickle cell anemia. Am Heart J 1984; 108:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/54\">",
"      Wooley JA. Characteristics of thiamin and its relevance to the management of heart failure. Nutr Clin Pract 2008; 23:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/55\">",
"      Seligmann H, Halkin H, Rauchfleisch S, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 1991; 91:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/56\">",
"      Kitamura K, Yamaguchi T, Tanaka H, et al. TPN-induced fulminant beriberi: a report on our experience and a review of the literature. Surg Today 1996; 26:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/57\">",
"      Shivalkar B, Engelmann I, Carp L, et al. Shoshin syndrome: two case reports representing opposite ends of the same disease spectrum. Acta Cardiol 1998; 53:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/58\">",
"      Lonsdale D, Shamberger RJ. Red cell transketolase as an indicator of nutritional deficiency. Am J Clin Nutr 1980; 33:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/59\">",
"      Akbarian M, Yankopoulos NA, Abelmann WH. Hemodynamic studies in beriberi heart disease. Am J Med 1966; 41:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/60\">",
"      Abelmann WH, Lorell BH. The challenge of cardiomyopathy. J Am Coll Cardiol 1989; 13:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/61\">",
"      Ikram H, Maslowski AH, Smith BL, Nicholls MG. The haemodynamic, histopathological and hormonal features of alcoholic cardiac beriberi. Q J Med 1981; 50:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/62\">",
"      Jeffrey FE, Abelmann WH. Recovery from proved Shoshin beriberi. Am J Med 1971; 50:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/63\">",
"      Shimon I, Almog S, Vered Z, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 1995; 98:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/64\">",
"      Hoffman RS, Goldfrank LR. Ethanol-associated metabolic disorders. Emerg Med Clin North Am 1989; 7:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/65\">",
"      Arroyo V, Bosch J, Gaya-Beltr&aacute;n J, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981; 94:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/66\">",
"      SHUSTER S. High-output cardiac failure from skin disease. Lancet 1963; 1:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/67\">",
"      Maisch B, Richter A, Sandm&ouml;ller A, et al. Inflammatory dilated cardiomyopathy (DCMI). Herz 2005; 30:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/68\">",
"      Chiu CY, Huang YC, Wong KS, et al. Poststreptococcal glomerulonephritis with pulmonary edema presenting as respiratory distress. Pediatr Nephrol 2004; 19:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/69\">",
"      Ozdemir S, Saat&ccedil;i U, Be��ba�� N, et al. Plasma atrial natriuretic peptide and endothelin levels in acute poststreptococcal glomerulonephritis. Pediatr Nephrol 1992; 6:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/70\">",
"      Cichoz-Lach H, Celi��ski K, S��omka M, Kasztelan-Szczerbi��ska B. Pathophysiology of portal hypertension. J Physiol Pharmacol 2008; 59 Suppl 2:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/71\">",
"      Milani A, Zaccaria R, Bombardieri G, et al. Cirrhotic cardiomyopathy. Dig Liver Dis 2007; 39:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/72\">",
"      Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 2006; 119:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/73\">",
"      Pacca R, Maddukuri P, Pandian NG, Kuvin JT. Echocardiographic detection of intrapulmonary shunting in a patient with hepatopulmonary syndrome: case report and review of the literature. Echocardiography 2006; 23:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/74\">",
"      Park SC, Beerman LB, Gartner JC, et al. Echocardiographic findings before and after liver transplantation. Am J Cardiol 1985; 55:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/75\">",
"      Su BC, Yu HP, Yang MW, et al. Reliability of a new ultrasonic cardiac output monitor in recipients of living donor liver transplantation. Liver Transpl 2008; 14:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/76\">",
"      Giustina A, Mancini T, Boscani PF, et al. Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study. J Endocrinol Invest 2008; 31:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/77\">",
"      Damjanovic SS, Neskovic AN, Petakov MS, et al. High output heart failure in patients with newly diagnosed acromegaly. Am J Med 2002; 112:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/78\">",
"      Wermers RA, Tiegs RD, Atkinson EJ, et al. Morbidity and mortality associated with Paget's disease of bone: a population-based study. J Bone Miner Res 2008; 23:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/79\">",
"      McBride W, Jackman JD Jr, Grayburn PA. Prevalence and clinical characteristics of a high cardiac output state in patients with multiple myeloma. Am J Med 1990; 89:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/80\">",
"      Inanir S, Haznedar R, Atavci S, Unl&uuml; M. Arteriovenous shunting in patients with multiple myeloma and high-output failure. J Nucl Med 1998; 39:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/81\">",
"      Morales-Piga AA, Moya JL, Bachiller FJ, et al. Assessment of cardiac function by echocardiography in Paget's disease of bone. Clin Exp Rheumatol 2000; 18:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/82\">",
"      Kanis JA, Gray RE. Long-term follow-up observations on treatment in Paget's disease of bone. Clin Orthop Relat Res 1987; :99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/83\">",
"      Korn TS, Thurston JM, Sherry CS, Kawalsky DL. High-output heart failure due to a renal arteriovenous fistula in a pregnant woman with suspected preeclampsia. Mayo Clin Proc 1998; 73:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/84\">",
"      Gong B, Baken LA, Julian TM, Kubo SH. High-output heart failure due to hepatic arteriovenous fistula during pregnancy: a case report. Obstet Gynecol 1988; 72:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/85\">",
"      Elliott JA, Rankin RN, Inwood MJ, Milne JK. An arteriovenous malformation in pregnancy: a case report and review of the literature. Am J Obstet Gynecol 1985; 152:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/86\">",
"      Swinburne AJ, Fedullo AJ, Gangemi R, Mijangos JA. Hereditary telangiectasia and multiple pulmonary arteriovenous fistulas. Clinical deterioration during pregnancy. Chest 1986; 89:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/87\">",
"      Robson SC, Dunlop W, Moore M, Hunter S. Combined Doppler and echocardiographic measurement of cardiac output: theory and application in pregnancy. Br J Obstet Gynaecol 1987; 94:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/88\">",
"      Kohrt H, Logan A, Temmins C, et al. Reversible high-output cardiac failure, an unusual marker of disease status in multiple myeloma. Leuk Lymphoma 2008; 49:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/89\">",
"      Aessopos A, Kati M, Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica 2007; 92:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/90\">",
"      Engel PJ, Johnson H, Baughman RP, Richards AI. High-output heart failure associated with anagrelide therapy for essential thrombocytosis. Ann Intern Med 2005; 143:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/47/9978/abstract/91\">",
"      Mehta PA, Dubrey SW. High output heart failure. QJM 2009; 102:235.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3462 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-E9920BD3B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9978=[""].join("\n");
var outline_f9_47_9978=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSICAL FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHYSIOLOGIC CAUSES FOR HIGH CARDIAC OUTPUT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CAUSES OF HIGH-OUTPUT FAILURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Systemic arteriovenous fistulas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Congenital fistulas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20429728\">",
"      Treatment of congenital fistulas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Giant cutaneous hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Hepatic hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Acquired fistulas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31124587\">",
"      - Mechanisms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31124594\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Chronic anemia and HF due to other causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Beriberi",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31124566\">",
"      - Mechanism of beriberi",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31124580\">",
"      - Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31124573\">",
"      - Treatment of berberi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dermatologic disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Acromegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Skeletal disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Miscellaneous causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20429951\">",
"      GENERAL TREATMENT CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6231?source=related_link\">",
"      Acquired arteriovenous fistula of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35672?source=related_link\">",
"      Alcoholic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=related_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23062?source=related_link\">",
"      Cardiovascular effects of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30776?source=related_link\">",
"      Causes and clinical manifestations of acromegaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7978?source=related_link\">",
"      Clinical manifestations and diagnosis of Paget disease of bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=related_link\">",
"      Epidemiology of and risk factors for atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44665?source=related_link\">",
"      Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=related_link\">",
"      Examination of the arterial pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10632?source=related_link\">",
"      Excitation-contraction coupling in myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=related_link\">",
"      Exercise physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37063?source=related_link\">",
"      Heart failure and hemodialysis arteriovenous fistulae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29816?source=related_link\">",
"      Hepatic hemangioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=related_link\">",
"      Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17608?source=related_link\">",
"      Hyponatremia in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1705?source=related_link\">",
"      Impact of anemia in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1577?source=related_link\">",
"      Management of heart failure in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25546?source=related_link\">",
"      Management of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=related_link\">",
"      Maternal cardiovascular and hemodynamic adaptations to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=related_link\">",
"      Myocardial dysfunction in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=related_link\">",
"      Overview of water-soluble vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=related_link\">",
"      Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/4/12358?source=related_link\">",
"      Pulmonary arteriovenous malformations: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21143?source=related_link\">",
"      Treatment of Graves' hyperthyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_47_9979="Coronary artery abnormalities";
var content_f9_47_9979=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Coronary artery abnormalities causing pediatric chest pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Anomalous origin of the left coronary artery from the main pulmonary artery (coronary artery fistula)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Anomalous origin of the left coronary artery from the right sinus of Valsalva",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Anomalous origin of the right coronary artery from the left sinus of Valsalva",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Coronary ostial stenosis or atresia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Premature arteriosclerosis (progeria), familial hyperlipidemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Kawasaki disease complicated by coronary artery aneurysm or stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Coronary artery spasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Coronary thrombosis associated with paradoxical embolus or hypercoagulable state",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Geggel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9979=[""].join("\n");
var outline_f9_47_9979=null;
var title_f9_47_9980="Causes of macrocytosis";
var content_f9_47_9980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F66772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F66772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes and mechanisms of macrocytosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Abnormalities of DNA metabolism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vitamin B12 (cobalamin) deficiency",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Folate deficiency",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Drugs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Hydroxyurea",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Zidovudine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Cytosine arabinoside",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Methotrexate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Azathioprine or 6-mercaptopurine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Cladribine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Capecitabine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Imatinib, sunitinib",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Shift to immature or stressed red cells",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Reticulocytosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Action of erythropoietin - skip macrocytes, stress erythrocytosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Aplastic anemia/Fanconi anemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pure red cell aplasia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Primary bone marrow disorders",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Myelodysplastic syndromes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Congenital dyserythropoietic anemias",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Large granular lymphocyte leukemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Lipid abnormalities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liver disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hypothyroidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Mechanism unknown",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alcohol abuse",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Multiple myeloma and other plasma cell disorders",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9980=[""].join("\n");
var outline_f9_47_9980=null;
var title_f9_47_9981="Anaphylaxis treatment in pregnant women";
var content_f9_47_9981=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F87553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F87553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rapid overview: Emergent management of anaphylaxis in pregnant women",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnosis is made clinically:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The most common signs and symptoms are cutaneous (eg, sudden onset of generalized urticaria, angioedema, flushing, pruritus). However, 10 to 20 percent of patients have no skin findings.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         <span style=\"color: #ff0000;\">",
"          Danger signs: Rapid progression of symptoms, respiratory distress (eg, stridor, wheezing, dyspnea, increased work of breathing, persistent cough, cyanosis), hypotension, dysrhythmia, chest pain, collapse",
"         </span>",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acute management:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The first and most important therapy in anaphylaxis is epinephrine. There are",
"        <strong>",
"         NO absolute contraindications",
"        </strong>",
"        to epinephrine in the setting of anaphylaxis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Airway:",
"        </strong>",
"        Immediate intubation if evidence of impending airway obstruction from angioedema; delay may lead to complete obstruction; intubation can be difficult and should be performed by the most experienced clinician available; cricothyrotomy may be necessary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Call for help. This might involve a multispecialty resuscitation team (anesthesiologist, obstetrician, neonatologist) in a hospital setting or emergency medical services in a community setting.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Promptly and simultaneously, give:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         IM Epinephrine (1 mg/mL preparation):",
"        </strong>",
"        Give epinephrine 0.3 to 0.5 mg intramuscularly, preferably in the mid-anterolateral thigh; can repeat every 5 to 15 minutes as needed. If symptoms are not responding to epinephrine injections, prepare IV epinephrine for infusion (see below).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Oxygen:",
"        </strong>",
"        Give 6 to 8 liters per minute via face mask, or up to 100 percent oxygen as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Place the woman on her left side (or in a position of comfort if there is respiratory distress and/or vomiting), and elevate her lower extremities. Manual displacement of the gravid uterus to the left might be necessary. Positioning on the back might lead to inferior vena caval compression and reduced venous return to the heart. Fatality can occur within seconds if she stands or sits suddenly.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Normal saline rapid bolus:",
"        </strong>",
"        Treat hypotension with rapid infusion of 1 to 2 liters IV; repeat as needed; massive fluid shifts with severe loss of intravascular volume can occur",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Start continuous electronic monitoring of maternal blood pressure, cardiac rate and function, respiratory status, and oxygenation and start continuous electronic fetal monitoring. If continuous electronic monitoring is not available, monitor maternal vital signs and fetal heart rate every five minutes or more frequently. Maintain a minimum maternal systolic blood pressure of 90 mmHg.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Also consider administration of:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Albuterol:",
"        </strong>",
"        For bronchospasm resistant to IM epinephrine, give 2.5 to 5 mg in 3 mL saline via nebulizer; repeat as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         H1 antihistamine:",
"        </strong>",
"        Consider giving diphenhydramine 25 to 50 mg IV (for relief of urticaria and itching only)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         H2 antihistamine:",
"        </strong>",
"        Consider giving ranitidine 50 mg IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Glucocorticoid:",
"        </strong>",
"        Consider giving methylprednisolone 125 mg IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        When indicated at any time, perform emergency cesarean delivery for anaphylaxis refractory to medical management as outlined above or for fetal distress",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130:597.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9981=[""].join("\n");
var outline_f9_47_9981=null;
var title_f9_47_9982="Oxygen extraction in sepsis";
var content_f9_47_9982=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F73725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F73725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Decreased oxygen extraction in sepsis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 320px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9982=[""].join("\n");
var outline_f9_47_9982=null;
var title_f9_47_9983="Inhalation challenge testing I";
var content_f9_47_9983=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 476px\">",
"   <div class=\"ttl\">",
"    Inhalation challenge testing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 387px; background-image: url(data:image/gif;base64,R0lGODlhyAGDAdUAAP///4CAgP+AgAAAAMDAwEBAQP8AAKCgoP/AwODg4CAgIHBwcP9AQP8QEPDw8FBQUDAwMLCwsBAQEP+goNDQ0JCQkP8gIP9vb/+/v2BgYP/w8P9gYP8wMP9fX//Q0P+wsP/g4P9wcP9/f/+QkP9QUH8AAP8PD/8fH79AQP8vL/8/P89wcI8AAL8AAN9gYIBAQO8AAJ9AQIBgYIAQEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADIAYMBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLVwCQS5BGAUBQcABQu2frq5TQsFSw4EFMOQAQPRA2AEAwEAAb9HBdPOcdLRTdxL1clKA+begOVCBAERDw8OAb5C2fQHFPEOQgcFBRWEOMhQ4IE1bL8SEAy2TIG1XQoLZGim7kw0XQAiMgRwIECCCgnGRfDIMQC/duiI+CsYgeMABSRXBqyIhx22ARIg4IQgYUAC/wDReL7UmQHAggELDAbUuSDDwZQECgRwmuFAT18JcgaQIIGmmWgBsgGIOnVAUW49o047MCCgBAVEbAp5sCCAwwRHJRSgcDRpW692bELblXIw0GSGU74Ni46C2bFPzR0gmHIcgApm6Q3YBVgMOMmUk3E7Oc5Bzgh/h8jNSM8hYXOLoaXrHEfw5sM3X+fG/TJstmrXgOPuy84ytAy+f9IGE24I8crdgHVzqvMkynRZIUy+nRIozLDalr/5OADCrsSIuafXbTAAgY6mFRA4eg16BLaiB0Sg4BhChPkUidcFWGFJdx90Q1hWzQAPFFHNdwdU84BahMmXQHvvXSOgG9BIs/9bYep9mMxAPUlwjVXoRAYABVelFEFPAUWgU3nKbbgFONOwmGJ+CUbnUEtxfQaAUznd1iEFJOKkoY1MNjmFAy85KeWUamC2JJVYZqnlllx26eWXYIYp5phklmnmmWimqeaabLbp5ptwxinnnHTWaeedeOap55589uknn8vU6EBHB1inmm+IJqrooow26uijkEYq6aSUVmqpe39iQkB7Q+jEDQRG0HPpqKSWauqpqEYqlReBDjFoNoYemuqstNZqK62cuSGNhqg1aBCQQxQop7BbbHqQEJ6Wd4Sotzbr7LPQihoHNBpSe9OVCKCAggACIAAnsVrsKkSvAPwa6pVvgtv/hrXXtutOAC+U0AID3X6LbhbsWsvuu9IOe+8a7GImzFEB8VtACQL460W+B+3r26oKv0EAVRC9RMBdRQSAcMRcBIyUUakRoa6bI6uBYz8OKRBesBvHWbIVE5tVsXwYZ/wvmy/roXHCLt9cxckcpbxysD6rmXMeO3O8btFpHo1H0j3D4TSaU9sBtb1SM0211la3/AkC3HLrrR9Vj1F2mWfPcTUlYIc9thBgM0Dv22m0LXYTaYORt5h7S+012wLIXW8R3Bph991gxD033lyb3Tjaj6v9dyWFH1E5EYojDsDhdFtxORN9dxH6l6OvOzklnxOR+hCrZ955FasnUboWs3NZ/7saa1POsxGxA9B762EPDnfwwgvR+7KR650838v7vbslvz+vuvSsU+865twK3vnx52Y95+2sEhorNqdPEj0S51tOffXqPwG+Eq8Wivz3zZORLKgZly9J+ryv77v/x4sd92xmvxThj4BKkwO5zCUy/RWCc/1DHwAnKMEkCNB/8xPDAvXTvQROq2EHMZgDCXE9wlGwfSiMYAVVyDizgfBeLjCAATC4Nau9cCwPY4EMGzABRvDPhCtkIRCDOD331c99N8RhWAwgAhEYIGp1EBjIZhIsA1wAAxd44iJ+WMQUDlGIX+xiC8UgRYK1wzdMdCIU6ZAAi9WsilfMog9PCEb2ef9RjHX8nxHH0Eaa+cQIMTRACNZIhwMILVQ6NAAP50hEIXjAAjK0gAfyqMc74tGOYxSDIV8yNHsEYAMcaMMEGqDIHsrifWfQWAga8LpDrO4DkDSABYjXgBRgAAMpYKUGLonJMPoSALCM5AdAd8QtFIgDG0iDBwTAAStiUYuxQKUZdiaAZP4BgnU0QAdu2QFBhs0AGBACBgzAABmSkwGkbMAIEAACXhoPg6nzgDa5aYBdKkGaUyiQBiwwgjJ8YAMWsMAGPuDMLFrAlK/AJxl2pgEDtNMPJfzlPDHQTSLU8pYpsMAQNICAgpIznQyIpQWG+Us7amACHCDlNikKTdkVk3b/GvJAA0j6BQHsUACTFMIoSzmBgCKUFQo128Y2YM0/BFB6G2iASGkKgEdGMqdD8OgQQDDRbiJzne+0IE6TyoEJaCCYsmQqEoIKBWJ9oAFQ3QIIytnEliKhpwdtBVnDkDSq2nMO2OzlFzUAyl1yUafp/GlVDYCAEYDSABwQKfFWucMNpJVbDyWm94YwAgvcFQsasKlN2+oEuMrwp6WY6xeyNa9ubYCGa4hoVleoAQ5wwJ5/XS0RwDrSIgw2BN+Mo1srmcmlFQGUWoAlA9pp0xlCwYoXaABOm6CBEQSWEqL1Qra21S0ENOCycrigVgHQ2g3cNba8LelgiSDVko71pfi6/xcyr7DW2loBnOMEqECHOYHPeuADgYulbqGLXtxdiQH93FzwWnkG7UpQpkWVrXljS1um7nSR5s0gh+61TxJ8NgqZnSF2p9CACyTXkcxUpIdlSa8PTLK8kojuwrClUQFrzw0GNgJYDSBW8NpYAJEt6QBF1t8rlEyeHm7AE3Zq3CzU1wCgpeotd0vkAKe4x2hQV1wVzIYY23al3bzsjRupV3fumGiTNQJ8d/tWFIehwx9GQghIwF9BqKunXVaDlac6XneG187gvTOV7wnlKrwMzbIEbRE8u98xHFnQG2XlJFTMhFYJRHwdJIIFxvZlK+TVy9LLcAiWumA6dnq7lJSwb/+PcGi4CtrUAHgwotcA5yfDwVhLul+kKcuAPXdBtXH+nHCJi2NL2lrPvz6qr8/LKgIICtKzVgJcGavUKeeBA6g9BKPPAZZxMahcHOSxETSg6EpfQdgqbC9NtzzsPM+Zz12AdacMKGom1HebFeWDdTe8iGnf81j6CuHD/lVNYHsB3CbMsAC07OnhvfjTwwa2t6UpLgBsEFhgPm44x+kHokbC3vaQBmcYdg1rGexfDQWBtz0HT+oR2QI53rNqLx3sgl8S18QWHb6T+PEoNADeQu4DtwmMCIxnRBcn8djAQuZJJBB15LAreRGA/ExLsjwJmSuevwE+PLf1Np8az3i1aL7/7yio2qihfITPjRCzDMzsYn/U9hGoilstsBzcJ02pmeM8hcMJD+ZUp8LscJGLoB+rjEQveiWczYixFwFom1RZsomQ1Gg7Adexoy1Xvfr1UG/h6XnPZ5/HQrGMuDHtamfbdR1heCvkrKOOf8K5ATBYumUeDSvP3uL8vHnEH3LxkSDBIBtRetorgV5cWH2d6e5vM1za7jy/OsA2rweqpjURvde7zxqchTmvVanCjDDSCRF9bDBfDxu4sCK6L4WcDZbeUYgxCBrv1/W9nvTfjwL5z4DmnEM//mIwP5bJLAXtZrYBGxBZqwdzvId/e3QJY1ZvBqg8SUB9Vac5AmZ1v/Rg/w0wXDq2Pk9XgGFWCfWngG5WNGFTa0MQewfHSzdHUfaHaaDQffNnBkfmZD23gF9wNNyycwiXTRNHZquXCSwog3ZAAqs2CC14gBUUODfoSzaFc762ffC3gdCTYNLmg6IDggnDbY/lcgoGUALwXHnEhBr4BkNofC12fx+oBJXTb3SXPhpAAq9VfDuICT24CfU0flKoBBQAHq6CbKGHQlQlgFioR63FALCldNhTgpsQh5rAAGJVCN0HDsIAALKGQEFkcS13YOtFfKmTgZcgTXcoFo8GK+0GPbsXg3DwC44xDQ8niSnUh5VYBDMmgpiYeodYe9LwiJGoipeAAGFHinHQR//twi4RR0Sn1YrktX8EdwQEuIKbZ4rhkIq4aAkNhX6B4HMdchtzwUH5FhxdB2qONHp/NXy2pomfoFC+mI1nFBYQowkckHx/4HN8RwD84ADcoA2AVzDb2EjA90NwxWl2BlQvVY25Yi7mqET9ogltx4ttkACeEhYJ0EdoVyOCZziBM3ubc13pg2oKJ4uh9VLvGI/zKAT1iHuV8AGwaAjRtyBZl3id9DKXxgATED0YaWteqIxcoJDowJAO+UbBmAkNRYbTuDxnxYUc1VPmxGYXSAuohJIXETScFIqXMGl2UFypF4bK1wQeZU7lZIxHOQuIuAnDSAfyxFlVeQUJECAz2Dz/HnVX4EhlyagKXakJE2CUciBTacR/Iml6s7FiU1B5QuCALzdgp1SHLtUJIJCCb8Bt3CJDU4leK/EPBaAAeTmFVEBuFfGWmiBJcdBdmocF1SgNkdkx9UOZ6mCZmUACMMgGmrmZWFAA5pELBJF/ofmHM4kKpIkJIyCXbdBX0pcFB/CIHOGbZzmZsqmRciWYMccJj2QFh1YFurmbVzA+jiOcXNaWgemEmtAAKQcFHTgFWyiNY1lWMAGRsCmdTgeYo2mcTokJQFgFYxaEZVZkvncFKMIgnaSX3PmHnVGbmICG/YdczeaeRFCYQeZjPXYABoETVNQE7wIs8TM+oZNngKGf/7k4hlDQeBcWk0XwVQBFSktGoFxAAQ7xmUiglBpyizsJBRDqFdK0oHkIineJgN65bc05aD41giEGbd6ynfH5nAYqDUXhBLjgEsngjCeqevgZoX1GosjCbi9qCYr4BK3VhkngWYo0UJe1nKbHmD2BExMhBQYqAS1hjjV3n1y2HKgUpPjhcNfGQGPqCQIwikvQXTEqBHU5nj6GDvW5LFlnFDzxC2J6j09AghQpHvj0pWHKdeiInnagi02AYE9Qp3SFXhQgnkvQkUQQDiG5h49nng8odbQxOwApBAvQp794LJq6CdE4paRETiiqmHZqBf7AEb+wAMC5BAHwALcaJTkJev8RiTVWYKlDgKkfY0bPuAnrmARzNy3oBQ3AIBoiegQR4BCNgTJNWaw402e3mqtwsauUSpVrcJBHkKzWWX7T8A/N+qq+qgXRGg17Qa2K16SWQJLo0wBcSAe1IxtcUQB6ga7poqjWypNkllTPVwf3iiPdwYAe5F+iAJUbNaNPg17vqAtmaZ+ExAbeugZfyV2uNafjGgXusCITi7AVu3yiEJdCIKd9ULDnulD+WpktW6ScUJhNBYDtuKzl+qygST8duwmxVJJ8ULAEAAGtGbI5m7BpcLFroKMpa7M4grOc+bLeIKGakIA1iwWN6Zi1KpkfiodxQbTOILVV4Gh/oLQ/C7X/qgGPnyg//0oFjigEd3iwNKFQfZe20IlP6gYIWEo2ZusS1miivYoECfAOyKAhFFAMxtYPK9Ic3AC3LusFbNG3TLq2QxC4ETC4bmu4ytFwAtJ9WbGURPq3R7Ag+joAv7C4mut5cHEd+bl5nXsbnwu6ocuuPVG6OLIkwEioZuuYRnJDbZoEwoEaWsNAkOG0SLl5unseSXSqsXsNwGurpoq7uKNxFSABIbG7HadvicoEwiEcyOCY9QAA8ki6QUK8XPmP0ku93IC816shveu7IXQQ3euY4XG7ZlqgW8q4RdCRpnsRmQqzDvK+J5IoELGQJEEBmGEe0GkLewd0+7sZmdq+/yMKwCWBKJxRdrlSv1pwFf+QtUlQuEHbFg7ArZILGcHxvP8LDruwvxcctX3mwTpRASH8ed3KNdtrwocHDhsCPhLAwU+Qvu66knurwN/nw0z5riN8JuDTFNMUxLUAtjWUBftLvjuarqM2slQQv8HAryRjtkjrCl18nFRssUxcvKvJF97LwzCls2A4xuWLBZsRxVrcJk6MxGz8nUbDxXUcTXlsq3ucUHisxoDwxf64s3dchkYbZX3sxVA2EoHrtWl8yKmUyMWpBUexGQ/woyIbxiQLyVAgARlgHvQQx9dKyE3TY288MVLsnItwAHnKyk24xo3gytAKcXSoBaypAErhBf8QbAhsUZ+9/MoTxgi/bAQsQss+iQU6Uh4JDDMPIxXR8swBcBQQsCjSDM3WnL1rsMuEMMxF4AAKkKAeWCyObEzOXCn/cCnnTCnp/ChM0cxh0c6Qss6TIs/zXM6SQs+Yks3ufM3OUs2LwhP8bM3pKJ+JMs4eWn7NkzdTw83e5xJ5Cq8QHdH+C4b2XM/oXNHxjNGKAs/o6MxaoSoa/Sj4DNLmjNErXAUNbI26fNJ2PJhlxTQM7X0xjW7yl9DJ4619k9M3DdPiq20VoADLfMRCPdSwa8sVkAvBgMsE2zzGAAVNnQSyHBfv8dChy9LkYNVX7bFY7QZP/dKqSYRIENVE8yL/Bq28fPzVTkBW2SYqqWwGXZ0pYfDWTiDXWS0FuRABxqwEdF3XWt3XYKAAJrIAEoCrbQ3Xhl0ILxINEsAX4HzYjt0Iy7DVbMAMLaq2R2DALtqgvlsMdAs/HcGgenjZFeCiCsrZTxDZQPfYkeAAo821cPC26eC3l+qZS/opSQA0su0qOsEUta0st03bTgA0c40jkr0IlN3Zop3ZoU12pq3ZSPAqoE3ayW3ZTRCxlPrchhvUZwDHcbC45vC6Q5AQzbim2WYEF2EM4A2SH3MX6Y24bRQdTHDexU0Ekf24190IsL1utn0EQgKJkcvfOOzf+20EDrDbHyPgvo0E/Z3W4NA4/0qp0rrSmsddG90xkKFLH6V6M+w6IRk+Vh+TvhZ+4Tb82wUx30ZAFZXg3dbmK+WtEp6HiuSd10Ig32rK4nktRewd41D94mUlM4fbBPUdDfedBtN8B7axvlDNDcIQ4kSAq0QSuMmbv7K7GUxeBP5w4E3g5Dgx5IAr5JZw5O0i4khOv7Nd4h0eKh9O5VFOdhiORJBpElGA4nGwAN/hiRRuDv2LBOmb59vgwMMaeERwh5t0GX/e2EZAxD0M4U0g55UA5mTeD0p+5keg5dRb5S8+uu6w5lYe6U/Qm3aB5dXt5d294G9gwOUBjyJMdtNcyQ0pw6E7zUQSw3405BFiEMKQ6v+qHs2iTg6wjhPafcJc3gg2wedFsOeFzgTGPnSGviLZ4BCEruzIrugKir9KwOivXQxlbQYqXMR5apMvASQqCbgzAgEUEe6/DRPhfXtH4O0KIONG4O3kHgWcXgmmjsC4rhqrLuT3Hhe9LgGy/pBhbSy37uqvruu8ugSX/OmPsyDBngYePOGq/Qjbbu75OyPt/sNJAO/lru7m3RvpXq3rbvHuviwlgsZ9bvJqUMnsGvEsvwh6YQ0KgPItP/N8sBkDMA8NQvM6Lwj6URAQUNiA0QtUvfOlUBeo0dOLgAzrMOJbovR+kMWZwB+O0BFQYBmTjRSWuyIEsQD8ELgQ4R5efx//DvcAEmHiq0D1id4G1A4J+oC1QtgRvqAP8lASrFG5q+L1rJELDoEpm7IRDtC98Se6s5sdWwEqNeweOIGnDJKtCQX3+bAPdE+5lov3Xo92fE/2XA++gP8F6FABEnESnv8AQOKJYtERH5EAf3/OeiCtK8/z5dETCkAU0gEZ6DC7h48ivtArR9EggB3NqavLBwG8mNESR1G4AFwNj3jAdt4KQQH7sj8Ogk+6t38VB6D719b7dM755eEQRdEX5tId0JEW2P/7d3BthgAiugH9wf8QEmwZ7fHpAMAVyNHwVHD4hjEYhy8c9rC4Mg8EAOGQWDQekUnlktlEDgqAwIAAgAIK/wMAYRAARLpcrxirBTy6AYVWIskEEk658Oq4SiAA+8Ma7ZcdhNre4uYMD40eFhAZG5eupqqusra6KgPIyCjLAjq9KB7WJAodjzK7KAYeCBQkAFIlArIwLQEqFggOVEt5e32bIKn+KE9pxyw3Zz1fQwdGf4eu/qSvqKM2mUVJoXkLCiAkvAsWucuPgiWvtYphZZEHIigqVAkiMrAOCLIozIsBDtZA4AdgwQAFGcLUirBGVSBzDyE6QTdsnSUx7WaViTdvlT18+gYMhGbtDLwpFQBIGLAAobohBfLti9hoQE2b0maWmzip4jEvBQ9aiqASpZqafNAYPJCTaVOnvXa69P8HFKGXoQOKMkRaU8FSnX7qoJFA7kCbgi6FJO36lG1bt2/hxpU7l25dRA/yJIhll29fv38BBxYsMYKQBX4GJ1a8mHFjx4QNI348mXJly5dzPhhbECVmz59BhxYthAJDCA5Hp1a9mnVdAiJbx5Y9m3Zt27dx59a9m3dv37+BBxdeOZ+QCIWHJ1e+fGYBLwQlM5c+nboTLjd3Vde+nfurAhIUeHsAu3t588KLn1e/HjgoceTYx5cvm2HN6PPx5/ecXX9//5cVmY6AKv67bcABDaEApuAyCMcb+ISr6ZH7CrzsJgm8aoIM4LKwiULfJBziAPEK00UBOP7xprMKJ5MwAQj/hAnAKxm3eEDFS1gcLcS0FjAqgYLCoaCgBdBYMUfGQtSFD5ICeCOLfGr5zYHDQEFuuB0BSECWNdIR5MQpPjwysBC5iIIkByrAK6HnfkuKgAz4SG5HvSA4AKEurfiSRjGRNEOXe0gCp4J5jAkOqwIIkEW5mjzhYpUsJFGAgATQwOQANvlMrKZc2ohDJZaqkbSgQoGDB9EC4rzyJgAQwiPGmihwoEFnMM1UsJvGE6Kssa7QBYo1GWxjjQxtLdbYchwQC8JjmW22kQi80JI8Z6mtVokThUDV2m25NUIYKcLsVlxjD3LAAQjuGVddZ6ewicB14TV2xAesjNdeMQ8g9t59/3O0salEPQlY4IEJLtjggxFOWOGFGW7Y4Yff/cWBSYdw4NIDUDMC4Ic57tjjj0EOueOIGQHowGmXmJgUi2XMWAhZRI5Z5plprrkT57ghoNIhYMwiDyRgtlnooYkuGuZubgpX452F6HmAn4nohN8jpB6JUeN2QaPeqGudWoquD7nUE30fufqLrOHZwhOcvea6nCmeg1uKKIuouu2XwT5k4r0NkXtuL+TemO27v367Frn9FkLwvPe1uxFfCYBgWSb8RpzuwgnHHBq/51mEMyIWz1zzRhSAQFJF5+B8JYKwqpvxex3v5c0BMqgiAYNYGWAbtzOPHREqED1sjtlrzxL3Nf92931q5R3BTtc11gL6dXuZn+MgCAIYaw7n/4Ge7Ophn94p8KkXnwkwanoGIvLjZb8p99eFfwkKAqhg97fNjz//nOQft/8jtFQBlz3kf90qIAH3578EGkEv6Rsg/kR3QHNI0FoUtMVKPjcTC/4FAQLwoAcR0JoN/mKEzbIg6ga3vgUmpoMCYAADBBBC1pSwFzQ81gkdBJ5xRMSGffGgbHroiCDa6oTYwckEV0iXFn5QhkT4YWyGyIgo8smCCTjQyXiYxLl08IUgNMITh7DEGH5mioco45HOCEEjiLGJAGAjL94Yxg+OsQhg/KIAisBFGLbRMmmUgx8rBMg5sAxjRlD/nh7pKARE8lEJcXSjC/dIhEXeMQl2HIIlL+NHQj4QbxHUIkScBrUhrMAABpjAETApBEw6UpGQTKQq8YjKWFISCalMZWX8GMokCPI/vGwCGLaytQZc4AINkGUtZynHLjISALZMphOfecloSvOYoEkjMEuytSH4sj/cXILlxuAJA2AAAwYAAS3RWcdpwrKa6YRmJad5S8qkEZyg80QMSnnKu3lTCfXc2DCL2YARqBOZBTUoQduJ0COEIJ9FYKgBGqDPVjKRMfS0ROLU1gkYENOYn3EkKzP5SXN0jnVGAgApTYkACzDAA9RM6DsPClN3DuGhEtUAAhAwAYA2YI4CaEAH/zDQgY62cpkVFWkTSJpBI4yznKCZJFEjScajcuN2kkKe65xogFjekqvrbGY815lKEOyUAaU0wAtJwFStznGcAGiqQheTxqrm7n5C2KlonCkafioBIEoxZK08wAALtDCmMp2pTiEqUZcKwQMC4EApyWkABGigCHclwk+DOtTFxnWqTOhr9I6AUsV6Jq+h2asUwTaCBliglNHsKjyH0NjHArUDBuDABkYQQsTydAMWsMAGPgAAyzq0oUR4aANMCVfFnLZuM9jAaEprzc6OL28gMIAIRLDWOZbVACFAwDlpWlwiTKC1vf3tB9paTgSMYAOPNcAFMHABrbY0vMmd6VeFQP9excoTMMyNmgw0+5noSrUx1btudnsqgAOfFbkNeOFOEwzQ+Q4Bs0Itwnvja4D7shOd+t3scqfLi05wILihGbAcKYpiL/bFv31j3AZau1TsalgIIEAAeiObYLUWYbej7fGG8ZtODwdZknNkZlxajLcQPNctIHXEiaH6yqfyJcl/ZNwtYaxVIwyXwhzd8GsLO2UPr9KVR4ZLlTvhgQA7ZcpMcDImyWvfL3tVLlV2QvXAbISaGiHOoyWycj9s2EemOL+mzDOVQ1wKqVmAvm7h7xHazOHLchS8gJY0ixPNvyuHldOwnXNhBb2EOGsZyEjOdCOkFoIQwCWVb+50bBUcWdv/CqDRfw61k9936ix6+tOgtnWgEZnIFhbVCQt+aV3Q7AWVsnqakf41AHYrAPNu4K4fmHZwDx1lM2tQ1yrktaWffelAi3vQhBbjK5dg7FKfudtmfE4DGn3ubfNCntm2K20nDG3xAkC2EE1sr99i5ybg+dVAtmSbnV0OBUPUtXRmN7Kfg1tlwhDd3Kh3wYmQXhqPGwAYli/A3SJwym3a1+G2NStxrXBaN4DJHK9zu10shA9wANwW96q9NWAA2gb4lh7fOMcfze0Cgw3hZS4ysWtOlx9q4LaUJTddhqiyil2Mk5ozZ6jNcXFQ97bBo70lYiFa6aebnCn+lboQNvlXSBu5/8iELnfFyT6XJzKdA04/eE/njcCcMQ0AupTeEEgwUJdDQ+sv1akGoEzN9jp97EHfNVx0FiW/8y4nCVf6LDWw+JN7EOlPCaJNnoNNrf09vwzAOiJAWvh0qjmEieew5hvvcKHDBfRYC2ZGj8aUlMv9mdRuLMbZMsTKXZRuoRNCzhnv+Im6PdKqV6gGLCD4u3d+sS8Euuwff+bDET+cN4P5YzDpUxIA/+15R/VR2/Wt4QOu+GvDFAkkqvxBU//ZzpcpCUjwYZBOkulMtnf5vW183OVlto/9akXk4CLSRs3PyIz+SOiorGhAHEJ1PKd1qAZTRiD/xk4J/s/+XGoELCD5sP9Pxeio/8Kt1YxO75wiAglgAmshqSxwm76PMZyMy2Jv9n6BeGzneHSH9Gps4+Tv+o5NCBEA3k7PEMZqBP5vA32BuXTQeKyqBylPOnYM3IIQET5vVbrHr3xQCEiMCUvO9U5QADQgopJuDtTMvRru25AoLrjns75nBj9DwryO/Lgh2YqAvcBwCOvv5jiNAVrukRzwEDxA3Y6QzNwOC+XwAavjoWBsv8hP3kjQ/PCQCNRsD0HO5WyplEKw7VaMFwxRE6PJ8qxs6KrjiYZsDNeI86JKEFuxnxZx5IzAArBtBE9PDFMpFCEiy1at5pYw5ozqFGdpyH5RDNUO6rpG1eKOD3H/EfOsjbVmjCk4LxA38BdTJxZrCBstw47GzA6fTv4q0RItYPPYzgrBCgniTAkfiwNiaOFs8cnI0AwPEfh2D6uCkTosibyyzM9MzhjtcS6Uh9HuLgVv8RzXSMKAi/GW0Rd+qAhrzQPFjRT/EcSEkc/eq5j4sA9LERmPYANCYAn/r6bWq71sqwrP8BeeCARFkA3HLQgREBYrcqkiSyGr0SAHTht3CWxmDiTt8Kfk67Zyy668bN1QcpbwTxR9zSVxUoiWcjJSScIaIATEDiLBsSmPccs2wBvtjbxE4K3Ga98Gj/AwL/pqMinf8SVzMiZ5LJ88AMY2gL6o0hbDsQioTSuB/8+nfHLNVFEak4n1+tEOldIU8bHgQCAEHAwB9uy+qhLi0JHUMnGzessDEtMcmyIfGwDx/NDXjosfr5IiB7OwEI+1htLSFhMa6GdP9IDq0vIIcs4uDUoDSKDu/rLkVM4INoDiWPLpKkwvO7MtTjND0m4ilcPZei6yhrA0f+EmyGHyepMIuGsNmRGPmI4B7C4zM9LmjAD6wFIIiQA2Ne4m3dAmlvNXRKmTpMPVkEDCBA/rkNMXliIVtED00uYCk0DnsusxYckDbmseaRM7t8wETKABcEoh+yyhPqABSGA3wRMu3lNC5LMwjE89bumhBGClHtImZbEcqupvOJQ+kcA+f//uBvkMuc7KF72xNpdKBVTgrLiLRRsAQPVy7hI0uDZzQeNiQ/3J/dgjzxRsllJpMmFSiAYwLdKmnoYgQm2zlHqxII/AAE6gAz6OP69TLI/gRQO0O3HKAFR01i4UAA6UBKrzGj1vSLOJQzFqdMzj0AJrsH5NzUYzSBuBBQPBAZ5ECGDQSJBUnTaAGvfyK580SpFySovyCAr0PwP0Gc8LAI6rxDBRBp9CTvWgTi+oAk0KLRvD3lQrrUxJAz7AhQyAtYwzQ33hRaCgExJgrq7KQ2XJusSuT6HNtwzz36T06F6xHIhznQqV3xwLot50IR31LUjVOeAAVaXwVyXUDq2LmEr/CYY+gLJssAt54ToGEA5X85hciDJf1QL0qRlXMRG5AT19zbpCNSyF8ymkdVO2ELSM9TyW0CTrizPLNeBIrgzbqKsmwLcgMSOvkC0gUrh6NTDvsTyGrVbD7Vnb09Q87V7Zs5TkkT2tEzD6dTIlcgoTw1JZCO82LFfJdV0R9qC0NdBy7gROIES/8WH/ol8H8hO/ySoVsUDiciMBkuQU6TLFTT+ddGSPs9kI0odM9gjFNGD742XvjGUp1rBg6NJUy4NiTDF11lvrAmXfsVo90z+E1kZf7ttYNchgk01ddWMhtme9dmUFk2rB1lfR9OEKa0/xS6XAlDtPMjCgNhvHNmjL//Zg0fal6PWDBApb3/Zrc9Ns4XRq6TY37VZeWbJCObHWRLRvT7ZsAVdqK5ZoW6NqRfVqfU0XF9dnByNuRUxyf1Y/Es4fi9ZwLzca8XNf7YJzFc1zYTY/cE10OTZaO8FKglNVFXNp+VbbnNJxUbc5zXV2p65lfPdIYNc8feFcn4M54zVzmdQT4S4xVJcpIe8mkpc8FUdHjWX6CNZ2ecGK/uEKHhRamxc/LwMF6a93l5cpvFcXoiB885RPUvZ50/dxNKMwjPR6ve9veRK6mlZlG1Vs4+IA6tdML8diVWNg5ddqsXBIFwAcluJ+cS+Fcnd8QeMKJ7Zy+YeBHZiAD5B1a/9DEs+vFCA1GrTgTsXXbQHtgi81autRgWdihOmghFdHqYx3nxItAB4Ahw0CCunqhIONj+ythR0DfeU24HIYDRSAh1M1dpcn0RbCPgaCWn0YYyk4Noi4c+HiiaEgir1neBuHdQ/IGvm3YznLkxjzEMTYqXbW8zzYhZv4jA0hjT2qHNvCgOe3fOB4DuR4Pux4dPllLuVgj+Wjj5n4j8E4iQQ5Pgi5htsGkJ0gkdljkc/2jTkSjZ8Jgc1PkdsYg73GkZsgfhMYPyRZkpPDk5ngivlYciUQ7VTzjttH11Y5NYX3hE85anuJaCGnaazXlROkEzJEHmZZlE8tl/tul7n3kW3/2T+Yq4GEIXz9mCbEM4btQz+CiJmrwJm9eO3WuFiYSxxexQAjWHy0JAIO4zko4Ioo5h9eIUmMxwyEmRu8uQog+H0biYqZxZfSjwAqYBQghYPDmQmu4zsGYCk6pPaGYEMVZ1SoGf3cZZ8ToJ/nGXsJx5fktKA3xYSf+UiF4nKOYPR0JQsmJ5Ih8EDoFDv0eYZjkJf1By7OOXKwwgGINXnEZyrEwRu8oqTJpp/f+RdaGkYEKKZp+YvnQqelOKMVxyIsQWwaJUt6xlQjJwAKolgHWdeIuouDOnzmFgn8QatNmlQNQptEOo+7twJQk0VGeZO7w5QRgQLaoGfQCK0Dt5EP/3kJxrmcSQOd42AKFgFLCuSszbiSkyCgVYKgseMTVAINyEaZ4RpyO3mulYAMwIBxXqQVaOets7qxxVpjkPonanpB0KAFuSRH/Lp3HDuwN/sfBKYKECIDrqKuFvqyKTlml2CrjyBZagICwLqbFvuq8RiwbRi2DTmzY1tw5Vq4gxtoi9u3k7uMQSNfksC59aq0fxu5LUMXEvt7r7uPpNszoNsIulu6EoOeJ8O6kYC8R8MJJZq7B/oIzNu0dvtI10ZYjaZoCgJ7CKa+5zu/BUaC2UJw5Fu/hwa/B0bAAXy++VswgsZhvOFhFlzB/5tgYKRHAmbBI1xhGrxhLhzDH9zCN/+cZM5swzmcYzI8xBOmwm9GWE0cYUacxB28xVMbuAH4c1vXu9fbddo7xmd8aN0tMA6oxxeIfW5cam48rt2Yk3F8MhBkx4FRxr07sQMARrI7m3l7yqU8LpJ8yZncyIlgyH25xoucyL+cylPjyuWAzK3DwzVkAaJcY9B8ttvczQ/BzD3jgOQczvmKbAbkuwH6zQObz/vcEOpcdIol0AW90A390BE90RV9X14jeAsJCc55G6zItY/0ilg5mI2AZWi3lSGdrB/dCVgwnZlgYq6o6nCj0S/904sAmB+9dk3B0mVZ1YtA0x3d1Fnd1Bnoiih91tEZ11eDfnBCeYdAJWqCHBD/oibS5Qm0UNjRDkYiXJd9RgmSJnWo1zpM+jeAHTGY3Qo8BNqfRtqX3Zhn3dlXp5ijPQmm/Y+qXUOuHTc6xA+wmQhqx1fWOQ9gBGVi+EDO5vaMgKSQJ96LYClux50HjnYGZNeJgNR9BeFp491tr0y9u533HeLPgQoQBODtdHX+HW1yW50HntprR9RTJs9rguFXo0wIEJwBCAyiAIKLwD5WwZ8NaXUgxeWLgAAUWt3DIwB8vQhWOzhQXuY1RqFtnoRRRZ65j2pongqK/khz/s4Mwjl6Xt4rWzeCvunbxX6THglyuFW0ZOuLYOAFOlHAnr1Beg4OoEfWIKSTYOBNnjau/77st/zsm/4MmsQZvl7lw94+VILs9d7sy90J0t4o2B4J3H43gh6jkeDe6/4lqEDxV11G1mBSS4oJdHp4jogJfh7opQHyjQBSPP8IQB+lTWoI6KevKJ+GkeDyyzzzl2Dzc0MenqYFgXrVceEqKCAV7D0ktBp7WgWmedC18wENFqH2NQZ7ovrtz+AN1mB/rkP5ZUP2IYD2g//4obrkjf/mfd8ZgD8KhT/yir/6TQH5S14OHoD5Odq0pfo2LLoKipoI4LPYheDYqx6AYORpuJgLKx5bngcIBooDoGg0JiADYeTofAICkoFkAb0CCgMrtuv9gsPisXY5IAAOCiHxmVwqmv/p9RD7HkAoRTUbCw8Y8dVd3cWNSVFxhWkpjjk+QkZKAjgQECQcJVxOcnZ6foKGio6SlpqeoqaqrrK2ur7CxsrO0tba3uLm6u7y9vr+AgcLDxOvBrQBHxcvMzc7Cxc0fkXDDhQ8Y3suXA9TFCBnhxdVJhwEOCQEyBHoaZYHYGo6AMhT4BHMpwfo0VccY4ayRkFZkYEVALIrkpACGgrzIgQIgEacMHNkBsgiMAAQRXEap+ABicZaFCpLJDgIcKYkgTJnDuBZE4GABAUFJHAEZXIJIJgQFEjQQxIASS1KCDywpqTjrWMBvlF48GCexXQRtgFKh0YrgTUSASCNNs/BtgL/OUNpXIC1YAax9L5q1RqBSIQHBTJMZOpKYwYAShJE2Ej0mkoiSQmoRJN4cBEFCggEfqASbwKAOiE4sHfNMb0BfYcWHTDTAZtNemktgTBFgZK+WsAuuTnggEZAtQ9M+RZ5wYAHAIAGWKCAlEZrUw4kkABBCgTYtjd+tAZTsuTTewW/rs14cWLuK0FLKCB+gQOX4DyBvpaeMePXe0Biti6L5OLQzgEElihYu/ukEdcAIIEEGcBDnGD5VSAaALwxtB90WxSR4HLnyYcKfxhpR99K3XnW0nfNOaDaVhGQmMZQOnFDkmqVQEjFXPYVAU8CWuRVYSsajnRNdg7q9xwg7mkR/1FEAES1hgSWgaJdbd5ZwqN2MZYhjY2lXHgfjiwll9pKZbCzxhIPJHgSPygWQRIF8M3DGx4wBmhGX1O6cqV9Sm5kD05BZiEaBQk+AJlrtGkxZpI82tMnUERS8dSDHFWwAAHTwYkKOUSiMWlC8tCDDyX4YApWXgzxo0mNSfKTkEKCUqDHQjVagmSkqsipI4Y8LihEBgdOUUEUXvqWVB+j0NnTGnkUwZsCt/ZYRAS8zvOqs89CG62001JbrbXXYputttsWZIm3FBxQgKDckluuuaW4FBtirp7brrvvisHQrXgxVKA5EYjVVql2kQevv/9yqxJHi2nhGBUF49cbb74B3GGww9IKHOOWs/6IkX8BAPiwxhvbGDFLed73WpBCclyyyRR5TDDFIPPp58kvw7xMyhOHjNGuX8acs84789yzzz8DHbTQQxNdtNFHI5200ksz3bTTT0MdtdRTU1211Vdj7XQQADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Types of specific asthmatic reactions after specific inhalation challenge testing: immediate, early late, isolated late, and dual (immediate and late). Mean and standard deviation of percent change in FEV1 (ordinate) are shown as a function of time (abscissa) from the challenge test.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Perrin et al, J Allergy Clin Immunol 1991;87:630.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_47_9983=[""].join("\n");
var outline_f9_47_9983=null;
